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Long INterspersed Elements (LINE or L1) have had an enormous influence on human 
genomic structure, comprising about 20% of the mass of the human genome.  In this analysis, 
the most recent L1 insertions in the human genome belonging to L1Hs Ta and preTa 
subfamilies were examined to further understand the impact L1 elements have had on human 
genomic structure and diversity.  Collectively, over 800 human specific L1 elements from the 
draft sequence of the human genome were characterized.  Estimates suggest that human 
specific L1 mobilization alone is responsible for increasing the size of the human genome by 
roughly 1.4 million bases, and that over 70 human specific L1 elements may still possess the 
ability to retrotranspose within human cells.  Interestingly, over 35 L1 insertions were found 
adjacent to exons, though the majority of insertions showed general preference for gene poor 
regions of the genomes with low GC content.  Analysis of over 500 L1 insertions by PCR on 
a diverse panel of humans representing geographically distinct human populations revealed 
that 115 (45%) of the Ta and 33 (14%) of the preTa human specific L1 insertions were 
variable in the human population with respect to insertion presence or absence.  Sequence 
analysis of L1Hs Ta and preTa subfamily members yielded estimated average ages of 1.99 
and 2.34 million years respectively.  The 148 newly identified L1 insertion polymorphisms 


















































Mobile elements were first identified as the cause of commonly observed chromosome 
break points at the Dissociation locus in the maize genome (McClintock 1956; McClintock 
1987) and are most simply defined as linear DNA segments that can or could at one time 
move within a genome.  Although some mobile elements are similar to viruses (Xiong and 
Eickbush 1988), they do not normally move from cell to cell.  Mobile elements have had 
interesting and diverse histories within genomes.  Although the origin and relationship 
between mobile elements and the genome in which they reside is a matter of debate, most 
often the function of mobile elements is unknown and probably not conserved from one 
species nuclear genome to another (Brosius 1991; Makalowski 2000).  However, in rare cases 
they appear to serve a function, such as the Het-A and Tart elements which have been co-
opted to maintain the integrity of telomeres in the Drosophila genome (Levis et al. 1993; 
Sheen and Levis 1994).  Despite their lack of conserved function, mobile elements are present 
in almost every genome studied to date and are firmly established residents in the tree of life.   
All genomes are organized differently with respect to their mobile element content.  
The pufferfish (Fugu rubripes) genome contains very few (<3%) mobile element derived 
repeats (Aparicio et al. 2002), whereas the fruit fly (Drosophila melanogaster) and the worm 
(Caenorhabditis elegans) genomes contain ~3% and ~10% mobile element derived repeats, 
respectively (The C.elegans Genome Consortium 1998; Myers et al. 2000; International 
Human Genome Sequencing Consortium 2001).  By contrast, mammalian genomes are much 
more repeat rich, with over 37% of the mouse (Mus musculus) genome and 45% of the human 
genome composed of mobile elements (International Human Genome Sequencing Consortium 
2001; Mouse Genome Sequencing Consortium 2002).  
In addition to the differences in mobile element content, each genome has different 
types of mobile elements that can be can be broadly grouped into two major classes, DNA 
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mobile elements and retrotransposable elements, based on their mechanism of mobilization.  
In general, DNA transposons move in nonreplicative manner by a “cut and paste” mechanism 
in which the element is excised from one location and is inserted into another location, with 
the assistance of transposase protein encoded by the element (Mizuuchi 1992; van Luenen et 
al. 1994).  Retrotransposons move by a “copy and paste” mechanism in which an RNA 
intermediate is generated (Weiner et al. 1986).  This intermediate is then reverse transcribed 
by a reverse transcriptase into a cDNA that integrates into a new genomic location (Luan et al. 
1993).  The major type of mobile elements found in mammalian genomes is the 
retrotransposons (Deininger 1993b).  
The most abundant type of mobile element in the human genome is a Short 
INterspersed Element (SINE) known as Alu (International Human Genome Sequencing 
Consortium 2001).  Full length Alu elements are 300 bp in length, are dimeric in structure 
with a right and a left half, and are derived from the 7SL gene, a part of the signal recognition 
molecule (Rubin et al. 1980; Ullu and Tschudi 1984).  Alu elements are RNA polymerase III 
transcribed retrotransposons and contain genomic encoded A rich tails (Rogers 1983).  Alu 
elements are non-autonomous mobile elements, meaning they do not encode any proteins and 
are not capable of directing their own mobilization.  Most Alu amplification occurred roughly 
40-60 million years ago, with Alu elements growing in copy number to over a million in the 
haploid human genome and now representing ~10% of its total mass (Deininger and Daniels 
1986; International Human Genome Sequencing Consortium 2001; Batzer and Deininger 
2002).  
Long INterspersed Elements (LINEs) are the other dominant mobile element family in 
the human genome (Singer 1982; Singer et al. 1993).  LINEs are autonomous 
retrotransposons, meaning they encode all of the proteins required for their own mobilization.  
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Furthermore, it is believed that in order to move, Alu elements must scavenge the necessary 
proteins from LINE elements, therefore defining LINEs as the drivers of mobile element 
evolution in mammalian genomes (Jurka 1997; Kajikawa and Okada 2002).  Full-length LINE 
elements are roughly 6000 base pairs (bp) in length and contain 5´ and 3´ untranslated regions 
(UTR) with an internal RNA polymerase II promoter (Prak and Kazazian 2000).  They also 
contain two open reading frames (ORFs), both of which are required for retrotransposition, 
that are separated by a highly conserved 66 bp intergenic spacer (Fanning and Singer 1987; 
Singer et al. 1993; Moran et al. 1996). The first ORF encodes an RNA/DNA binding protein 
of unknown function (Martin and Bushman 2001).  The second ORF encodes a reverse 
transcriptase with endonuclease activity (Sakaki et al. 1986; Mathias et al. 1991; Luan et al. 
1993; Feng et al. 1996).  In addition, LINEs usually have variable A rich tails at their 3´ ends.  
The youngest LINE class, LINE-1 or L1 elements, are believed to have arisen around the time 
of the mammalian radiation ~120 million years ago (Pascale et al. 1990; Smit 1996).  They 
exist at a copy number of over 500,000 in the haploid human genome and account for 21% of 
its total mass (International Human Genome Sequencing Consortium 2001).   
L1 elements mobilize using a process termed target primed reverse transcription 
(TPRT) (Luan et al. 1993). The process is initiated by an endonuclease generated nick at a 
target site that frees a short oligonucleotide sequence with a 3´ hydroxyl.  This short 
oligonucleotide sequence with a 3´ hydroxyl serves to prime reverse transcription at the target 
site, with the L1 RNA serving as the template.  The initial cleavage and reverse transcription 
event is followed by a second strand break of the DNA at the target site downstream of the 
initial endonuclease cleavage event.  The process is completed by a second-strand DNA 
synthesis, ligation, and filling in of genomic sequence flanking the L1.  This mechanism of 
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integration generates target site duplication sequences that can be used as useful landmarks 
defining the boundaries of newly integrated elements (Fanning and Singer 1987). 
L1 elements have had a dramatic influence on the architecture of the human genome 
through a variety of mechanisms.  First, L1 elements have greatly expanded the size of the 
human genome both, by their own retrotransposition and by providing the machinery 
necessary for the retrotransposition of other mobile elements, such as Alu elements (Jurka 
1997; Kajikawa and Okada 2002).  Second, L1 elements can disrupt normal gene function and 
have resulted in various human disease phenotypes, including Factor VIII hemophilia and 
Duchenne muscular dystrophy, by inserting within splice junctions, regulatory regions, or 
introns (Kazazian et al. 1988; Narita et al. 1993).  Third, L1 elements can copy and carry non-
L1 derived sequences throughout the genome in a unique L1-mediated duplication event 
known as three prime transduction (Moran et al. 1999; Goodier et al. 2000).  Fourth, like 
other mobile elements, L1 elements can facilitate evolutionary rearrangements by providing 
sequence homology blanketing the genome which can be exploited during recombination 
(Nicholls et al. 1987; Schwartz et al. 1998; Hughes and Coffin 2001).  More recently, L1 
elements have also been shown to have paradoxical roles in genomic stability, by serving both 
as molecular band-aids in the repair of double stranded DNA breaks and as suspects for the 
generation of genomic deletions (Gilbert et al. 2002; Kazazian and Goodier 2002; Morrish et 
al. 2002).   
Like other mobile elements, L1 and Alu elements also generate genetic differences 
both within and between primate species that can be analyzed using a simple polymerase 
chain reaction (PCR) assay, making them useful as genetic markers (Furano and Usdin 1995; 
Shimamura et al. 1997; Shedlock and Okada 2000).  In addition, L1 and Alu elements are 
stable insertions that are rarely removed, the ancestral state is known to be the absence of the 
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element, they have only two alleles with regards to the presence or absence of the element, 
and they are variable in the human (Batzer and Deininger 1991; Perna et al. 1992; Batzer et al. 
1994; Arcot et al. 1996), all of which makes mobile element insertion polymorphisms useful 
as unique genetic markers (Jorde et al. 2000; Roy-Engel et al. 2001; Watkins et al. 2001; 
Batzer and Deininger 2002).  Unlike other genetic systems, most mobile element insertions 
are identical by descent, meaning that if two individuals share a mobile element insertion, 
those individuals most likely inherited the insertion from a common ancestor (Batzer et al. 
1994; Hillis 1999).  The essentially homoplasy-free nature of mobile element insertions 
makes them a rich source of population specific genetic variation (Roy-Engel et al. 2001; 
Batzer and Deininger 2002). 
Despite the abundance of L1 elements in the human genome, only a limited number of 
L1 elements have been capable of mobilization throughout primate evolution under the 
“master gene” or limited amplification model (Deininger et al. 1992).  In this model, L1 
elements amplified from a series of “source genes” that gradually accumulated new mutations 
or “diagnostic” base substitutions.  This gave rise to a series of L1 sequences with common 
nucleotide differences that comprise subfamilies or clades.  In addition, the time frame over 
which a source gene was active has generated subfamilies with different genetic ages, based 
upon random, or non-diagnostic mutations that occur post integration (Deininger et al. 1992; 
Batzer et al. 1993; Deininger 1993a; Smit et al. 1995).  In the human genome, the most 
recently integrated human L1 elements were identified as a result of their sequence identity to 
known retrotransposition competent elements and disease-causing de novo insertions, 
(Kazazian et al. 1988; Woods-Samuels et al. 1989; Miki et al. 1992; Schwahn et al. 1998; 
Meischl et al. 2000) and belong to the L1 Human specific Ta (transcribed subset a) and L1 
preTa subfamilies (Skowronski et al. 1988; Boissinot et al. 2000) 
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Here, we determine the impact that L1 retrotransposition has had on human genomic 
structure and the amount of human genetic diversity associated with L1Hs Ta and preTa 
elements.  Using the established sequence structure of L1 elements, specific oligonucleotide 
sequences containing diagnostic mutations unique to the Ta and preTa subfamilies were 
designed (Boissinot et al. 2000; Myers et al. 2002; Salem et al. 2003).  These oligonucleotides 
were used to search the draft human genomic sequence to identify all of the Ta and preTa L1 
elements in the available sequence of the human genome.  Newly identified Ta and preTa 
elements were analyzed for sequence content and associated genetic variation, using L1 
element specific PCR assays on diverse human and non-human primate DNA samples (Sheen 
et al. 2000; Myers et al. 2002; Salem et al. 2003).   Using this approach, 830 recently 
integrated L1 elements from the human genome have been characterized.  The newly 
identified L1 elements will provide useful genomic landmarks for primate comparative 
genomics and human population genetics.  
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Introduction 
 Computational analysis of the draft sequence of the human genome indicates that 
repetitive sequences comprise 45-50% of the human genome mass, 17% of which consists of  
~500,000  L1 LINEs (Long INterspersed Elements) (Smit 1999; Prak and Kazazian 2000; 
Lander et al. 2001).  L1 elements are restricted to mammals, having expanded as a repeated 
DNA sequence family over the past 100-150 million years (Smit et al. 1995).  Full-length L1 
elements are ~6kb long and amplify via an RNA intermediate in a process known as 
retrotransposition.  L1 integration likely occurs by a mechanism termed target primed reverse 
transcription (TPRT) (Luan et al. 1993; Kazazian and Moran 1998).  This mechanism of 
mobilization provides two useful landmarks for the identification of L1Hs (L1 human specific) 
inserts: an endonuclease related cleavage site (Jurka 1997; Cost and Boeke 1998; Cost et al. 
2001) and direct repeats or target site duplications flanking newly integrated elements (Fanning 
and Singer 1987; Kazazian 2000).   
 L1 retrotransposons have had a significant impact on the human genome, through 
recombination (Fitch et al. 1991), alteration of gene expression (Yang et al. 1998; Rothbarth et 
al. 2001), and de novo insertions that disrupt open reading frames (ORFs) and splice sites 
resulting in human disease (Kazazian et al. 1988; Kazazian 1998; Kazazian and Moran 1998).  
L1 elements are also able to transduce adjacent genomic sequences at their 3′ end, facilitating 
exon shuffling (Boeke and Pickeral 1999; Moran et al. 1999; Goodier et al. 2000).  In addition, 
individual mobile elements may undergo post-integration gene conversion events in which short 
DNA sequences are exchanged by an undefined mechanism, thereby altering the levels of single 
nucleotide polymorphism (SNP) associated with the individual L1 elements (Hardies et al. 
1986).  Thus, LINEs have exerted a significant influence on the architecture of the human 
genome. 
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 Even though there are ~500,000 L1 elements in the human genome, only a limited subset 
of L1 elements appear to be capable of retrotransposition (Moran et al. 1996; Sassaman et al. 
1997).  As a result of the limited amplification potential of this diverse gene family, a series of 
discrete subfamilies of L1 elements exists within the human genome (Deininger et al. 1992; Smit 
et al. 1995).  Each of the L1 subfamilies appears to have amplified at different times in primate 
evolution, making them different ages (Deininger et al. 1992; Smit et al. 1995).  The most 
recently integrated L1 elements within the human genome share a common 3-bp diagnostic 
sequence within the 3′ untranslated region (UTR), and they comprise almost all of the de novo 
disease-associated L1 elements within the human genome, as well as several elements that have 
been shown to be capable of retrotransposition in cell culture (Kazazian and Moran 1998; 
Boissinot et al. 2000; Sheen et al. 2000).  This subfamily was first identified in human 
teratocarcinoma cells and has been collectively termed “Ta” (for transcribed, subset a) 
(Skowronski et al. 1988).  Some members of the L1 Ta subfamily have inserted in the human 
genome so recently that they are polymorphic with respect to insertion presence/absence 
(Boissinot et al. 2000; Sheen et al. 2000).  The L1 insertion polymorphisms are a useful source of 
identical-by-descent variation for the study of human population genetics (Boissinot et al. 2000; 
Santos et al. 2000; Sheen et al. 2000).  Here, we report the analysis of the Ta subfamily of L1 
elements from the draft sequence of the human genome.  
Materials and Methods 
 
Cell Lines and DNA Samples 
 
The cell lines used to isolate primate DNA samples were as follows: human (Homo 
sapiens) HeLa (American Type Culture Collection [ATCC] number CCL2), common 
chimpanzee (Pan troglodytes) Wes (ATCC number CRL1609), pygmy chimpanzee (Pan 
paniscus) (Coriell Cell Repository number AG05253), gorilla (Gorilla gorilla) Lowland Gorilla 
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(Coriell Cell Repository number AG05251B), green monkey (Cercopithecus aethiops) (ATCC 
number CCL70), and owl monkey (Aotus trivirgatus) (ATCC number CRL 1556).  Cell lines 
were maintained as directed by the source, and DNA isolations were performed using Wizard 
genomic DNA purification (Promega).  Human DNA samples from the European, African 
American, Asian or Alaskan native, and Egyptian population groups were isolated from 
peripheral blood lymphocytes (Ausabel et al. 1987), as described elsewhere (Stoneking et al. 
1997).     
Computational Analyses 
The draft sequence of the human genome was screened using the Basic Local Alignment 
Search Tool (BLAST) (Altschul et al. 1990), available at the National Center for Biotechnology 
Information genomic BLAST Web site.  A 19-bp oligonucleotide (5´-
CCTAATGCTAGATGACACA-3′) that is diagnostic for the L1Hs Ta subfamily was used to 
query the human genome database with the following the optional parameters: filter none and 
advanced options -e 0.01, -v  600, -b 600.  Copy number estimates were determined from 
BLAST search results.  Sequences containing exact matches were subjected to additional 
analysis as outlined below.  
A sequence region of 9,000-10,000 bp, including the match and 1,000-2,000 bp of 
flanking unique sequence, was annotated using RepeatMasker (version 7/16/00), from the 
University of Washington Genome Center, or Censor, from the Genetic Information Research 
Institute (Jurka et al. 1996).  These programs annotate repeat sequence content and were used to 
confirm the presence of L1Hs elements and regions of unique sequence flanking the elements.  
Polymerase-chain-reaction (PCR) primers flanking each L1 element were designed using 
Primer3 software, available at the Whitehead Institute for Biomedical Research, and were 
complementary to the unique sequence regions flanking each L1 element.  The resultant primers 
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were screened, by standard nucleotide-nucleotide BLAST (blastn) against the non-redundant (nr) 
and high-throughput (htgs) sequence databases, to ensure they resided in unique DNA sequences.  
Primers that resided in repetitive sequence regions were discarded, and, if possible, new primers 
were then designed.  A complete list of all the L1 elements that were identified using this 
approach and supplemental material from this manuscript are available from the Batzer Lab Web 
site, in the “Publications” section.  This supplementary data are also found as an appendix to this 
work.  Individual L1 DNA sequences were aligned using MegAlign, with the Clustal V 
algorithm and the default settings (DNAstar, version 5.0 for Windows), followed by manual 
refinement.  
PCR Amplification 
PCR amplification of 262 individual L1 elements was performed in 25-µl reactions that 
contained 50-100 ng of template DNA; 40 рmol of each oligonucleotide primer (see Table 2.1; 
APPENDIX B Supplementary Data Table 1); 200 µM of deoxyribonucleoside triphosphates, in 
50 mM KCl and 10 mM Tris-HCl (pH 8.4); 1.5 mM MgCl2; and 1.25 U of Taq DNA 
polymerase.  Each sample was subjected to the following amplification conditions for 32 cycles: 
an initial denaturation at 94 °C for 150 s, 1 min denaturation at 94 °C, and 1 min at the annealing 
temperature (specific for each locus, as shown in Table 2.1 and APPENDIX B supplementary 
Data Table 1), followed by extension at 72 °C for 10 min.  For analysis, 20 µl of each sample 
was fractionated on a 2% agarose gel with 0.05 µg/ml ethidium bromide.  PCR products were 
directly visualized using UV fluorescence.  The human genomic diversity associated with each 
Ta L1 element was determined by the amplification of 20 individuals from each of four 
geographically distinct populations (African-American, Asian or Alaskan Native, European 
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Table 2.1 - Summary of Ta L1 Computational and PCR Analysis1 
 
Classification Number of Elements  
Successful PCR analysis 262 
L1 elements inserted in other repeats 137 
L1 elements located at the end of sequencing contigs 69 
Total Ta L1 elements analyzed 468 
 
1 A full summary of GenBank accession numbers, PCR primers 
and conditions, and PCR amplicon sizes for these loci are shown 
in the APPENDIX B Supplementary Data Table 1.  
 
Cloning and Sequence Analysis  
L1 element-related PCR products were cloned using the Invitrogen TOPO TA Cloning® 
Kit, according to the manufacturer’s instructions, and were sequenced using an Applied 
Biosystems 3100 automated DNA sequencer, by the chain-termination method (Sanger et al. 
1977).  The DNA sequence for the common and pygmy chimpanzee orthologs of L1HS72 were 
assigned GenBank accession numbers AF489459 and AF489460, respectively.  Additional 
diverse human sequences from L1HS72 were assigned GenBank accession numbers AF489450-
AF489458.  DNA sequences derived from L1 pre-integration sites were assigned accession 
numbers AF461364, AF461365, AF461368-AF461383, AF461386, and AF461387. 
Results 
L1 Ta Subfamily Copy Number and Age 
To identify recently integrated Ta L1 elements in the human genome, we searched the 
draft sequence of the human genome (BLASTN database, version 2.2.1), using BLAST (Altschul 
et al. 1990) with an oligonucleotide that is complementary to a highly conserved sequence in the 
3′ UTR of Ta L1 elements.  This 19-bp query sequence (CCTAATGCTAGATGACACA) 
includes the Ta subfamily-specific diagnostic mutation ACA at its 3′ end at positions 5930-5932 
relative to L1 retrotransposable element-1 (Dombroski et al. 1991).  We identified 468 unique Ta 
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L1 elements from 2.868 x109 bp of available human draft sequence.  Extrapolating this number 
to the actual size of the human genome (3.162 x109 bp) and assuming the available sequence data 
is representative of the entire human genome, we estimate that this subfamily contains ~520 
elements.  Of the 468 elements retrieved, 69 resided at the end of sequence contigs and were not 
amenable to additional in vitro wet-bench analysis.  Of the 399 remaining elements, 124 (31%) 
of the elements were essentially full length, and the remaining 275 were truncated to variable 
lengths.  Alignment and sequence analysis of the full-length elements revealed that 44 contained 
two intact ORFs and therefore may be capable of retrotransposition.  This estimate of putative 
retrotransposition-competent L1 elements is in good agreement with the initial analysis of the 
draft sequence of the human genome (Lander et al. 2001).   
The ages of L1 elements can be determined by the level of sequence divergence from the 
subfamily consensus sequence by use of a neutral mutation rate for primate noncoding sequence 
of 0.15% per million years (Miyamoto et al. 1987).  The mutation rate is known to be ~10 times 
greater for CpG bases as compared to non-CpG bases, as result of the spontaneous deamination 
of 5-methyl cytosine (Bird 1980).  Thus, two age estimates that are based on CpG and non-CpG 
mutations can be calculated for the Ta subfamily of L1 elements.  A total of 89,929 bp from the 
3′ UTR of 459 Ta L1Hs elements were analyzed, and L1 elements characterized elsewhere were 
excluded from this analysis, as were nine elements that technically do not belong to the Ta 
subfamily according to the nucleotide present at position 6015 in the 3′ UTR of the elements 
(Ovchinnikov et al. 2001).  Three hundred thirty-one total nucleotide substitutions were 
observed.  Of these, 263 were classified as non-CpG mutations against the backdrop of 88,141 
total non-CpG bases, thereby producing a non-CpG mutation density of 0.002984.  Based on the 
non-CpG mutation density and a neutral rate of evolution (0.002984/0.0015), the average age of 
the Ta L1 elements was 1.99 million years.  A total of 68 CpG mutations were found across these 
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459 L1 elements from 1,788 total CpG nucleotides, thereby yielding a CpG-mutation rate of 
0.038031.  With the expectation that the CpG mutation rate is ~10-fold higher than the non-CpG 
mutation rate, the approximate age (obtained using the CpG mutation density) of the L1Hs Ta 
subfamily is 2.54 million years.  These estimates are in good agreement with one another, as well 
as with previous estimates derived from an analysis of a small number of Ta L1 elements 
(Boissinot et al. 2000).  
 Nine of the 468 elements analyzed do not technically belong to the Ta subfamily of L1 
elements, on the basis of a single-nucleotide substitution (L1HS19, -72, -274, -309, -318,  
-325, -390, -399, and -493) that is also considered diagnostic for the L1 Ta subfamily.  Although 
they all have the 19-bp query sequence ending in ACA in the 3′ UTR at positions 5930-5932, 
they lack a G at position 6015 (Ovchinnikov et al. 2001) and instead contain an A at that 
position, which is a diagnostic feature found in older primate-specific L1PA10-L1PA2 
subfamilies (Smit et al. 1995).  Thus, these elements may be Ta L1 elements that have undergone 
fortuitous single-base substitutions of the ancestral nucleotide, may be Ta L1 elements that have 
undergone backward gene conversion events, or may simply be older, “pre- Ta” L1 elements that 
were generated by a source gene (or source genes) that did not contain this diagnostic base.   To 
determine the effect that the Ta versus non-Ta designation has on the calculated age estimate, we 
examined a total of 1,807 bp from the 3′ UTRs of these nine elements.  There were 27 non-CpG 
mutations from a total of 1,771 non-CpG bases, thereby yielding a mutation density of 27/1,771, 
or 0.015246.  Dividing by the neutral rate of evolution for primate noncoding sequence 
(0.015246/0.0015), we arrive at an estimated age of 10.16 million years.  This is significantly 
older than the average age of 2.26 million years that was calculated from the larger data set (i.e., 
the data set of Ta L1 elements only including CpG and non-CpG mutations).  The CpG mutation 
density in the elements was also calculated.  There were 2 CpG mutations from 36 CpG bases, 
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thereby producing a CpG mutation density of 2/36, or 0.056.  This figure was divided by the 
projected CpG mutation rate (0.056/.015), arriving at an estimated age of 3.73 million years.  
This figure is lower than the non-CpG mutation rate, but it still suggests that these elements are 
at least twice as old as their true Ta counterparts.  In addition, all but one of these Ta L1 elements 
(L1HS493) was monomorphic for the presence of the L1 element in the human population.  
Thus, the higher levels of nucleotide diversity and absence of associated insertion polymorphism 
of eight of these L1 elements are consistent with their being older members of the L1 Ta 
subfamily, whereas L1HS493 may be the product of a gene conversion event. 
 The nucleotide-sequence substitution patterns were further examined with respect to the 
levels of presence/absence insertion polymorphism associated with each of the L1 elements (as 
outlined in detail below, in the “L1 Element-Associated Human Genomic Diversity” subsection).  
The 3′ UTRs of 139 fixed-present elements were analyzed for both CpG and non-CpG mutations 
and had an estimated average age of 2.45 million years.  This calculation yields an age that is 
somewhat older than the average age predicted for the subfamily as a whole, a finding that was 
expected, since these elements are thought to have inserted during the early stages of L1Hs Ta 
expansion in the human genome, such that they have become fixed across diverse human 
populations.  Similar calculations were repeated for the high-frequency, intermediate-frequency, 
and low-frequency L1 Ta insertion polymorphisms, with average ages of 2.24, 2.06, and 1.69 
million years, respectively.  Although the age differences across different insertion frequencies 
are not significantly different (P values >0.05) when tested with a one-tailed t test, they do 
suggest a progressive decrease in the calculated age of each group, with corresponding decreases 
in insertion frequency.  This is exactly what would be expected under a model in which newer 
elements arose more recently and have lower allele frequencies in the human population. 
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L1 Associated Human Genomic Diversity  
Of the 468 L1HS Ta elements isolated in silico, 262 were further analyzed using a PCR-
based assay and flanking unique sequence primers as described elsewhere (Sheen et al. 2000) 
(Table 2.1 and APPENDIX B Supplementary Data Table 1).  The remaining elements were not 
suitable for further analysis, for various reasons.  Some (137) of the L1 elements were inserted 
into other repetitive regions of the genome such that flanking unique sequence PCR primers 
could not be designed.  Sixty-nine additional elements resided at the end of sequencing contigs in 
GenBank, so the lack of flanking unique sequence information made PCR-primer design in this 
region impossible.  Three elements, L1HS17, L1HS47 and L1HS63, produced inconclusive PCR 
results because of the amplification of paralogous genomic sequences as described elsewhere 
(Batzer et al. 1991).  Another five elements produced non-specific PCR results, and they were 
excluded from further analysis.  Thirty-six of the Ta L1 elements mapped to chromosome X, and 
10 mapped to chromosome Y (Table 2.1 and APPENDIX B Supplementary Data Table 1).  All 
of the Ta L1 elements from chromosomes X and Y were tested using human DNA samples in 
which the gender had been determined using a PCR-based assay that was described elsewhere 
(Eng et al. 1994).  The human genomic diversity associated with the autosomal and sex-linked 
Ta L1 elements is summarized in Table 2.2 and APPENDIX B Supplementary Data Table 1 and 
2.  
A high degree (45%) of insertion polymorphism was found in the 254 (i.e., 262 - 8) 
remaining elements that were subjected to the two-step PCR-based assay across 80 individuals 
from four geographically diverse human populations (Table 2.2 and APPENDIX B 
Supplementary Data Table 2).  One hundred thirty-nine of the Ta L1 elements were fixed 
present, meaning that every individual tested was homozygous (i.e., +/+) for the presence of the 
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L1 repeat.  These elements are likely to be slightly older than their polymorphic counterparts, 
having inserted into the human genome prior to the migration of humans from Africa.   
Table 2.2 - Summary of Ta L1 Element-Associated Human Genomic Diversity1,2 
Autosomal Ta L1 elements Number of Elements 
High frequency insertion polymorphism 36 
Intermediate frequency insertion 
polymorphism 55 
Low frequency insertion polymorphism 15 
Very low frequency / fixed absent 3 
Fixed present 129 
X-Linked Ta L1 elements  
High frequency insertion polymorphism 1 
Intermediate frequency insertion 
polymorphism 1 
Low frequency insertion polymorphism 4 
Very low frequency / fixed absent 0 
Fixed present 8 
Y-Linked Ta L1 elements  
Polymorphic 0 
Fixed present 2 
 
 
1 The Ta L1 insertion polymorphisms are classified according to allele frequency 
as: high-frequency (HF) (present in more than 2/3 but not in all chromosomes 
tested), intermediate-frequency (IF) (present in more than 1/3 of chromosomes 
tested but in no more than 2/3 of the chromosomes), low-frequency (LF) 
(present in no more than 1/3 of the chromosomes tested), or very-low-frequency 
(VLF) (or “private”) insertion polymorphisms. 
2 A full summary of the genotypes for each locus, L1 allele-frequency data, and 
heterozygosity values are shown in the supplementary data and are also 
available from the Batzer laboratory web site.   
 
By contrast, 115 of the elements assayed by PCR were polymorphic, to some degree, in 
the populations that were surveyed.  A survey of human genomic diversity associated with a 
severely truncated L1 element is shown in figure 2.1.  A sample of the human genomic diversity 
associated with relatively long L1 insertion polymorphism is shown in figure 2.2.  Thirty-seven 
of the Ta L1 elements were high-frequency insertion polymorphisms with an L1 allele frequency 
that was >0.67, so that most of the individuals were homozygous for the presence of the L1 
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element.  Fifty-six of the polymorphic elements were intermediate frequency, with an L1 allele 
frequency >0.33 but <0.67 across the diverse human populations sampled.  Nineteen of the 254 
elements had insertion allele frequencies <0.33, and these were termed “low-frequency insertion 
polymorphisms.”  These elements include some of the youngest members of the subfamily, 
having inserted into the human genome so recently that the element only appears in the genomes 
of only a handful of individuals who were screened by our assay.  Three Ta L1 elements, 
L1HS44, L1HS287, and L1HS373, appeared to be absent from the genomes of all the individuals 
tested, and one of these (L1HS373) is full length and has two functional ORFs, suggesting that it 
may be retrotransposition competent.  Previous experiments with Alu elements have shown that 
 
                                                Figure 2.1 
Figure 2.1 - Human diversity associated with a truncated Ta L1Hs element, as shown by an 
an agarose gel chromatograph of the PCR products from a survey of the human genomic 
variation associated with L1HS7.  Amplification of the pre-integration site of this locus generates 
a 130-bp PCR product; amplification of a filled site generates a 326-bp product (by use of 
flanking unique sequence primers).  In this survey of human genomic variation, 20 individuals 
from each of four diverse populations were assayed for the presence or absence of the L1 
element, with only the African-American samples shown here; the control samples (gray lines) 
were TLE buffer (i.e., 10 mM Tris-HCl:0.1 mM EDTA), common chimpanzee, gorilla, and owl 
monkey DNA templates.  Most of the individuals surveyed were homozygous for the presence of 
the L1 element; in addition, this particular L1 element was absent from the genomes of 
nonhuman primates. 
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     Figure 2.2A 
 
     Figure 2.2B 
 
 
Figure 2.2 - Human diversity associated with a long L1HS Ta insertion polymorphism, as 
shown by an agarose gel chromatograph of the PCR products from a survey of the human 
genomic variation associated with L1HS364.  Because of the size (~6000 bp) of this L1 element, 
two separate PCRs are performed to genotype individual samples.  In the first reaction, flanking 
unique sequence primers were used to genotype the empty alleles (A); amplification of empty 
alleles from this locus generates a 97-bp PCR product.  In the second reaction, a Ta subfamily-
specific internal primer termed “ACA” and the 3′ flanking unique sequence primer were used to 
genotype filled sites (B); the amplification of filled sites generates a 170-bp product.  In this 
survey of human genomic variation, 20 individuals from each of four diverse populations were 
assayed for the presence or absence of the L1 element, with only the Egyptian samples shown 
here; the control samples (black lines) were TLE buffer, common chimpanzee, gorilla, and owl 
monkey DNA templates.  This particular L1 insertion polymorphism is a high-frequency 
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these types of elements are indeed present within the genomic clone that was sequenced as part 
of the human genome project, but also that they represent relatively rare, “private” mobile-
element insertion polymorphisms (Carroll et al. 2001). 
Overall, the unbiased heterozygosity values across all of the L1 elements subjected to 
PCR analysis were similar across the four populations, with values of 0.265 in African 
Americans, 0.233 in Asians, 0.252 in European Germans (i.e., white Germans of European 
descent), and 0.250 in Egyptians (Table 2.2 and APPENDIX B Supplementary Data Table 2).  
However, several of the polymorphic elements individually exhibited unbiased heterozygosity 
values that approached 0.5, the theoretical maximum for bi-allelic loci.  A subset of 31 of the 115 
L1 insertion polymorphisms are, to some degree, population specific, meaning that insertion 
frequencies differ by at least 25% in one of the tested populations, relative to the other three 
populations that were surveyed.  Detailed analysis of the human genomic variation associated 
with the polymorphic L1 elements will prove useful for the study of human population genetics.   
In order to determine if the LINE insertion polymorphisms were in Hardy-Weinberg 
Equilibrium (HWE), we performed a total of 460 χ2 tests for goodness of fit.  A total of 77 
deviations from Hardy-Weinberg expectations were observed in the comparisons.  However, 73 
of the deviations were the result of low expected numbers.  The remaining four tests that 
deviated from HWE did not cluster by locus or population.  A total of 23 deviations from HWE 
would be expected by chance alone at the 5% significance interval.  In addition, we applied the 
Fisher’s exact test to the data, using the Genetic Data Analysis program.  The test yielded only 
22 of 436 significant comparisons, which is approximately what would be expected on the basis 
of chance alone.  By Fisher’s exact test, only 6 of the 436 comparisons were significant at the 
0.01 level, and they did not cluster across all populations at any locus tested.   Therefore, we 
conclude that these L1 insertion polymorphisms do not significantly depart from HWE.   
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Phylogenetic Origin 
Almost all of the Ta L1 elements analyzed using PCR were located in the human genome 
and absent from the orthologous positions within nonhuman primate genomes.  Only a single 
truncated L1 element (L1HS72) produced unexpected results when subjected to the initial PCR 
by use of external flanking primers and nonhuman primate DNA as a template.  The 825-bp 
amplicon that corresponded to the L1HS72 insertion was found in loci in all 80 human 
individuals tested, as well as in the orthologous loci from the common chimpanzee and pygmy 
chimpanzee genomes (figure 2.3A).  However, the gorilla, green monkey, and owl monkey only 
amplified the small PCR product corresponding to the empty allele or pre-integration site (figure 
2.3A).  Subsequent PCRs by use of the internal subfamily-specific ACA primer and the 3′ 
flanking primer across the same DNA templates produced a characteristic L1 filled-site amplicon 
only in the human individuals and not in any of the nonhuman primate genomes (chimpanzee, 
gorilla, green monkey, and owl monkey).  It appeared that we had potentially isolated a Ta L1 
element that inserted into the genome before the divergence of humans from African apes, but 
the second PCR by use of the internal subfamily-specific ACA primer and the 3′ flanking primer 
again produced the expected product that corresponded to the presence of this Ta L1 element 
only in humans.  These data suggest that there is a difference in the sequence structure of this L1 
element in the human genome, as compared to the common and pygmy chimpanzee genomes, 
which contained putative Ta L1 filled alleles. 
Gene Conversion 
  To precisely define the sequence structure of the L1HS72 locus, we cloned and 
sequenced, for further analysis, the PCR amplicons from several human genomes, as well as 
those from the common chimpanzee and the pygmy chimpanzee (figure 2.3B).  Sequence 
analysis of the orthologous sites from the common and the pygmy chimpanzee genomes revealed 
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the presence of an older, primate-specific L1 element that had the greatest sequence identity to 
the L1PA3 subfamily (figure 2.3B).  Interestingly, this L1 element shared identical target site 
duplications with that of the Ta L1 element that was present in the human samples that we 
studied.  Both the human sequence and the chimpanzee sequence also contained many of the 
diagnostic mutations characteristic of an L1PA3 element.  However, only the human L1 
sequences contained the Ta diagnostic ACA mutation at position 5930-5932 in the 3′ UTR.  The 
common and pygmy chimpanzee sequences contained GAT at this position and an additional A 
mutation at diagnostic position 6015, both of which are characteristic of older L1PA elements 
(L1PA6 –L1PA2).  The most likely explanation for the presence of the L1Hs Ta ACA sequence 
in the human L1 element is a forward gene conversion event that affected a pre-existing older L1 
element at this locus.  To further investigate the putative gene conversion at this locus, we cloned 
and sequenced alleles derived from African American, Asian, European German, and Egyptian 
genomes.  Although there was a limited sample size, all nine individuals who were sequenced 
contained the ACA sequence, and at least four samples (European Germans 1 and 2, and 
Egyptians 2 and 3) contained SNPs, three of which occur at a specific CpG dinucleotide (figure 
3B).  Therefore, we conclude that gene conversion events have altered the L1 Ta subfamily-
specific diagnostic nucleotide positions at  
this locus within the human lineage.     
  In order to begin to examine the level of gene conversion across the entire Ta 
subfamily, we examined multiple sequence alignments of the 459 Ta L1Hs elements.  Close 
inspection of the multiple sequence alignment revealed some highly variable sequence features 
that were unexpected among such a young L1 subfamily, in which we would expect low levels 
of nucleotide divergence.  It appears that many of the single-base substitutions in Ta L1 elements 
are not completely random mutation events.  In fact, it became clear that a substantial number of 
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the elements possessed specific mutations that are diagnostic for older L1PA primate-specific 
elements in addition to the younger diagnostic mutations.  These mosaic elements all possessed 
the 19-bp Ta L1 consensus sequence, but they also contained short tracts of sequence diagnostic 
for other L1 subfamilies.   
There are two possible explanations for the presence of these mosaic elements.  The first 
theory is that L1Hs Ta source genes, while acquiring the young diagnostic mutations of the L1Hs 
Ta subfamily, also retained many of the other diagnostic mutations of their older L1 subfamily 
progenitors.  Over time, this gave rise to elements with combinations of young and old 
mutations, as proposed in the master-gene theory of LINE and short interspersed element (SINE) 
amplification (Deininger et al. 1992).  The second theory is that some of these mosaic elements 
are products of gene conversion events, a non-reciprocal transfer of sequence between a pair of 
nonallelic genomic DNA sequences such as interspersed repeats.  The donor sequence is 
unchanged, and the recipient sequence gains some of the donor sequence; alternatively, a 
nonintegrated LINE cDNA may also serve as the donor sequence for the gene conversion.  Gene 
conversion between SINEs and LINEs is a significant influence on the genomic landscape of 
young Alu elements, creating hybrid sequence mosaics of the various mobile element 
subfamilies (Batzer et al. 1995; Kass et al. 1995; Roy et al. 2000; Roy-Engel et al. 2001; Roy-
Engel et al. 2002).  Gene conversion may contribute to as much as 10-20% of the sequence 
variation between recently integrated Alu elements (Roy et al. 2000).  It is likely that the same 
process may also alter the sequence diversity of L1 elements, since they are also part of a large, 
nearly identical multigene family and since they have previously been shown to have undergone 
limited gene conversion (Hardies et al. 1986; Burton et al. 1991).  Unfortunately, the vast 













Figure 2.3 - L1HS72 gene conversion.  A) Agarose gel chromatograph of the PCR products 
derived from the amplification of L1HS72 in a series of human and nonhuman primate genomes, 
with a schematic of the primate evolutionary tree over the past 35 million years shown below.  
The yellow notched arrow represents the approximate time period when the L1HS72 element 
first integrated, and the red notched arrow represents the approximate time period of the gene 
conversion event of the pre-existing L1 element.  The fragment-length marker is a 123-bp ladder.  
B) Sequence alignment generated by sequencing the L1HS72 amplicons from nine diverse 
humans.  Sequences are compared relative to L1Hs Ta consensus sequence and the L1HS72 
sequence obtained from GenBank with only the diagnostic bases shown and positions reported 
relative to L1 retrotransposable element-1 (Dombroski et al. 1991).  The G and C at positions 
5536 and 5539 are indicative of the Ta-0 subset, whereas the Ta-1 subset has T and G at these 
nucleotides (Boissinot et al. 2000).  The G at position 6015 (in addition to the ACA at positions 
5930-5932) is diagnostic for the L1Hs Ta subfamily (Ovchinnikov et al. 2001).  The target site 
duplication sequence (TSD) is shown in brackets.  The mosaic elements seen in the human 
samples are believed to be the result of at least one gene conversion, some time after the 
divergence of humans from the great apes (approximately 5 million years ago), of a pre-existing 
L1 element with a younger L1Hs element.  In the representation of nucleotides, different colors 
are used to denote conserved sequences and sequence variations between samples:  green 
denotes bases unique to the common and pygmy chimpanzee genomes; blue denotes nucleotides 
unique to the human samples; orange denotes shared bases conserved between the common 
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been verified at the wet bench, to precisely define the expansion of L1 elements in a 
phylogenetic context.  Therefore, it is currently not possible to accurately estimate the level of 
gene conversion between L1 elements within the genome.  
Sequence Diversity 
One hallmark of L1 integration is the generation of target site duplications flanking 
newly integrated elements.  Two thousand base pairs of flanking sequence on each side of the 
element were searched for target site duplications.  Direct repeats >10 bp long are considered to 
be clear target site duplications.  Of the 399 elements (i.e., a total of 468 elements minus the 69 
elements located at the end of sequencing contigs), we were able to identify clear target site 
duplications for 272 elements.  All elements with clear target site duplications had endonuclease 
sites that matched those described elsewhere (Feng et al. 1996; Jurka 1997; Cost and Boeke 
1998).  A total of 13 elements (L1HS45, -70, -172, -178, -284, -372, -415, -416, -442, -443, -
448, -513, and -558) apparently lacked target site duplications or contained short target site 
duplications.   To further investigate these elements, PCRs specific for the pre-integration sites 
for those elements listed were performed on the common chimpanzee, pygmy chimpanzee, and, 
when possible, human samples.  The resulting amplicons were cloned and sequenced, to 
unambiguously define the pre-integration site for each element.   The resulting pre-integration 
sites were then compared with the original GenBank sequence for each locus.       
All 13 of the L1Hs elements lacked obvious target site duplications when compared 
with the common and pymgy chimpanzee pre-integration site sequences.  In addition, L1HS178, 
and L1HS284 had no observable target site duplications and atypical endonuclease cleavage 
sites.  One possible explanation for this observation is that these elements have integrated 
independent by endonuclease cleavage of target sequence; this mechanism has been proposed for 
the repair of doubled-stranded breaks in DNA (Moore and Haber 1996; Teng et al. 1996; 
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Morrish et al. 2002).  Alternatively, these elements may represent forward gene conversion 
events of pre-existing L1 elements that, by mutation, have rendered their target site duplications 
unrecognizable.  However, because little is known about the rates of these endonuclease-
independent insertion events in mammalian cells, further studies are required in order to resolve 
the mechanism underlying these integration events. 
Another aspect of L1Hs Ta sequence diversity is created by variable 5′ truncation such 
that some of the elements in the human genome are only a few hundred base pairs long, whereas 
some full-length elements are >6000 bp long.  This phenomenon is classically attributed to the 
lack of processivity of the reverse transcriptase enzyme in the creation of the L1 cDNA copy.  
The point of truncation is traditionally believed to occur as a function of length, where shorter 
inserts are more likely to occur in the human genome than longer elements (Grimaldi et al. 
1984).  Our data show that there is an enrichment of full-length elements in the human genome 
and that many Ta elements have been faithfully replicated in their entirety and inserted into new 
genomic locations.  Of the 399 elements examined, 119 were >6000 bp long, representing an L1 
Ta size class much larger than any other (figure 2.4).  By contrast, very few elements were found 
in the size class ranging between 3,500 and 5,500 bp, with only 22 of the 399 elements truncated 
to this particular size class.  A bimodal distribution of the size of the elements is created, since 
there are a significant number of Ta L1 elements that are severely 5´ truncated and that are full-
length.  One hundred ninety-eight elements were extremely small, having sizes <2,000 bp, with 
118 of these elements were between 25 and 1,000 bp long.  The distribution is noteworthy, 
although the mechanism by which severely truncated and full-length L1 elements are enriched in 
the human genome remains to be determined.  In addition, 20% (79/399) of the L1Hs elements 
examined are inverted at their 5´ end, which is an occurrence that is believed to be due to an 
event known as “twin priming” (Ostertag and Kazazian 2001), in which target primed reverse 
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transcription is interrupted by a second internal priming event, resulting in an inversion of the 5´ 
end of the newly integrated LINE.  Although L1 truncation is most likely the result of the 
relatively low processivity of the L1 reverse transcriptase, processes like twin priming that form 
secondary structures in the RNA or DNA strands present at the integration site may also be 
associated with L1 truncation. 
 
 
     Figure 2.4 
      
Figure 2.4 - L1 Ta element size classes (in bp), showing the size distribution of Ta L1Hs 
elements.  Elements are grouped in 500-bp intervals ranging from <500 bp to 7,000 bp long.  The 
two most common size intervals are shown in black.  
 
A significant amount of sequence diversity in the 3´ tails of members of the L1HS Ta 
subfamily was also observed.  The 3´ tails within this L1 subfamily range in size from 3 to 
>1,000 bp.  Thirty-six percent contain AT-rich low-complexity sequence, 31% have 
homopolymeric A tails, 5% have simple sequence repeats with the most common repeat family 
TAAA, and 26% contain complex sequence that likely results from 3´ transduction events.  The 
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diversity in the tails of the L1 elements is not surprising, since previous studies have shown an 
association, as well as direct evidence that mobile-element-related simple- sequence-repeat 
motifs mutate to form nuclei for the generation of simple sequence repeats (Economou et al. 
1990; Arcot et al. 1995; Ovchinnikov et al. 2001).  Three-prime transduction by L1 elements is a 
unique duplication event that involves retrotransposons and that has elsewhere been described in 
detail in L1 elements (Boeke and Pickeral 1999; Moran et al. 1999; Goodier et al. 2000).  A 
number of 3´ transduction events that are mediated by Ta L1Hs elements were identified and 
suggest that these elements have transduced a total of ~8,500 bp of sequence.  Computationally 
identification L1 element-mediated transduction event was also used in an attempt to identify 
putative retrotransposition-competent L1 Ta source gene.  L1HS169 has a 136-bp fragment that 
is located outside its direct repeats and that is adjacent to its 3´ tail; this fragment is also found 
adjacent to the 3´ tail of L1HS28 but inside its direct repeat (figure 2.5).  This suggests that 
L1HS28 is a daughter copy, or the progeny, of the full-length element L1HS169.  In addition, 
AC010966 from chromosome 18 appears to be the result of a transduction event that was also 
generated from an L1HS169 read-through transcript.  Therefore, we conclude that L1HS169 is 
responsible for multiple transduction events in the human genome and has produced two 
independent L1 integrations located on chromosomes X and 18. 
Discussion 
 
Here we report a comprehensive analysis of the dispersion and insertion polymorphism of 
the youngest known L1 subfamily (i.e., Ta) within the human genome.  The computational 
approach described herein provides an efficient and high-throughput method for recovery from 
the human genome of Ta L1Hs elements, many of which will be polymorphic for insertion  
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     Figure 2.5 
 
Figure 2.5 - L1HS169-mediated transduction, showing an L1Hs transduction event.  
L1HS169 marked by clear target site duplications is the putative source gene for L1HS28.  The 
L1HS28 insertion contains 3′ flanking sequences identical to that of L1HS169 and unique target 
site duplications flanking this entire sequence, suggesting that L1HS28 was created from a read-
through transcript of L1HS169 that, to give rise to L1HS28, integrated into a new location on the 
X.  In addition, a second transduction event, L1HS547 from chromosome 18, is also flanked by 
unique target site duplications and was also derived from L1HS169. 
 
presence/absence in individual humans.  Individual L1 insertion polymorphisms that were 
identified are the products of unique insertion events within the human genome.  Because each 
L1 element integrates into the human genome only once, individuals that share L1 insertions 
(and insertion polymorphisms) inherited them from a common ancestor, thereby making the L1 
filled sites identical by descent.  This distinguishes L1 insertion polymorphisms and other mobile  
element insertion polymorphisms from other types of genetic variation, including microsatellites 
(Nakamura et al. 1987) and RFLPs, (Botstein et al. 1980) that are not necessarily homoplasy 
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free.  In addition, the ancestral state of an L1 insertion is known to be the absence of the L1 
element.  Knowledge about the ancestral state of L1 insertions facilitates the rooting of trees of 
population relationships by use of minimal assumptions.  Therefore, the 115 new L1 insertion 
polymorphisms reported herein appear to have genetic properties that are similar to those of Alu 
insertion polymorphisms (Batzer et al. 1991; Perna et al. 1992; Batzer et al. 1994; Hammer 1994; 
Stoneking et al. 1997; Jorde et al. 2000), and they will serve as an additional source of identical 
by descent genomic variability for the study of human population relationships.   
It is noteworthy that the computational identification of L1 insertion polymorphisms 
introduces a selection for only those elements present in the draft sequence database.  As a result, 
elements that are not present in the database cannot be identified.  This has important 
consequences with respect to the frequency spectrum of the elements identified.  By use of this 
type of approach, a number of different types of L1 insertion polymorphisms are identified that 
vary in the frequency of the L1 insertion allele.  By contrast, PCR-based display approaches 
provide an alternative method for the ascertainment of mobile element insertion polymorphisms 
from the human genome (Roy et al. 1999; Sheen et al. 2000; Ovchinnikov et al. 2001).  In these 
approaches, polymorphic mobile elements are directly identified; however, elements that are 
polymorphic but have higher allele frequencies (i.e., high-frequency insertion polymorphisms) 
are lost in the process, since most genomes will contain at least one filled allele that contains the 
mobile element and would not be scored as an insertion polymorphism.  Therefore, more 
population-specific or private mobile element insertion polymorphisms will be identified using 
PCR-based displays or other types of direct selection (Roy et al. 1999; Sheen et al. 2000; 
Ovchinnikov et al. 2001).  Using our computational approach, we recovered only 14 of 49 Ta L1 
elements that were elsewhere identified using PCR-based displays (Sheen et al. 2000; 
Ovchinnikov et al. 2001) and that had sufficient flanking unique DNA sequences for comparison 
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to the data set that we studied.  Thus, computational and experimental ascertainment of mobile 
element insertion polymorphisms are quite complementary approaches for the identification of 
new mobile element insertion polymorphisms.  
The L1 Ta subfamily can further be subdivided into Ta-0 and Ta-1, according to the 
nucleotides that are present at positions 5536 and 5539 within ORF 2 (Boissinot et al. 2000).  Ta-
0 L1 elements are believed to be evolutionarily older, and they possess a G at position 5536 and 
a C at position 5539.  Ta-1 elements, however, have a T at position 5536 and a G at nucleotide 
5539.  Ta-1 elements are considered to be younger, and it is believed that all actively transposing 
elements in humans belong to the Ta-1 subset of L1 elements (Boissinot et al. 2000).  One 
hundred ninety-two of the 459 Ta elements identified from the draft human genomic sequence 
belong to the younger Ta-1 subset, and 137 are Ta-0 subset.  Another 105 of the elements either 
are 5´ truncated such that they terminated before these positions at 5536 and 5539 or are inverted 
or rearranged in the region in question.  An additional 25 elements are sequence intermediates 
having both Ta-1 and Ta-0 diagnostic bases. 
Inspection of the insertion polymorphism data for each of these Ta subsets showed that 
only 35% of the Ta-0 L1 elements analyzed by PCR were polymorphic, with the remaining 65% 
being fixed present in the human populations screened.  Consistent with the idea that Ta-0 L1 
elements are older, 9 of the polymorphic elements were high-frequency insertion 
polymorphisms, 10 were intermediate-frequency insertion polymorphisms, and only 5 were low-
frequency insertion polymorphisms.  None of the Ta-0 L1 elements were fixed absent or very 
low frequency in the populations that were analyzed.  By contrast, 56% of the Ta-1 L1 elements 
were polymorphic with respect to presence, with 18 high-frequency, 27 intermediate-frequency, 
and 11 low-frequency insertion polymorphisms.  In addition, we can use the non-CpG mutation 
density in Ta-0 and Ta-1 L1 elements to calculate the estimated age of each of the Ta-derivative 
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subfamilies.  The non-CpG mutation density for the Ta-0 and Ta-1 L1 elements was 0.003103 
and 0.002560, respectively.  Using a neutral rate of evolution of 0.15% per million years 
(Miyamoto et al. 1987), we derive estimates of 2.07 (i.e., 0.003103/0.0015) million years and 
1.71 (i.e., 0.002560/0.0015) million years from the Ta-0 and Ta-1 subsets, respectively.  
Although these estimates are not significantly different from each other, they do support the 
notion that the Ta-0 L1 elements are slightly older than the Ta-1 L1 elements, as do the 
differences in insertion polymorphism.  In addition, they provide direct evidence that the Ta-0 
and Ta-1 subsets have simultaneously amplified within the human genome. 
Forty-four of the 124 full-length Ta L1Hs elements that were identified have both ORFs 
intact and are presumably retrotransposition-competent elements.  This compares favorably with 
previous estimates of the number of potentially active L1 elements in the human genome 
(Sassaman et al. 1997).  In addition, it is also important that those full-length elements that no 
longer have intact ORFs might have previously acted as active “source,” or driver, genes for the 
expansion of Ta L1 elements but might have accumulated mutations over time that inactivated 
them.  These data, as well as data from the previous studies involving the isolation and 
amplification of some of these full-length Ta L1 elements within tissue-culture systems, 
demonstrate that multiple L1 elements have expanded within the human genome in an 
overlapping time frame.  It is interesting to compare the amplification of the L1 elements to that 
of the Alu SINEs within the human genome.  In the case of the L1 elements, one major family 
(Ta) with two subdivisions (Ta-0 and Ta-1) has expanded to a copy number of ~500 elements in 
the past four to six million years since the divergence of humans and African apes.  By contrast, 
the expansion of Alu elements is characterized by the amplification of at least three major 
lineages, or subfamilies of elements, that have collectively generated ~5000 copies (Batzer and 
Deininger 2002).  On the basis of these copy numbers alone, it would appear that Alu elements 
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have been 10 times more successful than L1 elements have been with respect to duplicating 
themselves, within primate genomes, over the past four to six million years.  However, if we 
make the estimate relative to the total family size of 500,000 L1 elements or 1.1 million Alu 
elements (Lander et al. 2001), then the relative difference is merely fivefold.  This difference in 
amplification is also apparent across the entire expansion of these repeated DNA sequence 
families, since the L1 elements have expanded to only 500,000 copies in 150 million years, 
whereas the Alu elements have expanded to 1.1 million copies in only 65 million years.  
Since Alu and L1 elements are thought to utilize the same enzymatic machinery for their 
mobilization, the differential amplification of both young and old Alu and L1 elements within 
primate genomes is quite interesting (Boeke 1997).   The two different classes of repeats 
putatively compete for access to the same reverse transcriptase and endonuclease; thus, it is 
possible that Alu elements are currently more effective than the L1 elements at attracting the 
replication machinery within the human genome.  If this competition between interspersed 
elements is important, then we may expect to see differential rates of L1 and Alu expansion in 
different nonhuman primate genomes as the elements compete for the common components 
involved in mobilization.  Differential mobilization of SINEs and LINEs has been elsewhere 
reported in rodent genomes (Kim and Deininger 1996; Ostertag et al. 2000).  Therefore, it would 
not be surprising to see something similar in nonhuman primate genomes.  Alternatively, the 
differential amplification may reflect differences in selection against new L1 and Alu insertions 
within the human genome (Lander et al. 2001).  Since L1 elements are typically much larger than 
Alu repeats, it is easy to envision that the larger insertions would be much more disruptive to the 
genome than the shorter Alu insertions are.  This type of selection has been suggested as one 
potential explanation for the differential distributions of L1 elements (Boissinot et al. 2001) and 
of Alu and L1 elements (Lander et al. 2001; Ovchinnikov et al. 2001) throughout the human 
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genome.  However, the argument that selection is responsible for the differential distribution of 
Alu sequences has recently been questioned on the grounds that older Alu sequences are not in 
enriched in GC-rich regions (Brookfield 2001).  Further studies of the expansion of interspersed 
elements within the genomes of nonhuman primates will be required in order to definitively 
address these questions.     
Our analysis of mosaic Ta L1Hs elements suggests that gene conversion alters the 
sequence diversity within these elements.  This is not surprising, since previous studies have 
indicated that gene conversion plays a role in the generation of sequence diversity in Alu repeats 
(Maeda et al. 1988; Batzer et al. 1995; Kass et al. 1995; Roy et al. 2000; Carroll et al. 2001; Roy-
Engel et al. 2002), as well as the generation of sequence diversity in L1 elements, within the 
genome (Hardies et al. 1986; Burton et al. 1991; Tremblay et al. 2000).  Unfortunately, an 
accurate estimate of L1-based gene conversion is not yet possible, because primate L1 subfamily 
structure is not yet clearly defined.  However, gene conversion appears to play a significant role 
in the sculpting of human genomic diversity (Ardlie et al. 2001; Frisse et al. 2001).  Because of 
the hierarchical subfamily structure of Alu and LINEs and because of the defined pattern of 
ancestral mutations, these elements provide a unique opportunity for the estimation of gene 
conversion throughout the genome.  It is also important to consider that the gene conversion 
between large multigene families, such as SINEs and LINEs, may occur by a mechanism that is 
completely different from that which occurs at other unique and low-repetition sequences within 
the human genome.  Nevertheless, large-scale studies of orthologous sequences from the same 
L1 element in different human genomes will begin to quantitatively address this issue and also 
will provide insight into the molecular mechanism that drives the process.  In addition, detailed 
pedigree analyses or studies of germ cell-derived L1 diversity will provide insight into the germ 
line rate of gene conversion between L1 elements.  Clearly, L1 elements continue to have a 
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significant impact on human genetic diversity, through recombination, insertional mutagenesis, 
gene conversion, sequence transduction, and the generation of other simple-sequence-repeat 
motifs (Kazazian and Moran 1998; Goodier et al. 2000; Ovchinnikov et al. 2001).   
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Introduction 
Computational analysis of the draft sequence of the human genome indicates that 
repetitive sequences comprise 45-50% of the human genome mass, 17% of which consists of  
Long INterspersed Elements (LINE-1s or L1s) (Smit 1999; Prak and Kazazian 2000; Lander et 
al. 2001).   L1 elements are restricted to mammals, having expanded as a repeated DNA 
sequence family over the last 150 million years (Smit et al. 1995).  Full-length L1 elements are 
approximately 6 kilobases (kb) long and propagate via an RNA intermediate in a process known 
as retrotransposition.  L1 retrotransposition likely occurs by a mechanism termed target primed 
reverse transcription (TPRT) (Luan et al. 1993).  This mechanism of mobilization provides two 
useful landmarks for the identification of young L1 inserts: an endonuclease related cleavage site 
(Jurka 1997; Cost and Boeke 1998; Cost et al. 2001) and direct repeats or target site duplications 
flanking newly integrated elements (Fanning and Singer 1987).   
 L1 retrotransposons have had a significant impact on the human genome through a 
variety of different mechanisms.  De novo insertions disrupting open reading frames and splice 
sites have resulted in a number of human diseases (Kazazian et al. 1988; Kazazian 1998; 
Deininger and Batzer 1999), new L1 integrations have been shown to have the potential to alter 
gene expression (Yang et al. 1998; Rothbarth et al. 2001), and once in the genome L1 elements 
provide regions of sequence identity blanketing the genome, that can be exploited during 
recombination (Fitch et al. 1991).   L1 elements also generate sequence duplications by 
transducing adjacent genomic sequences at their 3' end, thereby “shuffling” genomic sequence 
(Boeke and Pickeral 1999; Moran et al. 1999; Goodier et al. 2000).  More recently, it has been 
suggested that L1 elements have paradoxical roles in genomic stability by serving both as 
molecular band aids, repairing double stranded breaks in mammalian cells and as suspects for the 
generation of genomic deletions (Gilbert et al. 2002; Kazazian and Goodier 2002; Symer et al. 
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2002).  Thus, L1 elements exert a significant influence on the architecture of the human genome 
and provide dynamic units capable of ongoing change. 
As a result of the limited amplification potential of the diverse L1 gene family, a series of 
discrete L1 subfamilies exists within the human genome (Deininger et al. 1992; Smit et al. 1995).  
L1 elements have expanded at  different times during mammalian evolution, producing 
subfamilies of various ages (Deininger et al. 1992; Smit et al. 1995).  Depending on the 
amplification period of the L1 subfamily, some L1 elements may be unique to a single 
phylogenetic lineage, species, or even a single population.  Such is the case with the L1Hs 
(Human specific) Ta (transcribed, subset a) (Skowronski et al. 1988) subfamily, which has been 
shown to be present only in the human species (Myers et al. 2002).  
 Even though there are approximately 500,000 L1 elements in the human genome only a 
limited subset of 30-60 L1 elements appears to be capable of retrotransposition (Moran et al. 
1996; Sassaman et al. 1997).  De novo L1 insertions resulting in human disease are largely the 
product of L1Hs Ta integrations, which have been shown to be the youngest, most active L1 
subfamily found in the human genome (Boissinot et al. 2000; Sheen et al. 2000; Myers et al. 
2002).  However, at least one L1 insert (JH-28) in exon 14 of the factor VIII gene resulting in 
hemophilia A was the result of a preTa insertion, providing the first proof that preTa L1 elements 
are also currently capable of retrotransposition (Kazazian et al. 1988).  Previous studies have 
shown that some members of the preTa L1 subfamily have inserted so recently in the human 
genome that they are polymorphic with respect to insertion presence/absence (Boissinot et al. 
2000; Ovchinnikov et al. 2002), all of which makes preTa L1 elements a likely source of 
identical-by-descent mobile element based variation for the study of human population genetics. 
Members of the L1 preTa subfamily share a common three base pair diagnostic sequence 
within the 3' untranslated region (UTR), which separates them from the other L1 subfamilies.  As 
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the name suggests, the preTa L1 subfamily is believed to predate the amplification of the L1Hs 
Ta subfamily in the human lineage.  However, the phylogenetic origin and level of human 
genetic diversity associated with preTa L1 elements remains largely undefined.  The following 
work provides a comprehensive analysis of the preTa L1 subfamily from the draft sequence of 
the human genome.  
Results 
L1 preTa Subfamily Copy Number 
To identify recently integrated preTa subfamily L1 elements from the human genome, the 
draft sequence of the human genome (database version: BLASTN 2.2.1 [Apr-13-2001]) was 
searched using the Basic Local Alignment Search Tool (BLAST) (Altschul et al. 1990) with an 
oligonucleotide sequence that is complementary to a highly conserved motif in the 3' 
untranslated region (UTR) of preTa L1 elements.  This 19 base pair (bp) query sequence 
(CCTAATGCTAGATGACACG) includes the preTa subfamily-specific diagnostic mutation 
“ACG” at its 3' end (position 5930-5932 relative to LRE-1) (Dombroski et al. 1991).  Three 
hundred sixty-two unique preTa L1 elements were identifiedfrom 2.868 x109 bp of available 
human draft sequence.  Extrapolating this number to the actual size of the human genome (3.162 
x109 bp), provides an estimate that this subfamily contains about 400 elements.   Taken with the 
estimate from the L1Hs Ta data (Myers et al. 2002), suggests that there are over 900 human 
specific LINE-1 elements in the human genome.  Of the 362 preTa L1 elements retrieved, 6 
resided at the end of sequence contigs and were not amenable to additional analysis.  One 
hundred five (29%) of the 356 (362-6) remaining elements were essentially full length, and 251 
were truncated to variable lengths.  Alignment and sequence analysis of the full-length elements 
revealed that 29 contained two intact open reading frames and therefore may be capable of 
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retrotransposition.  The complete data set is available on the Batzer Laboratory of Comparative 
Genomics website (http://batzerlab.lsu.edu) under publications.   
Estimated Subfamily Age 
The average ages of L1 elements can be determined by the level of sequence divergence 
from the subfamily consensus sequence using a neutral mutation rate for primate non-coding 
sequence of 0.15% per million years (Miyamoto et al. 1987).  The mutation rate is known to be 
about 10 times greater for CpG bases as compared to non-CpG bases, as result of the 
spontaneous deamination of 5-methyl cytosine (Bird 1980).  Thus, two age estimates based upon 
CpG and non-CpG mutations can be calculated for the preTa subfamily of L1 elements.  A total 
of 74,048 bases from the 3' UTR of 356 preTa L1 elements was analyzed.  Three hundred sixty-
one total nucleotide substitutions were observed.  Of these, 303 were classified as non-CpG 
mutations against the backdrop of 71,912 total non-CpG bases, producing a non-CpG mutation 
density of 0.004213 (303/71,912).  Based upon the non-CpG mutation density and a neutral rate 
of evolution (0.004213/0.0015) the average age of the L1 preTa LINE-1 elements was 2.81 
million years old.  A total of 58 CpG mutations out of 2,136 total CpG nucleotides was found 
across the same 356 LINE elements, yielding a CpG based mutation density of 0.027154 
(58/2,136).  With the expectation that the CpG mutation rate is about 10 fold higher than the 
non-CpG mutation rate, the approximate age of the L1 preTa subfamily using the CpG mutation 
density is 1.86 million years old.    These estimates are in good agreement with one another and 
taken together, these estimates produce an average age of 2.34 million years old, which is in 
good agreement with the idea that the preTa L1 subfamily is evolutionarily older than the L1Hs 
Ta subfamily (estimated average age 1.99 million years) (Boissinot et al. 2000; Myers et al. 
2002).  In addition the average age estimates reported here provide a relative time frame by 
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which to compare L1 retrotransposition activity, and should not be confused with the age of 
origin. 
Similar to the L1Hs Ta subfamily, the preTa L1 subfamily can also be grouped into two 
subgroups, ACG/A and ACG/G, based on an “A” or “G” base at position 6015 relative to L1.2 
(Accession number M80343).  In order to determine the relative ages of each subgroup, we 
analyzed the level of sequence divergence in each subgroup.  The ACG/A subgroup contained 
127 total nucleotide substitutions with 98 of these classified as non-CpG mutations against the 
backdrop of 20,402 total non-CpG bases.  This yields a non-CpG mutation density of 0.004803 
(98/20,402) and produces an estimated age of 3.20 million years old.  Twenty nine of 127 total 
mutations were classified as CpG mutations against a backdrop of 606 CpG total bases, which 
yields a CpG mutation density of 0.047855 (29/606) producing an estimated age of 3.28 million 
years.  The ACG/G subgroup contained 221 total nucleotide substitutions with 191 of these 
classified as non-CpG mutations against the backdrop of 51,106 total non-CpG bases, which 
yields a non-CpG mutation density of 0.003737 (191/51,106), producing an estimated age of 
2.49 million years old.  Thirty of 121 total mutations were classified as CpG mutations against a 
backdrop of 1518 CpG total bases, which yields a CpG mutation density of 0.019763 (30/1518) 
producing an estimated age of 1.35 million years. We calculated the average age of each 
subgroup as 1.92 and 3.24 million years for the ACG/G and ACG/A respectively.  Although it is 
likely that the L1Hs Ta subfamily is derived from one of the preTa L1 subsets based on the 
estimated ages of these L1 subfamilies, the transition intermediates between preTa and Ta 
subfamilies are not clear.   
Features of L1 preTa Integration Sites 
One hallmark of L1 integration is the generation of target site duplications flanking 
newly integrated elements.  Two thousand bases of flanking sequence on each side of the 
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element were searched for target site duplications.  Clear target site duplications are considered 
to be target site duplications at least 10 bases in length. Of the 356 elements analyzed, we were 
able to identify clear target site duplications for 252 elements.  We then determined the 
integration sites for these 252 preTa L1 insertions with clear target duplications.  A complete list 
of L1 integration sites is shown in Table 3.1, and further supports the notion that some 
integration sites are more common than others (Feng et al. 1996; Jurka 1997; Cost and Boeke 
1998).   
Table 3.1 - PreTa L1 integration sites. 
 



























A large number of preTa L1 elements had no observable target duplication sites.  One 
possible explanation for this observation is that these elements have relatively short target site 
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duplications.  Alternatively, these elements may represent forward gene conversion events of 
older pre-existing L1 elements that by mutation, have rendered their target site duplications 
unrecognizable.  Some of these events may also represent integrations that have occurred 
independent of endonuclease cleavage, that has previously been proposed as a mechanism for the 
repair of doubled stranded breaks in DNA (Moore and Haber 1996; Teng et al. 1996; Morrish et 
al. 2002).   
To further characterize the preTa L1 insertions, we determined the DNA base content for 
sequence blocks 1 and 2 kb flanking all preTa L1 insertion sites with target site duplications of at 
least 10 bp.  Flanking sequence was then grouped according to GC content with only data for the 
1 kb sequence blocks shown in Figure 3.1.  Our data suggests that preTa L1 elements integrate 
preferentially in genomic regions with GC content less than 36%, but are present in genomic 
regions with GC content as low as 26% and as high as 52%.   A similar insertion site preference 
was observed for 2 kb sequence blocks as well as for the previously reported L1 Ta subfamily 
(Myers et al. 2002) and other L1 subfamilies (Szak et al. 2002).  In addition, we also analyzed 
preTa L1 elements inserted in repetitive sequences and grouped them according to the repeat 
family in which they reside (Figure 3.2).  This analysis showed that preTa L1 elements insert 
most frequently in other L1 elements,  which is expected both because L1 sequences occupy a 
large percentage of  the human genome and because L1 elements are less GC rich relative to 
other mobile element families, such as Alu elements, making them more susceptible to 
subsequent L1 integrations.  Lastly, preTa L1 containing regions were analyzed to determine the 
distance from the integration to the nearest gene.  Twelve preTa L1 elements reside within 25 kb 
of novel or known genes as denoted by GenBank annotation, including one full length preTa 
element, L1AD242, which inserted into intron 23-24 of the retinoblastoma susceptibility protein 
1 gene and accounts for 6072 bp of the 7988 bp intron.   
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Sequence Diversity 
PreTa L1 sequence diversity is also created by variable 5′ truncation with some of the 
elements in the human genome only a few hundred base pairs in length, whereas some full-
length elements are over 6000 base pairs.  This phenomenon is classically attributed to the lack 
of processivity of the reverse transcriptase enzyme in the creation of the L1 cDNA.  The point of 
truncation is traditionally believed to occur as a function of length, where shorter inserts are 
more likely to occur in the human genome than longer elements (Grimaldi et al. 1984).  Our data 
show that there is an enrichment of full-length elements in the human genome, and like the Ta 
L1 elements many preTa L1 elements have been faithfully replicated in their entirety and 
inserted into new genomic locations.  Of the 356 elements examined (362 total minus 6 elements 
located at the end of sequencing contigs), 97  were over 6000 base pairs long, representing a 
much larger preTa L1 size class than any other size class (Figure 3.3).  By contrast, very few 
elements were found in the size ranges between 4000 and 5500 bases, with only 14 of the 356 
elements truncated to this particular size range.  A bimodal distribution in the size of the 
elements is created since there are a significant number of preTa L1 elements that are severely 5 
prime truncated and those that are full-length with the average preTa element length of roughly 
2700 bp and the median preTa element length of roughly 1600 bp.  One hundred ninety-six  
elements were small with sizes less than 2000 bp, with 125 of these only 50-1000 bases in 
length.  In addition 28% (100/356) of the preTa L1 elements examined were inverted at their 5 
prime end, which is believed to occur by an event known as twin priming where target primed 
reverse transcription is interrupted by a second internal priming event, resulting in an inversion 
of the 5 prime end of the newly integrated LINE element (Ostertag and Kazazian 2001).   
Although L1 truncation is most likely the result of the relatively low processivity of the L1 
reverse transcriptase, processes that form secondary structures in the RNA or DNA strands 
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present at the integration site, like twin priming, may also be associated with L1 truncation.  One 
expectation of this model is that a common truncation point should exist for L1 preTa elements. 
However, from our data we were not able to identify any common truncation points. Similar to 
other L1 elements, preTa L1 elements exhibit a significant amount of sequence diversity in the 3 
prime tails.  In general, the 3 prime tails found in this L1 subfamily range in size from 4 to over 
1600 bp in length.  Sixty-four percent contain AT rich low complexity sequence, 13% have 
homopolymeric A tails with an average tail length of 15 bp, 6% have simple sequence repeats 
with the most common repeat family TAAAn, and 17% contain complex sequence likely 
resulting from 3 prime transduction events.  Three-prime transduction by L1 elements is a unique 
duplication event that occurs when an L1 sequence is transcribed along with genomic sequence 
at its 3 prime end.  This sequence then integrates at a different genomic location resulting in 
duplication of the source L1 sequence and the 3 prime genomic sequence flanked by target site 
duplications (Boeke and Pickeral 1999; Moran et al. 1999; Goodier et al. 2000).  We have 
 
Figure 3.1 
Figure 3.1 – Analysis of preTa L1 pre-integration sites.  GC content was calculated for L1 
insertion flanking sequences of 1 and 2 kb.  The 1 kb results are shown here. 
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identified fifty 3 prime transduction events mediated by preTa L1 elements and believe that these 
elements have transduced approximately 10,400 total bases of sequence with one transduction 
event responsible for duplicating a region over 1600 bp.  The diversity observed in the tails of 
the L1 elements is not surprising since previous studies have shown an association as well as 
direct evidence that simple sequence repeat motifs present in the 3 prime tail of mobile elements 
can mutate serving as nuclei for the generation of simple sequence repeats (Economou et al. 
1990; Arcot et al. 1995; Ovchinnikov et al. 2001).  A complete list of the preTa elements 
involved in transduction events is located at the Batzer Laboratory of Comparative Genomics 




Figure 3.2 - PreTa L1 integrations within other repetitive elements.  PreTa L1 insertions 
within mobile elements were grouped according to the element in which they inserted.  Mobile 
elements categories include LINE-2 (L2), LINE-1 (L1), Long Terminal Repeats (LTR), Alu 
(ALU), Mammalian-wide Interspersed Repeats (MIR), Medium Reiteration Frequency 
Sequences (MER), Low Complexity Sequence (LC), Alphoid Satellite Repeats (ALPHA). 
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Figure 3.3 
Figure 3.3 - PreTa L1 element genomic size distribution.  The following schematic shows the 
size distribution of preTa L1 elements.  Elements are grouped in 500 bp intervals ranging from 
25 bp in length to >6501 bp in length.   The two most common size intervals are denoted in gray. 
 
L1 Associated Human Genomic Diversity 
Of the 362 preTa L1 elements isolated in silico, 102 of the elements were inserted into 
other repetitive regions of the genome such that flanking unique sequence PCR primers could not 
be designed.  Six additional elements resided at the end of sequencing contigs in GenBank and 
lacked unique flanking sequence information making PCR primer design in this region 
impossible.  The remaining 254 were analyzed using a subfamily specific polymerase chain 
reaction assay and flanking unique sequence primers as previously described (Sheen et al. 2000) 
(summarized in Table 3.2). Three elements out of 254, produced inconclusive PCR results 
because of the amplification of paralogous genomic sequences as described previously (Batzer et 
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al. 1991).  Nine elements produced non-specific PCR results, and were excluded from further 
analysis.  Another nine elements produced subfamily-specific PCR products in all human 
samples tested, but did not produce pre-integration site in both human and non-human primate 
genomes.   This may be the result of some type of large deletion event that occurred in the 
human genome and not in the genome of non-human primates making the non-human primate 
pre-integration site much larger than expected and not detectable by our assay as reported 
previously (Myers et al. 2002).  Alternatively this could also be the result of mutations in the 
oligonucleotide hybridization sites rendering them ineffective for PCR.  In addition, we 
identified 36 preTa L1 elements that mapped to the X chromosome and eight that mapped to the 
Y chromosome, all of which were fixed present in the individuals tested (APPENDIX B 
Supplementary Data Table 3).  The human genomic diversity associated with the autosomal 
preTa L1 elements is shown in Supplementary Data Table 3 and Supplementary Data Table 4 
(APPENDIX B). 
Table 3.2 - Summary of preTa L1 analysis. 
 
LOCI ANALYZED BY PCR 254 
Fixed present 200 
High frequency insertion polymorphisms 11 
Intermediate frequency insertion polymorphisms 22 
Low frequency insertion polymorphisms 0 
Total preTa insertion polymorphisms 33 
 
Inserted in paralogous sequences 3 
No pre-integration site amplified in primates 9 
No PCR results 9 
 
LOCI NOT ANALYZED BY PCR  
L1 elements inserted in other repeats 102 
End of contig 6 
Total preTa L1 elements analyzed 362 
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Two hundred thirty three (254-9-9-3) preTa L1 elements produced unambiguous results 
when analyzed by a two-step PCR assay across 80 individuals from four geographically diverse 
human populations with 33 (14%) being polymorphic with respect to insertion presence/absence 
(APPENDIX B Supplementary Data Table 3 and 4).  Examples of human genomic diversity 
associated with preTa L1 insertion polymorphisms are shown in Figure 3.4A and 3.4B.  Eleven 
of the preTa L1 elements were high frequency insertion polymorphisms with L1 element allele 
frequencies greater than 0.70, so that most of the individuals were homozygous (+/+) for the 
presence of the LINE element.  Twenty-two of the polymorphic elements were intermediate 
frequency, with a LINE element allele frequency greater than 0.30 but less than 0.70 across the 
diverse human populations sampled.  None of the L1 preTa elements tested had insertion allele 
frequencies less than 0.30.  One possible explanation for the absence of low frequency preTa 
insertion polymorphisms would be that the preTa subfamily has largely undergone 
retrotranspositional quiescence and is no longer generating new copies.  As a result, the number 
of low frequency preTa insertion polymorphisms in the human genome would be limited.  It is 
also possible that the newly integrated preTa L1 elements are removed from the human genome 
as a result of negative selection.  However, we consider the former explanation more likely based 
upon the three-fold higher levels of insertion polymorphism in the Ta subfamily as compared to 
the preTa subfamily (45% vs. 14%) as well as the previously reported frequency distribution of 
Ta L1 insertion polymorphisms in the human genome  (Myers et al. 2002).  
Two hundred preTa L1 elements were fixed present in the human genome.  These 
elements are likely to be slightly older than their polymorphic counterparts, having inserted into 
the human genome prior to the radiation of humans from Africa.  Overall, the unbiased 
heterozygosity values across all of the L1 elements subjected to PCR analysis were similar cross 








Figure 3.4 - PreTa L1 insertion polymorphisms.  This figure is an agarose gel chromatograph 
of the PCR products from a survey of the human genomic variation associated with L1AD125.  
Amplification of the pre-integration site of this locus generates a 236 bp PCR product.  
Amplification of a filled site generates a 513 bp product (using flanking unique sequence 
primers).  In this survey of human genomic variation 20 individuals from each of four diverse 
populations were assayed for the presence or absence of the L1 element, with Asian samples 
shown in Figure 3.4A and African Americans shown in Figure 3.4B.  The control samples are 
denoted by the black lines and were TLE buffer (10 mM Tris-HCl: 0.1 mM EDTA), common 
chimpanzee, pygmy chimpanzee, gorilla, orangutan and owl monkey DNA templates.  In 
addition, this particular L1 element was absent from the genomes of non-human primates. 
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Europeans, and 0.269 in South Americans, with the African American population being the most 
diverse with respect to preTa L1 alleles (APPENDIX B Supplementary Data Table 4).  However, 
several of the polymorphic elements individually exhibited unbiased heterozygosity values that 
approached 0.5, the theoretical maximum for bi-allelic loci.   
To determine if the LINE insertion polymorphisms were in Hardy-Weinberg Equilibrium 
(HWE), expected genotype frequencies were compared with observed genotype frequency using 
chi-square tests for goodness of fit.  A total of 132 chi-square tests for goodness of fit are 
theoretically possible.  However, 28 of the comparisons involved populations that were 
monomorphic for the presence of the L1 insertion leaving 104 possible tests.  A total of 23 
deviations from Hardy-Weinberg expectations were observed in the comparisons.  Eighteen of 
the deviations were the result of low expected genotype frequencies.  Of the remaining five tests 
that deviated from HWE, none clustered by population or locus.  This deviation is not surprising 
since a total of 5.15 deviations from HWE would be expected by chance alone at the 5% 
significance level.  One short coming of this method is its inability to deal with low expected 
genotype frequencies.  To further test these polymorphisms for HWE, we performed an exact test 
for Hardy-Weinberg proportions using the Markov chain test available in the Arlequin program 
(Guo and Thompson 1992) , which is not hindered by low expected frequencies.  The exact test 
showed that none of the 104 comparisons deviated from HWE proportions at the one percent 
level.  Therefore we conclude that the newly identified L1 insertion polymorphisms do not 
significantly depart from HWE.  
Discussion 
Here we report a comprehensive analysis of the dispersion and insertion polymorphism 
associated with the preTa L1 subfamily within the human genome.  We estimate that there are 
approximately 900 lineage specific L1 elements present in the entire human genome.  In 
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addition, given the median size for preTa and Ta L1 elements (~1600 bp) and a conservative 
copy number estimate of 900 elements, we estimate that human lineage-specific L1 
retrotransposition has been responsible for increasing the size of the human genome by roughly 
1.4 million bases.  
The level of sequence diversity, estimated age, and the reduction of human genomic 
variation associated with this L1 subfamily relative to the Ta L1 subfamily provide strong 
evidence suggesting the expansion of preTa L1 elements began prior to the expansion of the Ta 
L1 subfamily that has been analyzed in detail previously (Boissinot et al. 2000; Myers et al. 
2002).  However, the expansion of preTa L1 elements also appears to have occurred over a time 
frame that predated the radiation of humans from Africa and continued until very recently, in fact 
it may still be occurring at a very  low level within the human lineage.  Thus, we conclude that 
the expansion of preTa and Ta L1 elements occurred in an overlapping time frame in the human 
lineage.  The reason(s) for the relative retrotranspositional quiescence of preTa elements remain 
unknown.  However, they may relate to alterations in the ORF2 protein of the preTa elements, 
decreased transcription from the preTa “source” elements or a decrease in the ability of the 
elements to undergo target primed reverse transcription (Moran 1999).   Further studies using in 
vitro systems to measure retrotransposition (Moran et al. 1996) will be required to definitively 
address this question.  
Sequence analysis of the preTa L1 insertions suggest that they have a slight preference 
for integrating into regions of the genome with low GC content.  This observation is 
contradictory to that previously reported (Ovchinnikov et al. 2001),  but is in agreement with 
results obtained by The International Human Genome Sequencing Consortium (Lander et al. 
2001).  The reason for this integration site preference is unclear, but may result from a subtle 
sequence preference of the preTa encoded endonuclease.  Alternatively, this observation may 
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reflect limitations on L1 preTa insertion events imposed by chromatin organization.  However, it 
is likely that both factors, as well as others not mentioned here, are important in determining 
where in the human genome young L1 elements will integrate.  It is also interesting to note that 
some preTa L1 insertions have occurred adjacent to known genes. The persistence of these 
newly integrated preTa L1 elements in these regions of the human genome is most likely 
indicative that they have had no negative effects with respect to the function of these genes.  
Twenty-nine of the essentially 105 full length L1 preTa elements identified have both 
open reading frames intact and are putatively retrotransposition competent elements.  The data 
collected from the L1 preTa subfamily along with the L1Hs Ta subfamily (44 elements) yields a 
computational estimate of 73 active L1 elements within the genome that is comparable to 
previous estimates of the number of potentially active L1 elements in the human genome 
(Sassaman et al. 1997).  Collectively, these data suggest L1 elements from multiple subfamilies 
may still be capable of retrotransposition within the human lineage.   In addition, it is also 
important to mention that those full-length elements that no longer have intact open reading 
frames could have previously served as active “source” or driver genes for the expansion of pre 
Ta L1 elements, but have accumulated mutations over time that subsequently inactivated them.   
The computational identification approach described here provides an efficient and high-
throughput method for recovering preTa L1 elements from the human genome, some of which 
are polymorphic for insertion presence/absence in individual human genomes.  Individual L1 
insertion polymorphisms identified, similar to other mobile element insertion polymorphisms, 
are the products of unique insertion events within the human genome.  Because each L1 element 
integrates only once into the human genome, individuals that share L1 insertions (and insertion 
polymorphisms) inherited them from a common ancestor, making the L1 filled sites identical by 
descent (Sheen et al. 2000; Myers et al. 2002).  This distinguishes L1 insertion polymorphisms 
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from other types of genetic variation that may not be derived from a single ancestral allele 
including microsatellites (Nakamura et al. 1987) and restriction fragment length polymorphisms 
(Botstein et al. 1980; Nakamura et al. 1987).  In addition, the ancestral state of an L1 insertion is 
known to be the absence of the L1 element.  Therefore the thirty-three new L1 insertion 
polymorphisms reported here appear to have genetic properties similar to the previously 
identified Alu (Batzer et al. 1991; Perna et al. 1992; Batzer et al. 1994; Hammer 1994; Stoneking 
et al. 1997; Jorde et al. 2000) and L1 (Boissinot et al. 2000; Sheen et al. 2000; Myers et al. 2002) 
insertion polymorphisms and  provide a unique form of genetic variation present in the human 
population that will serve as an additional source of identical by descent genomic variability for 
the study of human population relationships.   
Materials and Methods 
 
Cell lines and DNA samples 
The cell lines used to isolate primate DNA samples were as follows: human (Homo 
sapiens) HeLa (ATCC CCL2), common chimpanzee (Pan troglodytes) Wes (ATCC CRL1609), 
pygmy chimpanzee (Pan paniscus) Coriell Cell Repository Number AG05253, gorilla (Gorilla 
gorilla) Lowland Gorilla (Coriell Cell Repository Number AG05251B), green monkey 
(Cercopithecus aethiops) ATCC CCL70, owl monkey (Aotus trivirgatus) OWK (OWKidney) 
ATCC CRL 1556, and Orangutan (Pongo pygmaeus) (Coriell Primate Panel PRP00001 Cell 
Repository Number NG12256) .  Cell lines were maintained as directed by the source and DNA 
isolations were performed using Wizard genomic DNA purification (Promega).  Human DNA 
samples from the European, African American, and Asian population groups were isolated from 
peripheral blood lymphocytes (Ausabel et al. 1987) available from previous studies (Stoneking et 
al. 1997).    South American Human DNA was obtained form Coriell Human Variation Panels 
HD17 and HD18.  
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Computational Analyses 
The draft sequence of the human genome was screened using the Basic Local Alignment 
Search Tool (BLAST) (Altschul et al. 1990) available at the National Center of Biotechnology 
Information Genomic Blast page (http://www.ncbi.nlm.nih.gov/BLAST/).  A 19 base pair 
oligonucleotide, 5'-CCTAATGCTAGATGACACG-3' that is diagnostic for the preTa subfamily 
was used to query the Human Genome database with the following the optional parameters: filter 
none; advanced options -e 0.1, -v  600, -b 600.  Copy number estimates were determined from 
BLAST search results.  Sequences containing exact matches were subjected to additional 
analysis as outlined below.  
A sequence region of 9000-10000 bases, including the match and 1000-2000 bases of 
flanking unique sequence were annotated using RepeatMasker version 7/16/00 from the 
University of Washington Genome Center Server (http://repeatmasker.genome.washington. 
edu/cgi-bin/RepeatMasker) or Censor from the Genetic Information Research Institute 
(http://www.girinst.org/Censor_Server-Data_Entry_Forms.html) (Jurka et al. 1996).  These 
programs annotate repeat sequence content and were used to confirm the presence of preTa L1 
elements and regions of unique sequence flanking the elements.  PCR primers flanking each L1 
element were designed using Primer3 software available at the Whitehead Institute for 
Biomedical Research (http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgiand) and 
were complementary to the unique sequence regions flanking each L1 element.  The resultant 
primers were screened with standard nucleotide-nucleotide BLAST [blastn] against the non-
redundant (nr) and high-throughput (htgs) sequence databases to ensure they resided in unique 
DNA sequences.  Primers residing in repetitive sequence regions were discarded and new 
primers designed if possible.  A complete list of all the L1 elements identified using this 
approach is available from our website (http://batzerlab.lsu.edu).  Individual L1 DNA sequences 
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were aligned using MegAlign with the ClustalW algorithm and the default settings (DNAstar 
version 5.0 for Windows) followed by manual refinement.  
PCR Amplification 
 
PCR amplification of  255 individual L1 elements was carried out in 25 µl reactions 
containing 20-100 ng of DNA of template DNA, 40 рM of each oligonucleotide primer 
(APPENDIX B Supplementary Data Table 3), 200 µM dNTPs, in 50 mM KCl, 1.5 mM MgCl2, 
10 mM Tris-HCl (pH 8.4) and Taq DNA polymerase (1.25 Units).  Each sample was subjected to 
the following amplification for 32 cycles: an initial denaturation of 150 seconds at 94 °C, one 
minute denaturation at 94 °C, one minute at the annealing temperature (specific for each locus), 
and  an extension at 72 °C for one minute.   Following the cycles a final extension was 
performed at 72 °C for ten minutes.  For analysis, 20 µl of each sample was fractionated on a 2% 
agarose gel with 0.05 µg/ml ethidium bromide.  PCR products were directly visualized using UV 
fluorescence.  The human genomic diversity associated with each L1 preTa element was 
determined by the amplification of 20 individuals from each of four geographically distinct 
populations (African American, Asian, European, and South American) for a total of 160 
chromosomes. 
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Retrotransposons have had a major impact on human evolution by helping to shape the 
structure of the human genome and in the creation of genetic diversity.  In this study the 
impact of L1 mobilization on the human genome was examined and the human genetic 
diversity associated with the recently integrated L1 elements was measured. 
In chapter two, we analyzed 468 Ta L1Hs (L1 human specific) elements from the draft 
human genomic sequence and estimated that this subfamily contains over 520 members in the 
human genome.   A total of 262 Ta L1 elements were screened with polymerase chain 
reaction (PCR)-based assays across diverse human populations and various non-human 
primate species to determine their phylogenetic origin and the level of human genomic 
variation associated with each element. One hundred fifteen (45%) of the Ta L1 elements 
were polymorphic with respect to insertion presence or absence.  All of the Ta L1 elements 
analyzed by PCR were absent from the orthologous positions in non-human primate genomes, 
except for a single element (L1HS72) that was also present in the common (Pan troglodytes) 
and pygmy (P. paniscus) chimpanzee genomes.  Sequence analysis revealed that this single 
exception is the product of a gene conversion event involving an older preexisting L1 
element.   
One hundred twenty-four of the elements were full length (6 kb) and have apparently 
escaped any 5' truncation.  Forty-four of these full-length elements have two intact open 
reading frames and may be capable of retrotransposition.  Sequence analysis of the Ta L1 
elements showed a low level of nucleotide divergence with an estimated age of 1.99 million 
years, suggesting that expansion of the L1 Ta subfamily occurred after the divergence of 
humans and African apes.  
The preTa subfamily of Long INterspersed Elements (LINEs) was analyzed in chapter 
three.  Estimates suggest that this subfamily contains approximately 400 members in the 
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human genome, and has low level of nucleotide divergence with an estimated average age of 
2.34 million years old suggesting that expansion of the L1 preTa subfamily also occurred just 
after the divergence of humans and African apes.  Three hundred sixty-two preTa L1 elements 
were identified from the draft human genomic sequence, investigated the genomic 
characteristics of preTa L1 insertions, and also screened individual elements using PCR 
assays to determine the phylogenetic origin and levels of human genomic diversity associated 
with these L1 elements.  All of the preTa L1 elements analyzed by PCR were absent from the 
orthologous positions in non-human primate genomes with 33 (14%) of the L1 elements being 
polymorphic with respect to insertion presence or absence in the human genome.  
Computational analysis of the preTa L1 elements revealed that 29% of the elements amenable 
to complete sequence analysis are essentially full-length (approximately 6 kb) and have 
apparently escaped truncation.   Twenty-nine of these full-length elements have two intact 
open reading frames and may be capable of retrotransposition 
 Analysis of the L1 Ta and preTa subfamilies involved the characterization of over 
800 recently integrated L1 elements from the draft sequence of the human genome.  Estimates 
suggest that L1 mobilization alone is responsible for increasing the size of the human genome 
by roughly 1.4 million bases.  The impact of these elements is even more dramatic when one 
considers the subsequent expansion of Alu and other retransposonable elements that were 
driven by L1 enzymatic machinery.   Computational evidence suggests that over 70 human 
specific L1 elements may still possess the ability to retrotranspose within the human genome 
and include currently active L1 source genes that continue to fuel the expansion of 
retrotransposons within the human genome.  Interestingly, over 35 Ta and preTa L1 elements 
were found adjacent to exons, though the majority of insertions showed a general preference 
for gene poor regions of the genome with low GC content.  In addition, over 500 recently 
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integrated L1 insertions were analyzed using L1 element specific PCR assays.  One hundred 
forty-eight of these insertions are polymorphic with respect to insertion presence or absence in 
the human genome, providing further evidence that L1 mobilization occurred during recent 
human evolution.  Furthermore, the L1 insertion polymorphisms reported here will provide 
useful genetic markers to study human population genetics. 
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Table 1 - L1Hs Ta PCR Primers, Chromosomal Locations, and PCR Product Sizes. 
 
Product Sizes4  
Name Accession 
Chr. 
Loc.1 5' Primer Sequence (5'-3') 3' Primer Sequence (5'-3') A.T.2 
Human 
Diversity3 Filled  Empty  
Subfamily  
Specific 
L1HS1 AC010739 2 AGGGAATGCTTATATTGTTGATGAG ACTTCCTTCAGGGTTAATAGCAAAG 60 FP 3877 159 224+ 
L1HS2 AC010305 16 ACCAAATATCTGGACACTTTCTGG GAAGTCAGCAGTGGTTAATTTTACA 60 IF 6131 74 171 
L1HS3 AC008572 5 GCTTCTAGAATTGGAAGTAATATGG AGTAGCCTTGAATCATCTTTTG 56 FP 656 95 422+ 
L1HS4 AC009494 Y INSERTED IN REPEATS INSERTED IN REPEATS - R 467 - - 
L1HS5 AC020647  12 TCAACTACAAAGTTGAAGAATAGG GTTTCCATCAACAAGATCATGTCAAG 58 LF 546 376 455+ 
L1HS6 AC016138 3 TTTATTTCCCTGCATCTGATTA CCTGTTATTAGATAATGAGTTCTAGTC 54 HF 402 122 219+ 
L1HS7 AC004773 7q11 CCTTAGACATATTCTTGGAAATAG CCAGAATATTTGGGTATTTCATCTG 58 HF 326 169 256+ 
L1HS8# AC004491  7q INSERTED IN REPEATS INSERTED IN REPEATS - R 1689 - - 
L1HS9# AC004694 7p TCTTTCAATGGAAACAAGAGGTATC AGGGAGAGGGACACTGAGTTTAT 59 FP 6126 74 178 
L1HS10* AF149774 7p INSERTED IN REPEATS INSERTED IN REPEATS - R 6076 - - 
L1HS11 AL049842  6q INSERTED IN REPEATS INSERTED IN REPEATS - R 667 - - 
L1HS12* AC007538 Xq28 GTTAAAGCAATCAAGCAATCTACTG TAACAAGGCCACTGTAGAAAAGATT 59 FP 6188 104 209 
L1HS13# AC007938 7q31 ATGGGAAGGAACCCCATCTAT AATTACTCCTCTCTTTGGCCTGTT 59 HF 745 128 220+ 
L1HS14 L05367 17q AAGTGGATTAACAGTAACATACAGA CCAAGCTGATAACTGATTATCTCA 55 IF 601 251 158 
L1HS15# AC007556   2 AATGCATACCCATGAGGACAA ATGGTGTTGCACAACAAAAGAA 60 HF 6167 126 197 
L1HS16 AP000220 21q CCCTCACAGAGTGCTTGGTAA GGGAAGGTAGGAAAACAGATT 56 IF 368 101 207+ 
L1HS17# AC007486   X GCATCCCTAAAGCAATAATCCA GGAATTTTCCACTTGTGGTGTC 60 Paralog 4286 90 170+ 
L1HS18 AC005798 4 TTGAACAGCTTAGACTCGTCAGATA GCAGTTAGACAGGAAAACAGAAAGA 60 HF 6174 87 212 
L1HS19 AC007876 Y INSERTED IN REPEATS INSERTED IN REPEATS - R 6115 - - 
L1HS20 AC009241 2 AATGGAAGAGCTCTCAAATTCCTTA GCAACCATTCAAAAATTTACAACAG 61 IF 2302 62 181 
L1HS21 AC008277 2 GTGTTGGCATATTTCTATTCG TAAAGGCTGAACTTTGCATTG 57 LF 2606 84 178+ 
L1HS22 AC010682 Y GCTCTCGGGTTCTTCTACCTCT TCTACTGTTCCATGCAATAGATGTG 60 NR 3216 266 249+ 
L1HS24#* AC004554 Xp22 GTGTATTTTGCCTTTTGAACCAA CAAAAACTTGTTTCACTTGATTTTTAG 59 IF 6148 101 181+ 
L1HS25#* AC002385  7q31 GAGGACCTTATTCATTTATTGC CCATCTGAGCTTTAGTTTTGTCATA 60 FP 6140 94 191+ 
L1HS26# AC003689 11q12 GCTTCAAGCTTAAAAGATGTAGACT CCTACCCAAGTATCCACTGTCC 60 IF 2652 589 420+ 
 80
(Table cont.) 
         
L1HS27 AC007736   2 AGAACGTTGCCACATTATTTTGA GTAGGAAGGTCTGGACTGGAGTATT 58 FP 3667 68 214+ 
L1HS28*@ AC002980 Xp22 CTTTTGTGACACTGGATTTCTAGC CACTGTATATTGGAGCTGTTTTTCC 58 IF 6531 282 373 
L1HS29# AC005090 7p INSERTED IN REPEATS INSERTED IN REPEATS - R 1476 - - 
L1HS30# AL022166 Xp11 CCCTAAACAGAAAGGAAAATGAGAC TCCTCATTGTGGTTCAAGGTTATAC 60 IF 4795 97 175+ 
L1HS31@ AC019212  X GACAACACAAAGAAAACCCAAGAT CTTATGTCCCAAAGCTAGTGAGTGA 56 FP 2317 86 176 
L1HS32# AC004911  7q TCTCTAATCCAGCCTTTCAATTC TGTTTCTTTTCCTGTGTGTTTCC 57 IF 463 280 384 
L1HS34@ AC002122   5p15 ATGTCTGTCTTGACATTCCTAAGC AATATGTAGAATGGCACAGGCTTC 58 IF 2177 284 328 
L1HS35* AC010081  Y CTACCACATAACTGAGTGACAGTTT CAATGTGCATCCATATAGCTGTGTT 61 FP 6308 233 239 
L1HS36# AC004000 Xq23 INSERTED IN REPEATS INSERTED IN REPEATS - R 6038 - - 
L1HS37 AC003080 7q31 INSERTED IN REPEATS INSERTED IN REPEATS - R 6017 - - 
L1HS38# AC004142 7q31 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS39 AC005690 4 AGAACCAATCTTGCCCACAC TGAGGAGTTTCTGAGTAACCTGGTA 60 HF 6337 155 189 
L1HS41 AF222686    Xp11 INSERTED IN REPEATS INSERTED IN REPEATS - R 1959 - - 
L1HS42 AC020925 5 INSERTED IN REPEATS INSERTED IN REPEATS - R 580 - - 
L1HS43 AF172277 7q21 TTTATTGCACCTCCTGGTAAAGTAG AGAGCACCATTAAACAACACAAGAT 58 IF 6157 89 191 
L1HS44# AC004883 7q TAGCTGTGCTTGTTATGTCCAGTT GAATGAGTTTTGTGTGGTTCTGTG 57 VLF 2288 478 615+ 
L1HS45# AC004865    1 AATAGGCCCAGCTATTAGATTTAGC CCTTTAAACCTTTGAACACGATTT 53 FP 329 81 150+ 
L1HS46#* AC006027  7p CCTGTGTTCCTTTTGTAATCC CAAATGTCTCTTCAAGGACTG 55 HF 6382 326 183+ 
L1HS47 AC006986    Y AGTCAAATGATTTTTAACTGCTG GAGGGCAAGATCATGAAACA 58 Paralog 6177 86 230+ 
L1HS48# AC005105 7p CGAAAAGCTTAGGAAACTGTTTGT TAAGCAATCTTCAGTTTAGGAAA 58 FP 1242 810 420 
L1HS49 AC010202 12q INSERTED IN REPEATS INSERTED IN REPEATS - R 612 - - 
L1HS50 AF198097  Xp11 INSERTED IN REPEATS INSERTED IN REPEATS - R 6308 - - 
L1HS51 AC008055  12q22 GCCCCTTACGTTAGAATAGAAAC TGGATTGGTCCATACTACTGT 55 FP 1094 272 239+ 
L1HS55#* AC004704  4q25 INSERTED IN REPEATS INSERTED IN REPEATS - R 6063 - - 
L1HS56# AC005908 12p13 CCATTCATCAGCCATTTGCTA GTGGCTTTAAAACAACGAGATG 59 FP 6545 459 494+ 
L1HS57# AC006222 4 CAGCAAGACTCTGTCTCTAAAATGAT GGACTTGAATTTGGTCTTGTTTCTA 59 LF 589 195 284+ 
L1HS58# AC005939 17 INSERTED IN REPEATS INSERTED IN REPEATS - R 6101 - - 
L1HS59 AC003678 11q12 INSERTED IN REPEATS INSERTED IN REPEATS - R 2081 - - 
L1HS60# AC006465 7p GAAGTATGGAAATTGAGTCACA CCCTAAGCTGTATCACTTTAAAACA 56 FP 445 104 246+ 
L1HS61# AC002288 16p12 ACGTTTGTGCTTCACTCTAAGTTCT CAAAATACCGGGATTATAGTTGTGA 57 FP 353 68 175+ 
L1HS62 AC006840 4 ATTAAAAGGAATGGACATGCAACAC AATCTCAAAAGCTTCCTTGCACT 60 FP 6282 182 256+ 
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L1HS63 AC023423  Y AAGAAAGTGTTGTCAGAGAGTGTGA AGGCCATTGGTCAGTCATAATTT 60 Paralog 6160 115 200 
L1HS65# AC004053 4q25 INSERTED IN REPEATS INSERTED IN REPEATS - R 1781 - - 
L1HS68#* AC004200 6p21 INSERTED IN REPEATS INSERTED IN REPEATS - R 6242 - - 
L1HS69#@ AC004220 5 GGATGTTGATGATGGAGTCAGTC TAACCATTTGAAACCATTAGAGGTC 60 FP 1410 76 180 
L1HS70#@ AL049588 Xq GTTCATTTGAGTGAGGGTACTGTCT TAAGTCCCAAAAATTGCATCC 59 IF 3174 175 256+ 
L1HS72 AL133413 9q CTGAGATGAGACAGCAGGTCTTC TCTGCTGAGATTCTTCCATTTACC 60 FP 825 147 221 
L1HS73 AC018822 3p ATAAGGAGCCTAGGGAAGAACTTTT CAAGCATGCCTGAAACATCTAT 55 HF 1126 462 162+ 
L1HS74* AC011990 17 CTGGACGTATTTCTTACAGAGTTGA CCCTAAGTTATTTTCCTTGAGGCTA 60 LF 6163 125 186+ 
L1HS76 U08211 X END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS77#@ AB020867 8p TTCCTAAATGGCCTTACTATCCTTT TCAGAAGTGCTAACAACTCTAGTAGGA 58 HF 990 78 233 
L1HS78# AP000084 21q22 TAGTACCTCCCTTAAAGAGCTG GAGGAAAAGAAAAGTGCCTGATA 59 IF 374 107 175+ 
L1HS80# AC017051.4 UL INSERTED IN REPEATS INSERTED IN REPEATS - R 1823 - - 
L1HS81 AP000962 21q21 AAGTGTTATATATTGGAGCAATTC ACAAGACAATGCCAATTTTAAGAGA 60 FP 848 148 401 
L1HS83# AJ001189 Xq12 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS85 AC008132 22q11 TTTGTATGCCTTGTGTTTTGTATTG AGGAGAGTCTCATCTCCAGAGTTAC 58 LF 593 79 183+ 
L1HS86* AL121825 22 GCAGTATCAGGAAATGCAATACAC GGGATTCAGTCACCTTTATTAGACA 60 HF 6154 410 180+ 
L1HS87* AL078622 22 INSERTED IN REPEATS INSERTED IN REPEATS - R 6065 - - 
L1HS91# Z84572 13q12 ATACGTGCAAAACAGGAGATTTGA TGTTTATGGTGAAGGATAAGTCTCA 59 FP 1619 78 167 
L1HS92 AL022153 Xq ACAATCCCTACTTCAGAAAGTT CAACACTTTGATCATGAATAATAGCTC 57 FP 859 121 206 
L1HS93 Z95325 Xq21 INSERTED IN REPEATS INSERTED IN REPEATS - R 4882 - - 
L1HS94#* AL031586 Xq TCGTATGAATAACCTTGTGTTCTTG TTTAGATCCTCGTCACTCAAAGTGT 57 FP 6250 151 264 
L1HS95# AL023284 6q GGAAATTCTCAAGCTCAAGTTAAAA CTTTTAAAGTGTGTTCTCACAGTGG 60 FP 717 119 320+ 
L1HS97# AL030998 Xq AACCAAACCCACAATCAGTAGAA CTAGCTAAAGGTTTGCTATTTTT 58 FP 1640 182 407+ 
L1HS98# AL022099 6p ATCTGCATTGGGCCAAGTTTT TCTCCTGTAAGACAGCACCATA 60 FP 1561 129 242+ 
L1HS99# AL022726 6p INSERTED IN REPEATS INSERTED IN REPEATS - R 6290 - - 
L1HS100 Z98754 Xq INSERTED IN REPEATS INSERTED IN REPEATS - R 6161 - - 
L1HS101# Z72519 X END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS102# AL096677 20p CCATTTGCCATAAATAAAGGCATC ACTGTTACAAGTTTCCCCAAATGT 59 FP 6741 611 542 
L1HS103* AL121591 20 INSERTED IN REPEATS INSERTED IN REPEATS - R 6019 - - 
L1HS104# AL096799 20 GAGATGTGGTTTTGTTTGAACTG GCAGCTCACATAGTTTAGAGAAGAT 59 IF 6196 131 219+ 
L1HS106 AL117339 10 CTGACTGTTGAAACTTCTCCATTG CAATAGACATGAAGGCATGGAAG 57 FP 3103 378 345 
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L1HS108* AL031768 6p INSERTED IN REPEATS INSERTED IN REPEATS - R 6091 - - 
L1HS109* AL137191 14 GCCTTTCTATCTTTTGCTCTTGGT GACACATACCAATTACAGGCAAAG 59 FP 6549 501 381+ 
L1HS110#* AL078623 20 GGATTCTGACCTTATTCTAACAGCA AGTTGACTGTTGGTGTTGATTGTGT 56 HF 6263 212 253 
L1HS111# AC002069 7q21 INSERTED IN REPEATS INSERTED IN REPEATS - R 535 - - 
L1HS112 AC018755 19 AGGTTCCATCTCTAATACTGGATAA  TGATCACTTTGTTGTTAAGATGGAG 60 LF 1686 102 170 
L1HS113@ AL133386 6p AGTTTTGGCCTGAGAGAGAAGTAGA GGTAGGCTAGAGATCCCTTCAATTA 55 FP 405 184 328+ 
L1HS115 AL132639 14 INSERTED IN REPEATS INSERTED IN REPEATS - R 182 - - 
L1HS116 AC024610 18 CTGTGCACTTTTCCATATGTTTGAC TCTAATCTATGGTGGATGCTCTTTC 56 FP 252 76 189 
L1HS117#* AC005885 12q TGCAGTGTTCTATTTATGTCGTAGGT CGAGAGAGGGAGGAAAGTGAG 57 IF 6629 535 176+ 
L1HS118 AC020599 4 ATGCCAGAAATACCTCTTTTACCTT  CTAAGTGCAATTCTCTCAGATTTTG 60 IF 6321 286 277 
L1HS119# AC005739 5 GGCTTATTTAGAGCACCTGGATTTA GAGATCCAAAGCTTATGCTGTAAGT 60 FP 904 243 257+ 
L1HS123# AC005350 5q INSERTED IN REPEATS INSERTED IN REPEATS - R 397 - - 
L1HS124# AC004499 20q TGACATAATTAATGGAGAAAACCAG GAGATCCCTGTCCTTGTGTGAT 60 FP 749 515 373+ 
L1HS125 AF001905  Xq25 CCTCACGTTTCTCCACATTGTA TTCTGGCCTTCATAGTGTTTTA 60 HF 332 96 169 
L1HS126# AC004784 19q13 INSERTED IN REPEATS INSERTED IN REPEATS - R 1552 - - 
L1HS127 AC004384 X INSERTED IN REPEATS INSERTED IN REPEATS - R 225 - - 
L1HS129# AC003100  4q25 INSERTED IN REPEATS INSERTED IN REPEATS - R 1132 - - 
L1HS130 AL133320 1p INSERTED IN REPEATS INSERTED IN REPEATS - R 6066 - - 
L1HS131 AL163152 14 TTGACTGTGTACTGCCAGTCTCT GTAACCTACCAGTTTACAGTTACC 58 IF 381 179 212 
L1HS132 AP001693    21 CCCTGATACACCAGTATATCTTA GAAAAGAAAAGTGCCTGATA 56 IF 753 486 173+ 
L1HS133 AC008716 5 CATGGTGTCCCAGTGTTAAAAA TATCTCTTACCTCTTCTTGCCCATA 59 FP 3351 821 738+ 
L1HS134 AF265340 16 CACAGTCAACTCAACCACTGAATAA AAGGAGATGGAAGTAAGTGCAAAC 60 FP 751 433 603+ 
L1HS135 AL137804 11p TTTTTGAAGGGAGTACAGTAATAGGT GCCTTCCATAGTTCCTATTTGC 58 FP 6475 429 500+ 
L1HS136 AL157791 14 INSERTED IN REPEATS INSERTED IN REPEATS - R 175 - - 
L1HS137 AL157879 5 INSERTED IN REPEATS INSERTED IN REPEATS - R 6057 - - 
L1HS150 AP000966 21q21 CAAGAACAACTGAAAAATGCAGAT CCCCTCAGTCTCTGGTTACCTA 58 FP 642 89 141+ 
L1HS151 AC019205 6 CTTTGATCAGTTCTTGGAACTAGGA CCTCTATGCCTTATTCATGCTTATC 60 FP 573 405 476+ 
L1HS153 Z84814 6p CCAATTCACTTTGTCTCCTAGAAAT AGTTCACGAAGTTGAAAGCTTATGT 60 IF 931 169 219 
L1HS155 AC019050 2 TGGCATGTCAATATATACCTGAAGA GGAAAACAGAAATAAAAGACGGACA 60 FP 7004 596 720 
L1HS157# ALO49842 6q ATTCAAGTTCCAGTAAGCTGTGTTT GAACTTTGGAAAATTCACAACTACC 60 HF 892 143 245 
L1HS158# AC008467 5 CAGCCCAGAGTAGTTCATGTTTT GAAGGAAAAGGAGCTGCTTAGATA 59 IF 6194 147 207+ 
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L1HS159 AC009976 Y INSERTED IN REPEATS INSERTED IN REPEATS - R 1439 - - 
L1HS160 AL121938 6q CTAAATAGGCAGAGGAAAGGAAAAC TAAACTTCCAAGAGATCAGCACTTC 60 HF 1071 99 225+ 
L1HS162 AC009404 2 INSERTED IN REPEATS INSERTED IN REPEATS - R 463 - - 
L1HS163 AL139114    9p GGGACAGGGGTTAAGATTTTATTTT AGTTCTCAACTGTAAAGGCAGTGTC 60 IF 2898 85 251 
L1HS164 AB045357 1q GGAAGGAAGTGGGGATAATAAGTAA CCCAATTCAGTTTCTTCATTCTATG 60 FP 1507 193 267+ 
L1HS165 AC011666  1q21 CACAGTGATGGAGTTACAATCTTTG GCTTTAAAGTCAGACAGGCTTGAGT 62 FP 1509 200 276+ 
L1HS166* AC021017 8 TGCCTGAAATGCTATTGGTAGTATC GTGCCCAGCCCATAATATAAA 60 IF 6204 102 251 
L1HS167 AC018637 7 INSERTED IN REPEATS INSERTED IN REPEATS - R 2975 - - 
L1HS168 AC009492    2 CTTTTTCAAGGCCATCTGTGAG AATCCTTACAATGAAAAGGGTGT 61 FP 666 97 180 
L1HS169 AL118519 6q TATTGAGGTGTAACCAGCATACAAT CCACACGAAAGATATATGAATTGC 60 IF 6289 214 288 
L1HS171 AL137145 10 GAAAGTTCATGAAAGTTGTGATGC ACAAGAGAATCTATCTCCTGAAGAA 60 IF 6157 91 198 
L1HS172 AL133479 9p CTAAGATCAGTCACAGGCTTAATGA CAGGTGCAAGTGGTTTAATTTTC 60 IF 1326 111 193+ 
L1HS173 AL359218 14 CACCATCTAGTGATTTTATGTTCTGC AATAATCCCCATTGACTGTGTACTG 55 HF 319 123 217+ 
L1HS174 AJ271735 Xq INSERTED IN REPEATS INSERTED IN REPEATS - R 3252 - - 
L1HS175 AL136382 1p INSERTED IN REPEATS INSERTED IN REPEATS - R 717 - - 
L1HS176 AC025819 Y INSERTED IN REPEATS INSERTED IN REPEATS - R 1522 - - 
L1HS177 AC017015 18 CAAGTTCCTCACCAAATGAAACTAC  TCCATTTTACTGATGTTGAATAGGC 58 HF 693 165 273+ 
L1HS178 AC023480 3p GAATATTGAGCTTTCTTCACCTTT CAAGCATGCCTGAAACATCTAT 60 HF 508 54 162+ 
L1HS179 AC017089 4 INSERTED IN REPEATS INSERTED IN REPEATS - R 3573 - - 
L1HS180 AC009276 7 GGAGTGTAGAATACTGGGGAAAATC CTTATTTCCCAATGAGCCCTGTA 56 IF 507 84 225+ 
L1HS181 AC025759 5 INSERTED IN REPEATS INSERTED IN REPEATS - R 1179 - - 
L1HS183# AC000100 19 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS184 AL450108 X INSERTED IN REPEATS INSERTED IN REPEATS - R 6094 - - 
L1HS185 AL157837 1q CTGGCAGTTCCCTCAATGTAA GAGTAGCTAGCAAAACAGGTAATGAA 60 FP 604 108 214+ 
L1HS186 AL359332 14 GGTCTAACAATATTCATGATGC CCTCTTTTACCCTGTGAAGAAAAT 60 FP 6313 249 205+ 
L1HS187 AL357153 14 INSERTED IN REPEATS INSERTED IN REPEATS - R 6059 - - 
L1HS189 AL512407 6 INSERTED IN REPEATS INSERTED IN REPEATS - R 907 - - 
L1HS190 AC073893 Y TCTACTGTTCCATGCAATAGATGTG GGGTTCTTCTACCTCTGCATAACT 57 NR 3243 190 331 
L1HS191 AC007972 Y TCCTCCAAGACCCTCTAAAATAAAT TTTTGTCTTCCCTGAGTAAATTCTG 60 FP 2645 122 251 
L1HS192* AC018680 4 TTTCACTTTTTCTATGGTGATGAGG CTTAGAATGTTACACTTTTCCGACA 60 FP 6218 155 196 
L1HS193 AC018503 3 CTACAGTGGCATTTCTTTAGGACAA TATACAACAGAACTGAATCACTGAC 60 FP 6296 239 288 
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L1HS195 AC044791 15 GCTTACATCTCAAATTCTGGTACCTT TGTAAGAGCCAAAGCCTTTTAAACT 60 FP 1521 150 209 
L1HS196 AC025263 12 INSERTED IN REPEATS INSERTED IN REPEATS - R 6071 - - 
L1HS197 AC027332 5 TGGAGTAGAATTCAAGCAAACTGAA AGAGTTTATGATAGGTCCCCATTCT 60 HF 6226 97 260+ 
L1HS200 AC009892 19 INSERTED IN REPEATS INSERTED IN REPEATS - R 1686 - - 
L1HS202 AL391097 20 TTGTACCTATGATTTGTGTGATAGGC GCTCTACATAAAAAGATGTTCACCA 60 FP 990 754 435 
L1HS203 AL354750 10 INSERTED IN REPEATS INSERTED IN REPEATS - R 152 - - 
L1HS204 AL157815 13q ACTAGTTGATGACAAACTGGATGTG GAGTGGCATAATCAATTGCTAGAGA 60 FP 647 126 182+ 
L1HS206 AL355382 6 GTTTGTCAAGTGACAGGAATCTCTT GCTAAGTCATCAATAAGCCCCTAAT 60 FP 2704 154 186 
L1HS207* AL354861 9 CTTTGCATATCTCTGTCATCCTACA GATGAGATCATTCACACACTTTCTG 60 FP 6208 164 170 
L1HS208 AL354793 X AACATTGGGAGAAGTTTGCAGTAT CCAAGTTGTTAAGCACTCCATAGTT 60 FP 6639 570 689+ 
L1HS209 AL158159 9 GATGAGTTATCTTTGACGCTTTGAC TGATAGATGAATGAGCTTTATGGTC 57 FP 508 118 213+ 
L1HS210 AL135908 6 ATGTGGGGAAGATGAAGAAATC GAAAACCCCACTATAGGAGTAAATTG 59 NR 5322 132 564 
L1HS211 AC079598 12 TCTATCGTCTCTGTCTTCTTAATGC AATGACACTCTGCCTTCAGACTTAG 57 NR 3001 275 407+ 
L1HS212 AL157700 Xq TTCTAGCCCTCTACTAATGTCCTTG TTCTAAGGTAGCTGCAGATAAGTGG 60 FP 1045 184 234+ 
L1HS213 AC087432 3p AATGCCTGATAAAAGTAGACACACC GTGGGAATATATCTTCTTGGGTTT 60 HF 1710 89 188+ 
L1HS214 AC007483 3 TAGCTGAGAAACCATAAGCCTAGAA ACCTGAATGTCCACTCATTCACT 60 HF 4159 328 330+ 
L1HS215 AC037423 9 INSERTED IN REPEATS INSERTED IN REPEATS - R 1162 - - 
L1HS216 AC023880 7 CTATACCAAATGCAGTCAGGATGTT TCCCATAACTCTGTCACACTAGAAA 59 FP 714 197 228 
L1HS217 AC073148 7 INSERTED IN REPEATS INSERTED IN REPEATS - R 6063 - - 
L1HS218 AC016910 2 TCTTACAGCACTATTCAGTGTTTGC TTCCTCTCAAGGAACTCAAACC 60 FP 6136 82 174 
L1HS219 AC021020 3 INSERTED IN REPEATS INSERTED IN REPEATS - R 6096 - - 
L1HS220* AC016635 5 ATTGGCCTTCAGAAGTGATTAAGAC TAGATAGCCAGACAAACAAACCTTG 60 LF 6244 135 260+ 
L1HS222 AL445932 6 TCTTTCTCCTCTTGTAATGTCTCAG AAGATACTGTGCTTCACTCTTCTGG 60 LF 6195 118 238 
L1HS223 AL450488 X INSERTED IN REPEATS INSERTED IN REPEATS - R 4210 - - 
L1HS224 AL358934 9 GATCTGAATCTTTGCTCTCCAGATA ACGTGGTACAAAAGAAAACACTGTC 60 FP 1121 126 215 
L1HS225 AL445523 X INSERTED IN REPEATS INSERTED IN REPEATS - R 3537 - - 
L1HS226@ AL353153 6 CCCTAAGCCTGTCAGAAGTTAGTATC GCCATGAAAGATAAGGAGATAAGAG 60 LF 2114 120 359 
L1HS227 AL157701 X INSERTED IN REPEATS INSERTED IN REPEATS - R 518 - - 
L1HS228 AL353657 13q AATATCCACTACCCAATTCCATAGG GCTGCAATTTAGCAGGATTTCT 60 HF 1383 184 205 
L1HS230 AL359174 6 INSERTED IN REPEATS INSERTED IN REPEATS - R 1291 - - 
L1HS231 AL354896 13 GAGTATGAGAGCTCTGCTTTCTGTC CTTGAAGGACTGGGATACTTGAAA 60 HF 2289 379 481 
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L1HS232 AL365367 1p32 TGTCACTCCAGTGATAGAAGCTAGA ACAGTTAACTTCAAGGCAGGTTGAC 60 FP 1181 69 214+ 
L1HS233 AL357507 6 TAGTTGTCTACAACCAAGTGCTGAG TCTGCATAGATCAGGAATTCTAAGG 59 IF 1232 81 174 
L1HS234* AL356438 6 INSERTED IN REPEATS INSERTED IN REPEATS - R 6092 - - 
L1HS235* AL158193 13 ACAGGATCTTAAGGTTGAAGGTTTG GGTTCTACCCAAAGTAGTCAAGAAA 59 IF 6441 420 179 
L1HS236 AL365400 X INSERTED IN REPEATS INSERTED IN REPEATS - R 1711 - - 
L1HS238 AL357519 6 GCAGGTAGGATACATGTAAGCATTT ATCACAGCAATGGCATATCATC 60 FP 2155 374 360+ 
L1HS240* AL137845 X INSERTED IN REPEATS INSERTED IN REPEATS - R 6103 - - 
L1HS241 AP003112 8q23 GATAATCAGGTGATTGTGAACTGTG CTACCACCCTTTTTACTCCCTTTAC 60 FP 366 148 206+ 
L1HS242# Z80899 6p21 AGTTCACGGTCTCTATCTCTCCTTT AACCTGTCTTTGACTGTTGAGC 58 IF 576 150 277+ 
L1HS243 AC019041 2 CACTAACATTCTGCATCTCACAATC GTGGGAGGACATGAATAACACAT 58 FP 6148 96 202 
L1HS244 AC009269 15 INSERTED IN REPEATS INSERTED IN REPEATS - R 5512 - - 
L1HS245 AC017040  2 AAGGCTCTTTATCACAGGAAGTACC ACGTTAATCACCGATCATTGC 60 FP 2141 294 263+ 
L1HS246* AC068723 15q21 INSERTED IN REPEATS INSERTED IN REPEATS - R 6224 - - 
L1HS247 AC009274 7 GTGTGAAGTATTACCTCGGTGTTG CTGTGTGGAGCAATAGTAACCAGAT 60 FP 2238 286 275 
L1HS248* AL360236 6 AGAACAAGTGAGTGGCTAAAACCTC AGCCAACAATTTTCCCATCTC 60 FP 6705 658 710 
L1HS249 AL355852 X INSERTED IN REPEATS INSERTED IN REPEATS - R 1297 - - 
L1HS250 AL162373 13 AGTACCTGGTGAGTTCTCCTCAAC GGTCTTTTGTGAGATGTCATACCTG 57 FP 2055 110 194+ 
L1HS251 AL445429 6 INSERTED IN REPEATS INSERTED IN REPEATS - R 757 - - 
L1HS252* AP002768 11q INSERTED IN REPEATS INSERTED IN REPEATS - R 6026 - - 
L1HS253 AP001955 4q INSERTED IN REPEATS INSERTED IN REPEATS - R 1780 - - 
L1HS254 AC013546 8 INSERTED IN REPEATS INSERTED IN REPEATS - R 5961 - - 
L1HS255 AC022731 8 INSERTED IN REPEATS INSERTED IN REPEATS - R 1104 - - 
L1HS256 AC019218 8 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS257 AC016756 8 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS258 AC024905 3 GATTGGACTCCATTTCCTCTTGTAT ATAAATTCTGGGACCTCTGCTTAAT 57 FP 1717 1011 643 
L1HS259 AC020707 9 INSERTED IN REPEATS INSERTED IN REPEATS - R 1893 - - 
L1HS260 AL354982 9 GGCAACGGAATAATAGCTTCA GTCAGCACTCCCATCTTAAATGTCT 57 HF 6461 358 510+ 
L1HS261 AL161631 9 INSERTED IN REPEATS INSERTED IN REPEATS - R 1904 - - 
L1HS262 AC013579  1 GATCCCTGTGTCTGGAGCACT GGAATTCATGGAGAAGGTGAGTT 60 FP 1148 97 186 
L1HS263 AL356139 9q INSERTED IN REPEATS INSERTED IN REPEATS - R 889 - - 
L1HS264 AL391643 9 GAGGAGGAAGAAGGCTGATAATATG GACAGCCACTAAGTTAATGAGATCC 60 FP 284 133 174+ 
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L1HS265* AC018938 9 GCATTATTTCTGGAGCACTCACT GTCTTGTGCTATTAAGCCTGGTCT 60 FP 6087 105 207 
L1HS266 AL137021 9q31 INSERTED IN REPEATS INSERTED IN REPEATS - R 207 - - 
L1HS268 AC025428 10 CTTTGCTCTCTTGCTCCATGTAT TATCTGTTTACCAACCCATCTCACC 60 FP 6235 90 283+ 
L1HS269 AC020642 10 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS270 AC026989 14 INSERTED IN REPEATS INSERTED IN REPEATS - R 313 - - 
L1HS271 AC020644 10 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS272 AL157787 10 CTATGTCCTAGCCTTCCCAGATG AGAAAAGACAAGACAGGATAGGG 58 FP 1125 201 223+ 
L1HS273 AL354951 10 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS274 AC027118 10 GCACATGGCTTCTTAGCTAACTT CTTTCTTGCATAAATGACTCTGTCC 57 FP 2081 611 317 
L1HS275 AL590378 10 INSERTED IN REPEATS INSERTED IN REPEATS - R 1414 - - 
L1HS277 AC026393 10 INSERTED IN REPEATS INSERTED IN REPEATS - R 312 - - 
L1HS278* AC027591 11 INSERTED IN REPEATS INSERTED IN REPEATS - R 6020 - - 
L1HS280 AC078971  11 INSERTED IN REPEATS INSERTED IN REPEATS - R 6063 - - 
L1HS281 AC037434 11 INSERTED IN REPEATS INSERTED IN REPEATS - R 343 - - 
L1HS282 AP001002  11q CTTACCTCCAGAGCATGCACATTAT CCCCTCCTTCTCAATTTAAGGTTAC 61 FP 6448 156 249+ 
L1HS283 AP000409 11 INSERTED IN REPEATS INSERTED IN REPEATS - R 2294 - - 
L1HS284 AC018619 11 AGATAGGAGAATCCTCTGGTCTTCT CTATTGTTGGGTACTTGGGTCACT 58 FP 1877 174 268+ 
L1HS285 AC015772 11 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS286 AC011829 11 INSERTED IN REPEATS INSERTED IN REPEATS - R 1189 - - 
L1HS287 AC021304 11 CCTTTTATCTGAAATAAGTGGTTGG CTTCCTTTAGCTGGGCTGTTCTAAG 61 VLF 1693 95 216+ 
L1HS288* AC016775  11 INSERTED IN REPEATS INSERTED IN REPEATS - R 6081 - - 
L1HS289 AC021245 11 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS290 AP001179 11q CCTGTCAGTCTTATCTTTGCTCTACA GGCATAGAGACAAATCCAAATTAAG 60 NR 6537 285 235 
L1HS291* AC025410 6 CTCCCACTACTTTATGGGAAGGT AGGACTTCCAATTCCTAGTATGCAG 58 HF 5658 216 271+ 
L1HS292 AC073915 12q GACTCCACACTAGCTTCTTTGACTT GAGACTCAGTTGACAAGGAGTTACC 60 FP 1117 117 213 
L1HS293 AC026831 12 TTACAATGGATACGTTAGACAGCTC CCATAATTGGTTAGGATGATGAGAC 60 LF 2517 417 317+ 
L1HS294 AC027442 12 CTTTACCTGTTCCACTAATCAC GGCACAAGATGGATATAAAGGA 57 FP 6154 103 168 
L1HS295 AC012144 13 GAGGAATGGTTGAACAGCTTG ATGTGGCTGGAGAAATACCTCTAAG 61 FP 713 100 208+ 
L1HS297@ AC064857  12 GTCCAGAGTGATGCATTTTATTTGG GCATAGTCATTTAATGCATGTCAGC 58 FP 771 461 549+ 
L1HS298 AC025880 12 ATATACCATACTCCTTTCCCCTTCC TGAGCCCTGTATTTTAATCACTTGT 60 LF 1037 80 235+ 
L1HS299 AC027287 12 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
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L1HS300 AC026577  1 INSERTED IN REPEATS INSERTED IN REPEATS - R 3364 - - 
L1HS301 AC027382 1 CTATCCCATAGATGGTGGGTAGAAT GAGGAAATAGCACAGGTATGGTAAA 61 IF 1770 411 431 
L1HS302 AL365220 1p21 INSERTED IN REPEATS INSERTED IN REPEATS - R 2391 - - 
L1HS303 AL451063 1 CTATGTTCTGGGAGAAGAGCTGAT CTAGGGTCAGAAAGAACTTTGATGT 62 FP 780 87 170 
L1HS304 AL354885 1 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS305 AC016371 1 CAAAAAGCAGCCCTATATTAGC GCCTGCCTCATTATCTTTCATT 58 FP 3998 415 409+ 
L1HS306 AL136459 1 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS307 AL390860 1 INSERTED IN REPEATS INSERTED IN REPEATS - R 6066 - - 
L1HS308 AL390200 1 CCTACTAGGCCCTCTTCTTTTGTAT GTCTTGTTGTGCCAGACACTTTA 62 IF 3441 455 652+ 
L1HS309 AL391904 1 INSERTED IN REPEATS INSERTED IN REPEATS - R 2161 - - 
L1HS310 AL157946 1p31 INSERTED IN REPEATS INSERTED IN REPEATS - R 286 - - 
L1HS311 AL162402 1p13 INSERTED IN REPEATS INSERTED IN REPEATS - R 693 - - 
L1HS312 AL139225 1p13 INSERTED IN REPEATS INSERTED IN REPEATS - R 783 - - 
L1HS313 AC034157  1 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS314 AL357975 1 TGGCTAGCAAAAAGGTGGAC AGGGCAGAGAAAAATGGTCA 58 IF 6215 109 255+ 
L1HS315 AL139137 1 AAGTCCCAATTCCCTAGTCTGTCT GACACAGAATCATGTCACAATACCC 61 FP 6286 77 332 
L1HS316 AC026905 1 CTTTAGCAGTTTTCATGCCTCCT AGGTTGATGGTAACCTGTAGGAAC 59 FP 6240 173 245 
L1HS317 AL356323 1 CTCTGCCTCAAGTGTGTCTTGACTA GAGAACACACCCTTGCTCAGTAAAT 59 FP 901 711 626+ 
L1HS318 AL365225 1 INSERTED IN REPEATS INSERTED IN REPEATS - R 5243 - - 
L1HS320 AL357973 1 GGGATTCAAATGGGAAACAAG CTCCTTTCCAGTATCTGCTCTTATG 60 IF 1748 140 305 
L1HS321 AL356455  1 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS323 AC068071 1 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS324 AL139284 1 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS325 AL360154 1 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS326* AC025702 1 CTCACCGTTATCAAAGGGTAGAAAC CTAGCCCCAAATTTGAGAAACAG 60 FP 6250 156 289+ 
L1HS327 AC018874 1 GGTACAATGTAATCATGGGTTGG GAGTTAACCGTTAGTCCACAAGATG 58 FP 4695 172 413 
L1HS328 AL135842 1q21 INSERTED IN REPEATS INSERTED IN REPEATS - R 2188 - - 
L1HS329 AC058795 1 CTTCACCTCTGAATGACACACAT GGCTTCATAATGCATCGCTAA 60 FP 1188 454 365+ 
L1HS330 AL139285 1p31 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS331 AL138777 1q31 INSERTED IN REPEATS INSERTED IN REPEATS - R 1064 - - 
L1HS332 AC008110  1 CATGTTAGAACTGGCTCAAGTATCC CCTGCAGAAATTTGCCTTTAG 58 IF 2850 87 227+ 
 88
(Table cont.) 
         
L1HS333 AC023026 1 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS334 AC026253 2 ACACTTCTGAGAATTTCCCTGTG TTACTCCCTCTTTACTGTCTTGGTG 60 FP 1095 199 341 
L1HS335 AC023434 1 CATGCATCTCTGAACTACTGACTTG ATAAAAACCTGTTTAGGCCAAGG 60 IF 1276 395 284+ 
L1HS336 AC013264 1 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS337 AC010890 2 GGTACAATATGAGGCATCACGTA GTAGCATCCTTTATAGCTTTGCTGA 60 HF 3174 210 329+ 
L1HS338 AC068953 2 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS339 AC017035 2 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS341 AC069384 2 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS342 AC018591 2 GAGACTCAGTTGACAAGGAGTTACC AAACAGGACCTGCTGTCCATAA 60 FP 1087 78 183+ 
L1HS343 AC068572 2 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS344 AC048375  2 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS345 AC073509 2 CACAGCATTTACCAAAGCACTC CTCAGTTCATTGCACAGTTTGG 60 LF 2587 192 229+ 
L1HS346 AC016674 2 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS348 AC018378.3 2 GAAATGGGAAGAGGAGTTGACA CCTATTTTTATCTCAGCTGATGTCG 60 HF 748 283 526+ 
L1HS349 AC009963 2 GGAGCTGGGAGAATTATTGAAAC CCACTCTCAACTACTGTCCAACAAG 60 HF 229 114 182 
L1HS350 AC022605 2 TGGTATATAGTTCTAAGGACCCACAG GCTACTTTTGCTTCTGGGTGTT 58 FP 725 243 331+ 
L1HS351 AC013262 2 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS352 AC073874 2 INSERTED IN REPEATS INSERTED IN REPEATS - R 970 - - 
L1HS353 AC019324 2 TCCATGATAGAACACACTCTTCC AATCCCTGTCAAAACCAATCC 59 HF 1822 426 167 
L1HS354 AC012442 2 INSERTED IN REPEATS INSERTED IN REPEATS - R 6217 - - 
L1HS355 AC011901 2 INSERTED IN REPEATS INSERTED IN REPEATS - R 6067 - - 
L1HS356 AC009290 2 CATCCTGTTGAAGAACAGAGAGATG ATAGAGTGACCAGAAACTCCAGAGA 60 FP 6290 156 250+ 
L1HS358 AC019130 2 GAGACTCTTTGGACTCAGAGTATAACC AGTCCTGTCATACCAGTTATTGGAC 59 FP 6621 128 673 
L1HS359 AC024062 2 INSERTED IN REPEATS INSERTED IN REPEATS - R 4808 - - 
L1HS360 AC023416 2 GAGGTCTTTGTGCAGAGGTATAAGA CTCACCAACATCAGTTTCCTTTG 60 IF 3222 153 218+ 
L1HS361 AC073642 2 AGCCCATTAGATATATGTGGCTGT CTTTTTATATTGGTCACCCCCAAC 61 FP 6319 281 372+ 
L1HS363@ AC010913 2 GTTAGACAGCGACATGCACAG ACCTCTGTGCCTTACCAAAAAC 60 FP 577 106 198+ 
L1HS364 AC026860 3 CTTAGCCTCTGTCTTTAGGGAAAAC CATGACCAACGGTGCATAATA 60 HF 6139 97 170+ 
L1HS365 AC068355 3 INSERTED IN REPEATS INSERTED IN REPEATS - R 888 - - 
L1HS366 AC083853 3 AGAAAACTTCCAGACACCTATCC CTATGTCCTAGCCTTCCCAGATG 60 FP 1088 163 183 
L1HS367 AC078805 3 GACTCATATTACCCTGGACAACAAC AGTCTCTCCTTGCTCAGTTTGGTAG 60 FP 6784 83 401+ 
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L1HS368 AC023144 3 INSERTED IN REPEATS INSERTED IN REPEATS - R 168 - - 
L1HS369 AC076971 3q END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS370 AC068365 3 GCAATCAGTTTCACACTCAACTG CATGTGATCTATTGTGTACCATCAGG 58 FP 3436 146 323+ 
L1HS371 AC026611 3 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS372 AC022077.13 3 GAAGAGAAAGAGGAAATAGCACAGG CTATCCCATAGATGGTGGGTAGAAT 60 IF 1779 599 431+ 
L1HS373* AC022838 3 GAAAGAGAGTTCTCTGTACCACACC GTCATGTCCCAACAGGACATTT 60 VLF 6294 215 231 
L1HS374 AC063919 3 INSERTED IN REPEATS INSERTED IN REPEATS - R 6265 - - 
L1HS375 AC023139 3 TGTGGTACAGTCACACTACAAAG GATAGCATACACCATCATGCACT 60 IF 3862 430 469+ 
L1HS376 AC069203 3 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS377 AC078856 3q GGGAGATGTAGAGTTTTATGTGACC CTAATGTGCTGGGCAAACATAAGAT 57 FP 577 139 201 
L1HS378 AC069225 3 CTCCCCTTTTTGCCTTACTTCT  CTTACTTGCAATAGCCCATTCAC 60 IF 5569 646 369+ 
L1HS380 AC024470 3 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS382 AC055732  3 GCAGACACTAGAAGCTTTTGCAT GCCACAAAATCTGGCACTTATAG 58 FP 3357 426 185 
L1HS383* AC017085 3 ATTAGTCAGTAATAGAGCCCCCTGT AAAGACTTCTTTCCAGCTCTACCC 60 FP 6493 267 515 
L1HS385 AC078808 3 INSERTED IN REPEATS INSERTED IN REPEATS - R 6068 - - 
L1HS386 AC023438 UL END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS387 AC069417 3 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS388 AC025818 3 INSERTED IN REPEATS INSERTED IN REPEATS - R 713 - - 
L1HS389 AC024216 3 CATGTAGAGATGATCTTCAAAGCTG GCCTGATAAAAGTAGACACACCTG 60 FP 1782 162 263 
L1HS390 AC036128 4 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS391 AC022040 4 GTGGACATCAGAGTATCCCTTTCT AGAAGGGTACATGACAACTGGTTAG 60 HF 889 113 203 
L1HS393 AC013336 4 TACACAGAATCTGATGCTAGGAGAG CGGGAACATAAAGTCATAGCGTAAC 61 LF 751 277 412+ 
L1HS395 AC067804  4 GTTGCATTTTGGAAAGGAAGG TAGTGGAAAGACAGACAGTTTAGGG 61 IF 1218 119 214 
L1HS396 AC007512  4 AGACTCAAACTCAAAACTCCTGTGT TCACAAGCAGACATTTCTTACTGAA 60 FP 6643 562 373+ 
L1HS397 AL161439 6 ACTCATCCTAGAGCTTTACCCAGTT CACAAAGTCAACAGGTTTGATCC 58 FP 1085 259 231+ 
L1HS398 AC069349 8 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS399 AC027502 4 INSERTED IN REPEATS INSERTED IN REPEATS - R 614 - - 
L1HS401 AC068037 4 INSERTED IN REPEATS INSERTED IN REPEATS - R 1342 - - 
L1HS402 AC020593 4 INSERTED IN REPEATS INSERTED IN REPEATS - R 361 - - 
L1HS403@ AL158816 6 INSERTED IN REPEATS INSERTED IN REPEATS - R 360 - - 
L1HS404 AC021700 4 CCACCTTACGTTCAGCTGTTAAT CGGTGATTAGGTGACAGCTTTT 60 LF 3262 163 231+ 
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L1HS405 AC032017 4 ATCAAAAGTCCTGTGTGTTTGTCTT GAAATTTTGCTAGACATAGCTGTCC 60 FP 1206 396 202+ 
L1HS406 AC067842 4 GCAAGTTTTACCCATAGTACACAGG GTATGTAGAAGGCAGGGGTACACT 60 HF 3589 209 302 
L1HS407 AC041010 4 CTCACCAGTACGAGAAGCAAGTT TCTGACCTAGGGATGATTCTTCA 60 FP 413 227 217 
L1HS408 AC019133 4 TTTTAGCCAAGCTCTTTGTTCC CATTATGGCAGCGTAGACATTG 56 FP 2059 106 209 
L1HS409 AC027782    4 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS410* AC011633 4 GCTAAGCAATGGAGGAAAATATCG TGTACATGGTGTGAGGTATGAA 57 IF 6211 100 244+ 
L1HS411 AC073338 4 ACACACACACGATGGAAAGTATCT AGCACATCCTAAATCTTCCTCTCT 60 FP 2670 136 246 
L1HS412 AC067901 4 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS413* AC023332 4 TCATGAGCATCACTCTTACCATGT ACTCAGCTGACTTGCCATAAATGT 60 IF 6199 127 191 
L1HS414 AC025955 4 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS415 AC009816 4 TCAGACCCATATATGAGCATAACC GCTTAGAAGAATTTTTAGCCAGGTG 56 HF 1360 590 476+ 
L1HS416 AC068256 4 TTAGTCACTATGACTTGAGCCACTT TAGTGATAGTGTAGAGAGGGGGTTG 61 FP 822 238 284 
L1HS417 AP001860 4 INSERTED IN REPEATS INSERTED IN REPEATS - R 865 - - 
L1HS418* AC011981 2 CGATTTCTGTCTTTGTGAACGTAGT CCTTACAGAGTAGAAATCTCACGAT 60 IF 6380 328 358 
L1HS419 AC061978 4 INSERTED IN REPEATS INSERTED IN REPEATS - R 6034 - - 
L1HS420 AC041038 4 INSERTED IN REPEATS INSERTED IN REPEATS - R 6066 - - 
L1HS421 AC024974 UL END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS422 AC009577 4 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS423 AC022672 11 CTCCCTGTCTTCTGGGTTAAAATA GGAAGTCCCACTTTTTCAGTAGAG 60 HF 5680 201 248+ 
L1HS424 AC080124 4 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS425 AC013724  4 INSERTED IN REPEATS INSERTED IN REPEATS - R 6120 - - 
L1HS426 AC023921 5 AGATTCCCTTTGGTATCCAAATCAC GTTGCCATACTCCGCATAAAGTC 60 IF 3394 204 252 
L1HS427 AC015990 4 TACGGGCAAAGACTGAGAGTACTAA TTCAGCCTTCTGACATCAAACT 57 IF 2230 139 220+ 
L1HS429 AC060816 4 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS430 AC024963 4 CAGAGAACCAACATGTAGGAACAA GTTACAGGTCAAAGGAGGTCTGAG 60 LF 4034 127 223+ 
L1HS432 AC011399 5 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS433 AC027339 5 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS434 AC010437 5 ACCTGGGCCACATTTATTTTTC TGTAGAAGAAGACACCGTCGTTAG 60 FP 2637 250 246+ 
L1HS435 AC026403 5 GACTCAGTTGACAAGGAGTTACCA ACACTAGCTTCTTTGACTTCACCA 55 FP 1115 111 211+ 
L1HS437 AC023526 5 ATCTATCATTTATCTGCCCCGTCT ACAAGGATTAGCAGGAAGTCTGTT 60 IF 2954 256 201+ 
L1HS438 AC011433 5 TCCTCTCACCAACCACATAAAGTA ATCCCTTGGATACAAAGATGTGC 60 FP 1909 570 345 
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L1HS439 AC016573 5 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS440 AC010409 5 INSERTED IN REPEATS INSERTED IN REPEATS - R 6133 - - 
L1HS441 AC026444 5 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS442 AC027325 5 GACGGTTACTCAGAAAAACACAAG GTAGATGCCACTGTTACCCTGACT 60 IF 907 224 185+ 
L1HS443 AC021600 5 GCTAGACTCTCTACCTTTGGCTTT TGATACCTGACTCTATGCACCACT 56 FP 891 261 382 
L1HS444 AC027315 5 TTATTGGAATAGCTTCTCCTGTCAC GCTGTTCCTAACTCTAGTCCTCCA 60 FP 464 303 296+ 
L1HS445 AC008374 5 INSERTED IN REPEATS INSERTED IN REPEATS - R 551 - - 
L1HS446 AC010314 5 CTCGTGACATTTCCATCATATAGC TTAAGTCACCTAAGGGTTGTAAGTG 56 LF 6142 109 182+ 
L1HS447 AC018759 5 GTACATCTCTTTGGACACTTCCACT GTTTAAGTCCAACATCCTGTTCTG 59 IF 691 560 386 
L1HS448 AC016545 5 GTCAATTAGAGCATGAAGAAACCAC GTACATCTCTTTGGACACTTCCACT 60 IF 652 525 382+ 
L1HS449 AC011378 5 CTAGGGAGGTGAAAATTCAGATGT GCATGTTGCACAACAGTATGTA 60 FP 1797 281 315+ 
L1HS450 AC011413 5 GTGAAGACTGTTGGTCAGTTACTTGT GTCATTGAGATTGGCAGGTAAAAG 60 HF 6179 128 189+ 
L1HS451 AC010490 5 INSERTED IN REPEATS INSERTED IN REPEATS - R 994 - - 
L1HS453 AL360232 6 INSERTED IN REPEATS INSERTED IN REPEATS - R 6064 - - 
L1HS455 AC027643 6 CATACACAAGGGCGAAGAGTTAAA GCCTCTTTTACATCAGTTACCACTC 60 FP 259 110 213+ 
L1HS456 AC026966 6 TAACACTTAGTGATTGCTGGGAGAG GGACAAGGTGAAGTGGAAAACTAGA 60 FP 1641 121 215 
L1HS457 AC025887 18 INSERTED IN REPEATS INSERTED IN REPEATS - R 286 - - 
L1HS460 AL355489 6 INSERTED IN REPEATS INSERTED IN REPEATS - R 6044 - - 
L1HS461 AL358992 6 ATCCAGCAAAAGTATCCCTTAAGTA TCCTGTCCCAATTCTTTGTATTAT 60 LF 4143 324 417 
L1HS462 AC069403 11 INSERTED IN REPEATS INSERTED IN REPEATS - R 4163 - - 
L1HS463 AL391336 6 ATTAAATCTGTGTGGGAGTGG AGGGTGACTTCAGTGATATCTTCA 60 FP 6304 247 346 
L1HS465 AL356601 6 INSERTED IN REPEATS INSERTED IN REPEATS - R 1936 - - 
L1HS469@ AC020586 UL GGTACTGGCTGTTCAGTATTTTT GTCTCAAAGCCCATTTCATAGTTC 60 FP 6458 101 212+ 
L1HS472 AC018400 UL END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS476 AC079756 7 INSERTED IN REPEATS INSERTED IN REPEATS - R 897 - - 
L1HS477 AC024730 7 INSERTED IN REPEATS INSERTED IN REPEATS - R 1271 - - 
L1HS478 AC069008 7 INSERTED IN REPEATS INSERTED IN REPEATS - R 991 - - 
L1HS479 AC079855 7 CACTCGAAGGGTAAGTGAGATTTT CCACTAGCGCACCATTTTTCTAAT 58 FP 6223 146 276 
L1HS480 AC021836 4 AGAGGTAACCACTACCTTGCAACT GCCTCATGACAGGAGAAGAGATAAA 60 IF 2701 272 265 
L1HS483 AC026011 8 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS484* AC073647 7 INSERTED IN REPEATS INSERTED IN REPEATS - R 6692 - - 
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L1HS485 AC027189 8 CTCAGTTCCACATAAACCTTGACA GAAGCAATTAACCTAGCAGTAGGAC 60 FP 548 74 183+ 
L1HS486 AL356516 9 CCCTCATCACCAAATATCTGAGAA AGCTGACAGTCTAGTGAATGAGGTC 60 IF 905 139 196 
L1HS487 AL162731 9 INSERTED IN REPEATS INSERTED IN REPEATS - R 6079 - - 
L1HS488* AL353649 9 CAAATTGTCAATGCTAACCACTCC GGAAAAAGGCACTTTGGCTTATC 62 FP 6787 724 472+ 
L1HS489 AC009284.2 9 TCTCCAGAAACCATCACAGTAAGA AGGAGTTGAAAGTAGGATGGGTTT 60 FP 322 104 202+ 
L1HS490@ AL358937 9 CAGCTGTCTTGCTAAGAATCCAT AGACCACAGACTCTTTGAGGGTAAG 60 FP 2289 397 206 
L1HS491 AL355303  10 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS492 AL450466 10 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS493 AL138764 10 GACTACCTTTCTGCGTATTCCTTTC GTCTAACAGGTACACGAGACTCCAT 61 IF 1603 111 241+ 
L1HS494 AC068972 8 INSERTED IN REPEATS INSERTED IN REPEATS - R 2974 - - 
L1HS495 AC083848 8 INSERTED IN REPEATS INSERTED IN REPEATS - R 1341 - - 
L1HS496 AC024929 8 CCTTTGGAAGAGAAAGAGGATATG CTCCCAATGGAAAGGAACTTGTAT 60 FP 617 70 177 
L1HS497 AC060775 8 GCCTAGTGGGAAGACAAAAAGTATT GCTGTAATGTTAACCTCGAAGTCGT 60 FP 950 346 439+ 
L1HS498* AC067844.3 8 AGGTTTCCCCAAAATTTACCC CTGATGTGTGGATTCACTGTTCTT 58 FP 6281 184 295 
L1HS499 AC024649 8 INSERTED IN REPEATS INSERTED IN REPEATS - R 1045 - - 
L1HS500 AC009630.5 8 GTGTTGCCTTCACCACAATAGTA TTTCTCCGAGTACAGGTTACGAG 60 FP 1145 206 227+ 
L1HS501 AC022207 12 GTTGGCAACTTACTCTCAAATGG AAATACACTCGACTGGCCACTAA 60 FP 6254 199 306+ 
L1HS502 AC011881 UL INSERTED IN REPEATS INSERTED IN REPEATS - R 537 - - 
L1HS503 AC055118 13 GTGAGGAATGGTTGAACAGCTT TGTGGCTGGAGAAATACCTCTAA 60 FP 713 101 206+ 
L1HS504 AL158045 13 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS505 AL162716 13 INSERTED IN REPEATS INSERTED IN REPEATS - R 384 - - 
L1HS506 AL138684 13 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS507 AC064832 15 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS508 AC048381 15 ACAGAACCTTTTAGAGGGAATCG CTCCGTGTGGTAAAATTAGCTGT 58 HF 6144 103 184 
L1HS509 AL356017 14 CACTCATGACTGCCTGACTTCT CAGGGATTACTCTTCTGTTGTGG 61 FP 443 131 220+ 
L1HS510 AL390800 14 INSERTED IN REPEATS INSERTED IN REPEATS - R 1837 - - 
L1HS511 AL162632 14 INSERTED IN REPEATS INSERTED IN REPEATS - R 6088 - - 
L1HS512 AC021839 14 AAAGAGACAATCCACAGCATAGTTG GATTTATTCCTTCATGGAGATGTGC 61 HF 2071 722 266+ 
L1HS513 AL160156 13 CCAAACTTGAGCCTCCTGTAATC CCTTGAAATAAGCAGGAAGAAGC 61 IF 809 142 235+ 
L1HS514 AL138961 13 CCTCAGCTTTGGATCCTGTAGTT AGAAGAATTGGGTCCTGTTGAA 60 FP 6670 334 361 
L1HS515 AL163537 13 GGATGGTAAAGGAGTGGCATAAT TGTGGAGCCCAGATCTTTTAAT 60 FP 637 106 193 
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L1HS516 AC044907 15 CCACAGTTTACACAGAAGCTGAA GAAGGAGTGGATGTGTTTCAGTAA 60 IF 6151 101 212 
L1HS518 AC074236 15 INSERTED IN REPEATS INSERTED IN REPEATS - R 2636 - - 
L1HS519 AC074100 15 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS520* AC015558 15 INSERTED IN REPEATS INSERTED IN REPEATS - R 6087 - - 
L1HS521@ AC067951 15 GCTTTGTTTACCTTTCTGCTCACT CACCAAAAGGAGAAGCCAATAAAG 60 FP 1248 344 441+ 
L1HS522 AC009555 15 INSERTED IN REPEATS INSERTED IN REPEATS - R 190 - - 
L1HS523 AC009658.6 15 CGTGGAAGATGTTACGAGGATTA AGAGAATGCGATGTCGATTAGAG 60 FP 570 105 204 
L1HS524 AC020892 15 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS525 AC009057 16 END OF SEQUENCING CONTIG  END OF SEQUENCING CONTIG - EC - - - 
L1HS526* AC025289 16 ACCCTCCAAGGTAACTGAATCTTA ATGCCCATGCTTGTTAGCTACTAC 60 IF 6076 223 324+ 
L1HS527 AC026472 16 INSERTED IN REPEATS INSERTED IN REPEATS - R 1224 - - 
L1HS528 AC009021.4 16 CGGATGGGAGCACAAAATTACTA TGCCTACTAAGATACCTTGGAAATG 61 FP 991 172 278 
L1HS529 AC022164 16 TGAGTAATGTGGCGGTTTAGTTC AACCAGTCAAGAAGCCAAAGAG 61 FP 6143 116 193+ 
L1HS530 AC009063 16 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS531 AC055852 17 INSERTED IN REPEATS INSERTED IN REPEATS - R 2839 - - 
L1HS532 AL356138 20 CCTCTAATCTATGGTGGATGCTCT TGGTAGGGAGCTGGTAAAAGTCTA 61 FP 308 175 242+ 
L1HS534 AC007448 17 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS535 AC034266 17 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS539 AC034266  17 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS541 AC068204  18 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS542 AC023983 18 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS543 AC009267 18 TACATTAGTCTGCCTCTGATTCCA GGCCATTCTTTTCATCTGTTGTAG 61 FP 547 99 183 
L1HS545 AC007768 18 TGGGAACTCATGTTACAGTTTCAC ATTTGTCATGATCACAGCCACCT 59 FP 2514 95 216 
L1HS546 AP001460 18 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS547 AC010966 18 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS548 AP001113 18 INSERTED IN REPEATS INSERTED IN REPEATS - R 6237 - - 
L1HS551 AC021325 18 INSERTED IN REPEATS INSERTED IN REPEATS - R 184 - - 
L1HS552 AP001564 18 CAGTGAACTGCTTTCTCACAATTC CAAGAAGTTTTCCTGGAGTCTCTC 60 IF 4144 123 235 
L1HS554 AC027230 18 INSERTED IN REPEATS INSERTED IN REPEATS - R 561 - - 
L1HS556 AC026898 18 END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS557 AP001019 18 ACAAAAGCACCTAGAAGCAGTCAT CTTTTTCTCCTATGCTCGTGGTAT 60 FP 2277 85 229+ 
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L1HS558 AC015819 18 TGCTTTCTTTCTTTCACATAGATCA GCAGACACGAATCACAGTTTGTAT 61 HF 983 128 203+ 
L1HS559 AC023394 18 INSERTED IN REPEATS INSERTED IN REPEATS - R 1620 - - 
L1HS561 AC013620 14 TACCCATTTAAAGGGCAAAGTG CTACCCATTTAAACCACTAATGCTG 61 LF 430 114 239+ 
L1HS562* AC019175 X TGTCTGTTCAGTCCTTTCTCACAT AGCAAAATGTATGCCGAAGACT 59 FP 6170 115 181 
L1HS564 AC034155.5 X TGCAATTGACATAGATACTGCAGAG CCCTTCCCTTTCTGTACATGTCTT 61 LF 2085 471 425+ 
L1HS565 AL442646 X INSERTED IN REPEATS INSERTED IN REPEATS - R 6029 - - 
L1HS567 AL158143 X END OF SEQUENCING CONTIG END OF SEQUENCING CONTIG - EC - - - 
L1HS568 AL356003 X INSERTED IN REPEATS INSERTED IN REPEATS - R 1297 - - 
L1HS569 AC021992 X INSERTED IN REPEATS INSERTED IN REPEATS - R 596 - - 
 
 
*   Full length elements with intact open reading frames. 
#  Elements previously identified by Boissinot et.al. 2000  
@ Elements previously identified by Sheen et.al. 2000 and Ovchinnikov et.al. 2001 
 
1. Chromosomal location was determined from Accession information or by PCR analysis of NIGMS monochromosomal hybrid cell 
line DNA samples.  
2. Amplification of each locus required 2:30 min @ 94°C initial denaturing, and 32 cycles for 1 min 94°C, 1 min Annealing 
Temperature (A.T.), and 1 min elongation at 72°C.  A final extension time of 10 min at 72°C was also used. 
3. Elements at the end of sequencing contigs are denoted (EC), those residing in other repeats (R), those having paralogs (Paralogs), 
and elements with inconclusive PCR results (NR).   Elements represented here are classified according to allele frequency as: high 
frequency (HF), intermediate (IF), low (LF), very low (VLF) or “private” insertion polymorphisms, or as fixed present (FP) 
insertions.  Fixed present: every individual tested had the LINE element in both chromosomes.  Low frequency insertion 
polymorphism: the element is present in no more than 1/3 (33%) alleles tested. Intermediate frequency insertion polymorphism: the 
element present in more than 1/3 (33%) of alleles tested and no more than 2/3 (67%) of the alleles.  High frequency insertion 
polymorphism: the element is present in more than 2/3 or 67% but not all alleles tested.  Indeterminable data is denoted (-). 
4. PCR Product Sizes: Empty product size is calculated computationally by removing the L1Hs Ta elements and 1 direct repeat from 
identified filled site.  Subfamily Specific product size is calculated from internal subfamily specific primer located in the 3’ UTR to 
the proximal 3’ primer.  In cases where target site duplication sequence were not found flanking the element PCR product sizes may 
vary from those reported.  Elements with subfamily product size denoted “+” were found in 5´→3´ orientation in GenBank and are 
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assayed using the internal subfamily specific primer and flanking reverse primer.  All other elements were assayed using the internal 
subfamily specific primer and flanking forward primer. 
 
Table 2A - L1Hs Ta autosomal associated human genomic diversity. 
 
African American Asian/Alaskan Natived German Caucasian Egyptian   
Genotypes Genotypes Genotypes Genotypes 
Elements  +/+ +/- -/- fc Ha +/+ +/- -/- fc Ha +/+ +/- -/- fc Ha +/+ +/- -/- fc Ha AHb 
L1HS2 1 7 11 0.24 0.37 11 6 0 0.82 0.30 8 9 3 0.63 0.48 7 7 2 0.66 0.47 0.40 
L1HS5 0 2 18 0.05 0.10 0 2 18 0.05 0.10 1 7 12 0.23 0.36 0 6 12 0.17 0.29 0.21 
L1HS6 17 1 0 0.97 0.06 18 0 0 1.00 0.00 18 0 1 0.95 0.10 14 0 0 1.00 0.00 0.04 
L1HS7 17 3 0 0.93 0.14 19 0 0 1.00 0.00 19 1 0 0.98 0.05 19 0 0 1.00 0.00 0.05 
L1HS13 15 0 0 1.00 0.00 15 0 0 1.00 0.00 18 0 0 1.00 0.00 18 1 0 0.97 0.05 0.01 
L1HS14 9 11 0 0.72 0.41 7 9 3 0.61 0.49 1 11 8 0.33 0.45 2 9 9 0.33 0.45 0.45 
L1HS15 13 4 2 0.79 0.34 20 0 0 1.00 0.00 18 2 0 0.95 0.10 15 5 0 0.88 0.22 0.17 
L1HS16 1 6 13 0.20 0.33 7 9 3 0.61 0.49 3 6 11 0.30 0.43 1 3 11 0.17 0.29 0.38 
L1HS18 19 1 0 0.98 0.05 19 0 0 1.00 0.00 20 0 0 1.00 0.00 18 0 0 1.00 0.00 0.01 
L1HS20 3 15 2 0.53 0.51 9 7 3 0.66 0.46 14 6 0 0.85 0.26 15 5 0 0.88 0.22 0.36 
L1HS21 0 3 17 0.08 0.14 0 0 20 0.00 0.00 0 0 20 0.00 0.00 0 0 17 0.00 0.00 0.04 
L1HS26 5 4 9 0.39 0.49 8 1 3 0.71 0.43 11 2 2 0.80 0.33 11 4 3 0.72 0.41 0.42 
L1HS32 9 8 2 0.68 0.44 13 5 1 0.82 0.31 15 5 0 0.88 0.22 13 4 1 0.83 0.29 0.32 
L1HS34 0 10 10 0.25 0.38 3 14 3 0.50 0.51 1 10 6 0.35 0.47 1 5 12 0.19 0.32 0.42 
L1HS39 11 3 1 0.83 0.29 15 1 0 0.97 0.06 12 0 0 1.00 0.00 11 1 3 0.77 0.37 0.18 
L1HS43 4 10 6 0.45 0.51 8 11 1 0.68 0.45 12 7 1 0.78 0.36 7 9 1 0.68 0.45 0.44 
L1HS44 0 0 20 0.00 0.00 0 0 20 0.00 0.00 0 0 20 0.00 0.00 0 0 19 0.00 0.00 0.00 
L1HS46 16 3 0 0.92 0.15 16 0 0 1.00 0.00 20 0 0 1.00 0.00 13 0 0 1.00 0.00 0.04 
L1HS57 0 3 17 0.08 0.14 0 2 18 0.05 0.10 0 3 17 0.08 0.14 6 4 9 0.42 0.50 0.22 
L1HS73 19 1 0 0.98 0.05 20 0 0 1.00 0.00 20 0 0 1.00 0.00 18 0 0 1.00 0.00 0.01 
L1HS74 0 1 19 0.03 0.05 2 5 13 0.23 0.36 2 7 11 0.28 0.41 1 5 12 0.19 0.32 0.28 
L1HS77 6 12 2 0.60 0.49 19 1 0 0.98 0.05 18 2 0 0.95 0.10 17 2 1 0.90 0.18 0.21 
L1HS78 1 6 13 0.20 0.33 5 3 11 0.34 0.46 3 4 13 0.25 0.38 0 5 12 0.15 0.26 0.36 
L1HS85 0 0 9 0.00 0.00 0 3 17 0.08 0.14 0 2 18 0.05 0.10 0 2 14 0.06 0.12 0.09 
L1HS86 14 0 0 1.00 0.00 14 1 0 0.97 0.07 12 1 2 0.83 0.29 17 1 0 0.97 0.06 0.10 
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L1HS104 7 8 5 0.55 0.51 9 5 4 0.64 0.47 5 12 3 0.55 0.51 10 5 3 0.69 0.44 0.48 
L1HS110 20 0 0 1.00 0.00 19 1 0 0.98 0.05 20 0 0 1.00 0.00 18 2 0 0.95 0.10 0.04 
L1HS112 0 2 17 0.05 0.10 0 5 14 0.13 0.23 1 4 15 0.15 0.26 1 1 7 0.17 0.29 0.22 
L1HS117 8 1 1 0.85 0.27 9 3 1 0.81 0.46 9 8 1 0.72 0.41 7 4 3 0.64 0.48 0.40 
L1HS118 0 6 13 0.16 0.27 3 8 8 0.37 0.48 0 7 13 0.18 0.30 0 3 15 0.08 0.16 0.30 
L1HS131 10 0 2 0.83 0.29 8 3 3 0.68 0.45 5 3 4 0.54 0.52 14 2 0 0.71 0.44 0.42 
L1HS132 2 12 6 0.40 0.49 4 13 2 0.55 0.51 3 8 9 0.35 0.47 0 9 11 0.23 0.36 0.46 
L1HS153 6 6 8 0.45 0.51 2 9 8 0.34 0.41 4 7 8 0.39 0.49 3 6 8 0.35 0.47 0.47 
L1HS157 17 0 0 1.00 0.00 17 1 0 0.97 0.06 18 1 0 0.97 0.05 18 0 0 1.00 0.00 0.03 
L1HS158 4 12 4 0.50 0.51 9 7 1 0.74 0.40 6 13 1 0.63 0.48 2 14 4 0.45 0.51 0.48 
L1HS160 18 0 0 1.00 0.00 18 0 0 1.00 0.00 19 1 0 0.98 0.05 16 0 0 1.00 0.00 0.01 
L1HS163 4 11 4 0.50 0.51 1 13 6 0.38 0.48 12 6 0 0.83 0.29 5 9 5 0.50 0.51 0.45 
L1HS166 0 3 17 0.08 0.14 4 7 9 0.38 0.48 3 10 7 0.40 0.49 1 5 12 0.19 0.32 0.36 
L1HS169 13 1 1 0.90 0.19 8 8 2 0.67 0.46 12 4 1 0.82 0.30 12 0 0 1.00 0.00 0.24 
L1HS171 3 9 8 0.38 0.48 0 6 13 0.16 0.27 1 15 3 0.45 0.51 1 2 10 0.15 0.27 0.38 
L1HS172 14 4 2 0.80 0.33 5 12 3 0.55 0.51 12 5 3 0.73 0.41 10 9 1 0.73 0.41 0.41 
L1HS173 15 1 0 0.97 0.06 17 0 0 1.00 0.00 12 0 0 1.00 0.00 4 1 3 0.56 0.53 0.15 
L1HS177 20 0 0 1.00 0.00 18 0 0 1.00 0.00 19 1 0 0.98 0.05 12 0 0 1.00 0.00 0.01 
L1HS178 17 3 0 0.93 0.14 19 0 0 1.00 0.00 19 1 0 0.98 0.05 12 1 0 0.96 0.08 0.07 
L1HS180 1 6 13 0.20 0.33 1 9 10 0.28 0.41 4 10 6 0.45 0.51 4 8 7 0.42 0.50 0.44 
L1HS197 11 1 1 0.88 0.21 8 1 0 0.94 0.11 12 0 1 0.92 0.15 14 0 0 1.00 0.00 0.12 
L1HS213 20 0 0 1.00 0.00 20 0 0 1.00 0.00 20 0 0 1.00 0.00 18 2 0 0.95 0.10 0.02 
L1HS214 20 0 0 1.00 0.00 17 0 0 1.00 0.00 19 0 0 1.00 0.00 17 3 0 0.93 0.14 0.04 
L1HS220 0 0 20 0.00 0.00 1 1 18 0.08 0.14 0 2 18 0.05 0.10 0 4 16 0.10 0.18 0.10 
L1HS222 1 6 8 0.27 0.40 0 3 16 0.08 0.15 0 1 18 0.03 0.05 0 2 18 0.05 0.10 0.18 
L1HS226 0 3 17 0.08 0.14 0 1 18 0.03 0.05 2 6 12 0.25 0.38 1 4 15 0.15 0.26 0.21 
L1HS228 17 0 0 1.00 0.00 14 0 0 1.00 0.00 18 0 0 1.00 0.00 12 1 1 0.89 0.20 0.05 
L1HS231 20 0 0 1.00 0.00 17 2 0 0.95 0.10 20 0 0 1.00 0.00 18 1 1 0.93 0.14 0.06 
L1HS233 1 4 14 0.16 0.27 1 6 11 0.22 0.36 1 7 11 0.24 0.37 0 7 13 0.18 0.30 0.32 
L1HS235 1 15 3 0.45 0.51 1 9 7 0.32 0.45 1 11 8 0.33 0.45 3 12 5 0.45 0.51 0.48 
L1HS242 4 11 5 0.53 0.39 0 11 8 0.29 0.42 2 11 7 0.38 0.48 4 5 10 0.34 0.46 0.44 
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L1HS260 20 0 0 1.00 0.00 19 0 0 1.00 0.00 18 2 0 0.95 0.10 19 0 0 1.00 0.00 0.02 
L1HS287 0 0 20 0.00 0.00 0 0 20 0.00 0.00 0 0 20 0.00 0.00 0 0 20 0.00 0.00 0.00 
L1HS291 20 0 0 1.00 0.00 20 0 0 1.00 0.00 18 2 0 0.95 0.10 20 0 0 1.00 0.00 0.02 
L1HS293 1 4 15 0.15 0.26 4 8 7 0.42 0.50 1 4 15 0.15 0.26 0 2 18 0.05 0.10 0.28 
L1HS298 2 1 15 0.14 0.25 0 1 16 0.03 0.06 0 4 16 0.10 0.18 0 0 8 0.00 0.00 0.12 
L1HS301 4 14 1 0.58 0.50 11 8 0 0.79 0.34 7 11 1 0.66 0.46 4 12 1 0.59 0.50 0.45 
L1HS308 1 5 13 0.18 0.31 2 5 11 0.25 0.39 1 7 10 0.25 0.39 4 9 5 0.47 0.51 0.40 
L1HS314 4 5 6 0.43 0.51 1 4 11 0.19 0.31 1 8 9 0.28 0.41 2 9 9 0.33 0.45 0.42 
L1HS320 5 12 2 0.58 0.50 0 4 14 0.11 0.20 0 4 16 0.10 0.18 2 7 8 0.32 0.45 0.33 
L1HS332 3 5 7 0.37 0.48 1 3 13 0.15 0.26 1 3 6 0.25 0.39 1 1 4 0.25 0.41 0.39 
L1HS335 8 9 2 0.66 0.46 13 5 1 0.82 0.31 10 10 0 0.75 0.38 14 4 1 0.84 0.27 0.36 
L1HS337 17 3 0 0.93 0.14 17 3 0 0.93 0.14 19 1 0 0.98 0.05 14 6 0 0.85 0.26 0.15 
L1HS345 0 1 19 0.03 0.05 0 1 18 0.03 0.05 0 2 18 0.05 0.10 0 1 18 0.03 0.05 0.06 
L1HS348 18 2 0 0.95 0.10 15 4 1 0.85 0.26 17 3 0 0.93 0.14 16 4 0 0.90 0.18 0.17 
L1HS349 19 1 0 0.98 0.05 20 0 0 1.00 0.00 14 3 3 0.78 0.36 15 2 0 0.94 0.11 0.13 
L1HS353 16 2 0 0.94 0.11 20 0 0 1.00 0.00 18 2 0 0.95 0.10 17 2 0 0.95 0.10 0.08 
L1HS360 0 10 10 0.25 0.38 3 10 6 0.42 0.50 2 11 7 0.38 0.48 3 6 7 0.38 0.48 0.46 
L1HS364 4 12 4 0.50 0.51 20 0 0 1.00 0.00 18 1 0 0.97 0.05 17 3 0 0.93 0.14 0.18 
L1HS372 8 10 2 0.65 0.47 11 8 1 0.75 0.38 4 13 3 0.53 0.51 8 11 1 0.68 0.45 0.45 
L1HS373 0 0 20 0.00 0.00 0 0 20 0.00 0.00 0 0 20 0.00 0.00 0 0 20 0.00 0.00 0.00 
L1HS375 6 12 1 0.63 0.48 11 8 0 0.79 0.34 4 16 0 0.60 0.49 11 9 0 0.78 0.36 0.42 
L1HS378 18 2 0 0.95 0.10 8 10 2 0.65 0.47 14 3 3 0.78 0.36 13 5 1 0.82 0.31 0.31 
L1HS391 18 0 0 1.00 0.00 19 1 0 0.98 0.05 20 0 0 1.00 0.00 19 0 0 1.00 0.00 0.01 
L1HS393 1 2 14 0.12 0.21 0 0 19 0.00 0.00 0 0 19 0.00 0.00 0 0 14 0.00 0.00 0.05 
L1HS395 7 9 1 0.68 0.45 8 9 3 0.63 0.48 3 12 5 0.45 0.51 9 7 3 0.66 0.46 0.48 
L1HS404 1 9 10 0.28 0.41 0 0 18 0.00 0.00 0 0 20 0.00 0.00 0 2 16 0.06 0.11 0.13 
L1HS406 17 3 0 0.93 0.14 16 4 0 0.90 0.18 18 2 0 0.95 0.10 16 4 0 0.90 0.18 0.15 
L1HS410 0 10 10 0.25 0.38 5 10 5 0.50 0.51 3 10 6 0.42 0.50 7 11 1 0.66 0.46 0.47 
L1HS413 0 11 9 0.28 0.41 1 9 9 0.29 0.42 0 7 13 0.18 0.30 3 6 10 0.32 0.44 0.39 
L1HS415 17 1 0 0.97 0.06 18 2 0 0.95 0.10 18 0 0 1.00 0.00 20 0 0 1.00 0.00 0.04 
L1HS418 4 10 6 0.45 0.51 13 4 1 0.83 0.29 5 12 3 0.55 0.51 2 8 8 0.33 0.46 0.44 
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L1HS423 18 2 0 0.95 0.10 17 0 0 1.00 0.00 17 1 1 0.92 0.15 15 1 1 0.91 0.17 0.10 
L1HS426 1 14 5 0.40 0.49 7 5 5 0.56 0.51 2 5 9 0.28 0.42 3 6 10 0.32 0.44 0.47 
L1HS427 5 13 2 0.58 0.50 15 5 0 0.88 0.22 8 9 3 0.63 0.48 11 8 0 0.79 0.34 0.39 
L1HS430 0 2 18 0.05 0.10 0 4 14 0.11 0.20 0 0 20 0.00 0.00 1 0 19 0.05 0.10 0.10 
L1HS437 1 14 5 0.40 0.49 0 3 17 0.08 0.14 1 4 15 0.15 0.26 2 10 7 0.37 0.48 0.34 
L1HS442 10 10 0 0.75 0.38 17 1 0 0.97 0.06 14 6 0 0.85 0.26 8 7 2 0.68 0.45 0.29 
L1HS446 0 2 18 0.05 0.10 0 2 17 0.05 0.10 1 6 12 0.21 0.34 0 0 17 0.00 0.00 0.14 
L1HS447 12 7 1 0.78 0.36 11 3 3 0.74 0.40 14 5 1 0.83 0.30 13 4 2 0.79 0.34 0.35 
L1HS448 9 2 7 0.56 0.51 3 13 2 0.53 0.51 14 5 1 0.83 0.30 7 8 2 0.65 0.47 0.45 
L1HS450 12 4 4 0.70 0.43 20 0 0 1.00 0.00 19 0 1 0.95 0.10 18 1 1 0.93 0.14 0.17 
L1HS461 0 3 14 0.09 0.17 0 1 19 0.03 0.05 0 1 18 0.03 0.05 0 0 17 0.00 0.00 0.07 
L1HS480 3 8 9 0.35 0.47 4 8 6 0.44 0.51 5 10 5 0.50 0.51 4 10 6 0.45 0.51 0.50 
L1HS486 3 7 10 0.33 0.45 7 9 4 0.58 0.50 1 2 17 0.10 0.18 0 1 18 0.03 0.05 0.30 
L1HS493 5 8 6 0.47 0.51 5 8 7 0.45 0.51 9 7 3 0.66 0.46 9 2 4 0.67 0.46 0.49 
L1HS508 16 4 0 0.90 0.18 17 3 0 0.93 0.14 11 8 1 0.75 0.38 17 2 0 0.95 0.10 0.20 
L1HS512 19 1 0 0.98 0.05 18 0 0 1.00 0.00 19 0 0 1.00 0.00 17 0 0 1.00 0.00 0.01 
L1HS513 0 4 16 0.10 0.18 6 10 3 0.58 0.50 4 7 9 0.38 0.48 2 6 10 0.28 0.41 0.39 
L1HS516 2 8 9 0.32 0.44 1 2 16 0.11 0.19 6 9 5 0.53 0.51 3 7 6 0.41 0.50 0.41 
L1HS526 5 13 2 0.58 0.50 13 6 0 0.84 0.27 3 12 4 0.47 0.51 3 7 9 0.34 0.46 0.44 
L1HS552 0 6 11 0.18 0.30 5 7 8 0.43 0.50 2 14 3 0.47 0.51 1 5 12 0.19 0.32 0.41 
L1HS558 16 4 0 0.90 0.18 16 3 1 0.88 0.22 17 3 0 0.93 0.14 18 2 0 0.95 0.10 0.16 













Table 2B - L1Hs Ta X-linked associated human genomic diversity. 
 
African American Asian/Alaskan Natived 
Genotypes Population Genotypes Population 
Females Males Females Males 
 Element  +/+ +/- -/- + - fc Ha +/+ +/- -/- + - fc Ha 
L1HS24  1 5 3 1 8 0.30 0.40 3 2 1 8 2 0.73 0.43
L1HS28 5 4 0 6 3 0.74 0.42 0 3 3 3 7 0.27 0.44
L1HS30  0 5 5 4 5 0.31 0.48 1 4 2 7 3 0.54 0.53
L1HS125  7 1 1 7 1 0.85 0.26 6 0 0 10 0 1.00 0.00
L1HS562  1 5 3 1 8 0.30 0.40 3 2 1 8 2 0.73 0.43
L1HS564 0 3 7 2 7 0.17 0.32 0 0 6 1 9 0.05 0.10
 
 
European/German Caucasian Egyptian 
Genotypes Population Genotypes Population 
Females Males Females Males 
  
  
Element  +/+ +/- -/- + - fc Ha +/+ +/- -/- + - fc Ha AHb 
L1HS24  5 3 1 7 3 0.71 0.44 5 8 4 1 2 0.51 0.50 0.44
L1HS28 1 5 3 9 1 0.57 0.49 9 6 1 2 1 0.74 0.43 0.44
L1HS30  2 4 3 6 4 0.50 0.53 3 10 3 3 0 0.54 0.39 0.48
L1HS125  9 0 0 9 0 1.00 0.00 16 0 0 3 0 1.00 0.00 0.07
L1HS562  5 3 1 7 3 0.71 0.44 5 8 4 1 2 0.51 0.50 0.44
L1HS564 0 2 7 1 9 0.11 0.20 0 3 13 0 3 0.09 0.09 0.18
 
 
a. This is unbiased heterozygosity. H=(2*sample size * (1-sum freq of homozygotes))/(2*sample size – 1) 
b. Average heterozygosity is the average heterozygosity for all populations. 
c. f represents the frequency of the element.   




Table 3 - PreTa L1 primers, PCR Conditions, and associated human genomic diversity  
 
PCR Product Sizes4 
Name Accession 
Chrm. 






(ACG)3 Filled Empty 
Subfamily 
Specific 
L1AD1 AC080166.6 2 AATTCGCTGCATAATTTCTT AAACATATGGCCATCTTGAC FP 55 60 6835 249 578 
L1AD2 AC090955.2 3 TTTTCTCCATGACTTGAGATGGT TGCAATCATGAAAACCAGTG FP 60 60 6308 245 265 
L1AD3 AC018878.8 2 TGCACATGGATGTGTAAGAATAC TTCTTCCCATAAGCATTGGT FP 60 60 6448 339 245 
L1AD4 AC053545.5 4 TTGATGCATTTCTGCATAAGG CCAAGATTTTGGCTAGCATTT FP 55 60 4528 295 188 
L1AD5 AC079801.2 16 TCATCTCACAGAGCTCACAG CTAGGAATCCTTCTGTCTGG NP  60 749 326 150 
L1AD6 AC073647.9 7 GCAAACACTGGTTCAAGAAG TGGAGATAGTGTAGGCACAG FP 55 60 1741 87 233 
L1AD7 AC093607.3 4 INSERTED IN REPEATS R      
L1AD8 AC079926.7 4 GCCTCTTTCTTAGTCAAGCA AGGTCACAAGGGACATTTCT NP  60 857 417 208 
L1AD9 AC012593.8 2 CAGGTAGGGGAAAGGAGGAG TGGGCTTATTATCCCCTTGA FP 55 60 1034 392 342 
L1AD10 AC016906.7 2 TGTATTTACCGGGGATGAGG GCTGTCCCAAATTTCCAGAG IF 60 60 3602 172 229 
L1AD11 AC018465.8 2 GCACCTTGCTATTTGTTTTCT CCCTAGAGCAATCACCAAAGA FP 60 60 6515 458 185 
L1AD12 AC083950.4 2 GGATAGGCAATGTGTTAGGT TGCAGAGGCAGTTGTAACAT FP 55 60 1106 603 303 
L1AD13 AC097484.3 4 AAACCTATACATAGAAAATTGCTG ACCCAGAACAAATGAACACT FP 60 55 1368 473 424 
L1AD14 AC012665.8 2 TTCTGCAACTATAGCCGTAA ACAACAGACACAGAAGCAAA IF 60 55 6187 136 173 
L1AD15 AC093584.3 4 INSERTED IN REPEATS R      
L1AD16 NG_000004.1 UNK GGTTGAGAACCACTGTCATAA GCCAGTGCTTAGATTTACCA FP 60 60 6213 145 260 
L1AD17 AC105459.1 7 ATTCCCCATTTTACGATTTT GCTACTGCCGTGTTTTACA FP 55 60 440 276 309 
L1AD18 AC096764.3 2 AGATGCCCGGTCTACTACTT AGCACTTTAAAGGCATCAAC FP 55 60 3467 151 249 
L1AD19 AC009156.9 16 ATATTGGCCAAAGCCTCTTA TGGCAAGTCCTGAATGATAA IF 55 55 3974 88 191 
L1AD20 AC009156.9 16 CATTAGCAAGCTGATTCAAA CTTTTGCCATGATTAGTGGT HF 55 60 474 147 205 
L1AD21 AC097522.4 4 CAGAAAGTCATCTCATCTTCC TAAAGCATTCGTTGTTGTTG FP 55 60 6528 353 587 
L1AD22 AC092570.3 2 CCTCCTCACCTCCTTTTAAT ATGAAGGGAAACGAGAAAAG FP 55 60 562 63 220 
L1AD23 AC018673.4 12 INSERTED IN REPEATS R      
L1AD24 AC097451.2 4 TCGTTCCTCATCTCTTTGTT AGCAAAAGCAGTCACTTTTC FP 55 55 3467 382 396 
L1AD25 AC023154.5 4 INSERTED IN REPEATS R      
L1AD26 AC096769.3 4 TTGAGTTTTCCCTCCATGAAA TCTGATGAATTGTGCCTGACA FP 60 60 381 157 263 
L1AD27 AC093877.3 4 AATATTTAACATGGCCCATAA GGCATTGGTGTCAATGAGAA FP 60 60 1171 110 834 
L1AD28 AC096749.2 4 GAAGGCTTTATACTCCTTCTTGGA TCATGGGAGATTTTTCAACTTTC FP 55 60 6459 419 330 
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L1AD29 AC105150.2 8 GGACAGAAATACTGGCATCT CACAATCTTATCTCAAGGGAAT FP 60 60 6398 318 354 
L1AD30 AC055820.7 18 CTTGATGGCAATACAGCCTAA CCATTAATGTGGGCTCATAATCT FP 60 60 1855 78 208 
L1AD31 AC018626.8 18 GGGAAACGACAGAAGATGGA GAATTTTGATTTGTGGGCATA FP 60 60 1143 209 204 
L1AD32 AC091613.3 1 END OF CONTIG EC      
L1AD33 AC092798.3 3 INSERTED IN REPEATS R      
L1AD34 AC012642.5 5 GGCTTGTGCTACACAGAGTT CCAACCAGGAACAATAAAAG FP 55 55 2816 519 247 
L1AD35 AC021538.8 UNK AAATGCCCACAAAATTCCTG CCATGGGAGCTACTGGAAAA FP 55 60 984 386 479 
L1AD36 XM_037013.1 UNK END OF CONTIG EC      
L1AD37 AC099515.2 5 INSERTED IN REPEATS R      
L1AD38 AC026703.4 5 CCCAGTTCTCCAAAATATCA CACTTGCCTATGGTTCATTT FP 55 55 5984 240 468 
L1AD39 AC078857.12 3 INSERTED IN REPEATS R      
L1AD40 AC078857.12 3 TCGTGACCTTATTAGCCACT CCTCCATTTGCTACCTAGAG FP 60 60 1680 512 633 
L1AD41 AC078857.12 3 TGTTATTTCAGCTTTAACCATCAA TTTAAAAATCAAGTATGGGAAAAA FP 55 55 1202 141 242 
L1AD42 AC093515.3 16 INSERTED IN REPEATS R      
L1AD43 AC011597.27 3 INSERTED IN REPEATS R      
L1AD44 AC079943.18 3 ATGCCATCCCCTGGATTT TGGTTGCTCCAAAGGAACTT NP  60 6591 530 316 
L1AD45 AC061710.16 3 GAGCAAATTTGTCAGACAGAACA TGGGATGGTTGAAATCAAATG FP 60 60 3854 147 199 
L1AD46 AC072051.8 UNK CCCTATTTTCCCCATCATCA AAGCAGGCAGATGGTCACTT FP 55 60 3706 69 166 
L1AD47 AC008006.10 18 CGTCACACACATAACCAGAG GATCAGGAATATGGCAAAGA FP 55 55 471 212 284 
L1AD48 AC027553.6 UNK TGCATGAAGCACTACTCAAAGA TGCAAGATGTGTCAGTATTTAGC FP 60 60 6181 106 226 
L1AD49 AC018991.10 UNK INSERTED IN REPEATS R      
L1AD50 AC008948.8 5 INSERTED IN REPEATS R      
L1AD51 AC008728.7 5 INSERTED IN REPEATS R      
L1AD52 AC093566.3 8 INSERTED IN REPEATS R      
L1AD53 AC020783.8 8 INSERTED IN REPEATS R      
L1AD54 AC068062.5 10 CCTTTGTTTCTTGGGTGTGG CCCACATCACCAAACCATTT FP 60 60 357 128 212 
L1AD55 AC064875.5 2 GCCACACTCCTTTGTTTGCT CAAGCACAAAAGCAGGAACA FP 60 60 724 193 273 
L1AD56 AC073275.8 7 INSERTED IN REPEATS R      
L1AD57 AC010747.10 2 CGGAAAATTTGTTACTTGCT AGGTATGCTGCATTTCTTTC FP 55 55 3903 97 272 
L1AD58 AC012509.13 2 CCCTGGATGCTGAGTTTCTT TCCATCTGGCATTGACTCAG FP 60 60 1062 139 213 
L1AD59 AC009964.11 2 TGGGACATTGACTCCTACTC GGCATAGGTTTCTGGAAGTA NP  60 760 340 282 
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L1AD60 AC009961.11 2 INSERTED IN REPEATS R      
L1AD61 AC078851.4 2 TTTATGCTGATCACTGTTCTTC AACTAGTTGCATCGTGATCATA FP 60 55 2090 80 208 
L1AD62 AC016720.9 2 CTTTCGCATCATCGTAAAGT ATTGCCAACTGGTTACAAAG FP 55 55 2886 114 261 
L1AD63 AC012492.9 2 AAAAACCCTTTAAGCTCAGT TGGAAGCATACAAAATGAAA FP 55 55 6402 342 180 
L1AD64 AC069285.8 7 GCCACTGCTAATCAATTCAC CCAAAGCAGACACAATTTCT PARALOG 55 60 6131 77 172 
L1AD65 AC026029.8 4 TTTCCTCAAAGTTGATGCTC CCTGGAAGGCATAACTGATA NP  55 6787 271 575 
L1AD66 AC025223.6 2 TATCCAAATATCCCTTGCAG TTGTAGTTTGTGGAACTGGA PARALOG 55 55 717 201 197 
L1AD67 AC095347.6 12 INSERTED IN REPEATS R      
L1AD68 AC069242.13 3 CCTATGGATGAAAAATGGAC TCTGAAAATGTTGCCATTG FP 55 55 294 111 176 
L1AD69 AC092325.2 16 INSERTED IN REPEATS R      
L1AD70 AC079841.10 3 TCCAAGAGCAGGCAGTATTA TTCCTGACTACTCCAGTTCAG FP      
L1AD72 AC092468.9 3 GTGCAGGTGTAAGGAAGAAA GTCTTCAAACCAGACTGCAT FP 55 55 546 93 218 
L1AD73 AC097657.3 4 TGATTTGCAGTATTTTTCCTT GCATGACCCAGATTAGAAAA FP 55 55 1148 126 168 
L1AD74 AC097463.2 2 NO RESULTS NR      
L1AD75 AC092018.2 1 TTTCTCTCCCTCAAGCCTTTT CCAAAATTCATGCTGGGAAC IF 60 60 1636 129 124 
L1AD76 AC027345.5 4 AAACCTCCCTTTAGTCTCCA CACCAGACCCAATTTTTAGA FP 55 60 4500 221 173 
L1AD77 AC097110.1 4 TCAAGGAAGGGAGTTAAAAA ACTTCTTTCATGCCCCTTAT HF 55 55 991 729 237 
L1AD78 AC026439.4 5 TCTTGAGGCTTGCAAATACT ATGAGCAACAAGAAATCACC FP 55 60 1559 295 306 
L1AD79 AC016620.7 5 INSERTED IN REPEATS R      
L1AD80 AC092185.3 3 AAGCAGTATGTCTGGCACA ACAAACTGACACTCCAAACC FP 60 55 6148 72 197 
L1AD82 AC022165.8 16 GGTGTCTCCACAGTTGATTC CCACCGCCAGATTTTACTA HF 55 55 2876 117 196 
L1AD84 AC090525.8 12 TTCCCTGGGTCACTTTTCTC TGCCAAATTGCTTTGCATAC FP 55 55 2068 255 333 
L1AD85 AC026120.33 12 INSERTED IN REPEATS R      
L1AD86 AC093865.2 2 ACATGATGTCCCATCTTCCA AAGAGCCATATGAGAGCTTCC FP 60 60 1046 271 304 
L1AD87 AC022446.6 5 AATTTTTCCCCACATGTTC ACAGAATGGATTTAGCTTGC FP 60 60 3761 118 248 
L1AD88 AC090519.3 15 INSERTED IN REPEATS R      
L1AD89 AC084819.17 12 INSERTED IN REPEATS R      
L1AD90 AC092601.3 2 INSERTED IN REPEATS R      
L1AD91 AC008571.6| 5 TGCTAAACAGAAGGCACATA ATAGATCCATCTGCCAAATC FP 55 60 6266 170 314 
L1AD92 AC092638.2 2 TTATCCAAAGAAGGGGAAAGG TTTGCCTTATAAGCATTGTGAAAA FP 55 55 6224 181 195 
L1AD93 AC096653.1 4 CAACACTCATTACAACCTGTG CAGAGTTTATCAGCCAGACC FP 60 60 2336 382 399 
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L1AD94 AC092581.2 4 CTCCACGTTAACAGATAGGG TGAGCTTCACTTAACCACTG FP 60 60 507 341 239 
L1AD95 AC096569.1 2 CCAGCACTGATTTCATAGATGC TTCAGACAACTGAAGTGCCTTT FP 55 55 6161 89 224 
L1AD96 AC092631.1 4 TAATTAGGTAACGCCTGTGG CAGGAAGCCTAAACTGCTT IF 60 60 932 98 245 
L1AD97 AC008709.6 5 CCCCAGGCTTTTGAAAATTA ATTCTCGGGGTCCCAATTAC FP 60 55 6164 111 214 
L1AD98 AC060796.7 17 ATGGAAAGGGGAAGATTTTA GGCTATACTACAACATCCCTCA FP 55 55 6164 126 203 
L1AD99 AC090791.6 11 GTGACACAAAAAGCACAATTAC CAATGATTCATGAGTTGGAA FP 55 55 2737 292 303 
L1AD100 AC026729.5 5 CCTGGGTCACAATATGAAGA TCTGATAACCAGAAGATGAAGA HF 55 60 6324 258 352 
L1AD101 AC025467.5 5 AGTCTCCCTTTCAGAAGCA AATGCTGGGAATCTTACCTC IF 55 55 6091 66 163 
L1AD102 AC025467.5 5 GAATGGGGTGTGCTGTAA TTTTAACAAGATCCCAGACC IF 60 55 3721 78 164 
L1AD105 AC010275.6 5 ATTCTCGGGGTCCCAATTAC CCCCAGGCTTTTGAAAATTA FP 55 55 6164 111 214 
L1AD108 AC008550.5 5 CACAATCATACCTTCCCAACTG CAGATGAGACTTTGGACGTGA FP 60 60 6154 84 187 
L1AD110 AC092721.2 16 ATTTTGTGGTTCAGCATTTT CATAGAAAAGGGAACAAATGA FP 60 60 1590 82 226 
L1AD111 AC092357.2 16 AAAAGTTGTTTTCCTGATTTTT AGTTTTCTCTGCAGCTCATC FP 56 55 6252 188 184 
L1AD112 AC034219.5 5 TTTCCAAAAACAGCTAGGAG CGTTTTTCTAGCTTAGCAATG FP 55 55 406 106 209 
L1AD113 AC005406.2 UNK ACCTTGATTGCAAATTGTTT GGTTTCTTGGCCTCTTTACT FP 60 60 2881 80 189 
L1AD114 AC020651.19 3 INSERTED IN REPEATS R      
L1AD115 AC084032.23 12 AACTGCCATGAAAACTTACC AAAGATTGTCCACATCAAGG FP 55 60 253 100 190 
L1AD116 AC025176.5 5 END OF CONTIG EC      
L1AD117 AC022024.6 10 CAGCAACCATAGGTTGATAAG GGATTACTGCCCAAAGAAAC FP 60 60 852 487 310 
L1AD118 AC026113.25 12 GACTGCTGGATCAAATGTTAG ACCACCTTACTCCTGCTACA R 55 60 6231 188 272 
L1AD119 AC024941.30 12 CTTTATTCATGGCAGAAAGC CTCATGAGATCTGGTTGTTT R 55 60 1347 112 249 
L1AD120 AC066613.7 UNK INSERTED IN REPEATS R      
L1AD121 AC010857.8 4 INSERTED IN REPEATS R      
L1AD122 AC011712.6 18 CCCAGGGGAATATATGGAAATTA AATTGAATGCAGATGGTTTTACC FP 60 55 6631 139 608 
L1AD123 AC010928.7 18 CCAGGAGTCAGAGGATTACA TCTGTTGTGAGAAGCAAATG FP 60 60 410 98 172 
L1AD124 AC013759.6 18 INSERTED IN REPEATS R      
L1AD125 AC013759.6 18 AAACGGTGAAGGAAATGTTG GACATGAGCAACCATCAGGA IF 60 60 513 236 309 
L1AD126 AC021082.4 5 INSERTED IN REPEATS R      
L1AD127 AC012323.7 16 INSERTED IN REPEATS R      
L1AD128 AC025097.41 UNK INSERTED IN REPEATS R      
L1AD130 AC039057.8 UNK INSERTED IN REPEATS R      
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L1AD131 AC073258.9 7 INSERTED IN REPEATS R      
L1AD132 AC017014.4 2 GGGAAGTGAAGGCTAACATA ACCATGGAGCTCAATTTACA FP 60 60 469 84 187 
L1AD133 AC069294.5 7 GGTTGAGAACCACTGTCATAA GCCAGTGCTTAGATTTACCA FP 60 60 6212 145 259 
L1AD134 AC084732.1 4 CTACCCAGAACAAATGAACAC AACCTATACGTAGAAAATTGCTG FP 60 60 1368 475 422 
L1AD135 AC008276.4 2 CTCAAGGGTTCTCATCACTAA GGAAAGGATACCACAATCAA HF 60 60 1871 87 191 
L1AD136 AC017015.4 3 TGGCTGACAAATTGGTGATT CCCATGTGAACTGCATTGAA FP 60 60 712 293 217 
L1AD137 AC010970.3 Y INSERTED IN REPEATS R      
L1AD138 AC012284.5 15 GAGCTGAAGAAACAAAGGAA ACCTCAAATTCATTTTGGAA FP 55 60 780 75 200 
L1AD139 AC009479.4 Y INSERTED IN REPEATS R      
L1AD140 AC010722.2 Y TTCAGGAACATTGCTATGAGGAT TAGGCATTTATCATGTGCTC FP 55 55 1643 218 283 
L1AD143 AC079175.24 X CAGTAAACTGGGCTGCTATC GAGAGTCAAGCAGTGGGTAA FP 55 60 5078 80 208 
L1AD144 AC023842.5 8 CACAAGATTCAATACCTGAGTGACA TGGGCATTACTAGTTGAACCTAAAG FP   1641 141 261 
L1AD145 AC087883.12 12 GAAGGAAGCCCCCATATGAT GAGGTGAAAGGCCATTAAAGAA FP 60 55 473 147 243 
L1AD146 AF280107.1 UNK END OF CONTIG EC      
L1AD147 AC063951.22 12 END OF CONTIG EC      
L1AD148 AC024060.5 3 AACTTCCTTAGGACCTCATTT TGTGTTTAACGTTCTAAACCTG FP 60 60 1361 65 229 
L1AD149 AC087433.4 15 CCGAAACACAGATAAGCACT AGTGTAAAAATCTGCATAGCC FP 55 55 2160 508 274 
L1AD150 AC073572.19 12 ATTCCCCCAATTCTCCAAAA GCAAGGGCCAACTATGCTAA FP 55 55 1195 124 187 
L1AD151 AC023795.18 12 INSERTED IN REPEATS R      
L1AD152 AC079865.14 12 GGGAGATCCAGACATACAAC TGTGTAACTCTTTTGCGATG FP 60 60 569 369 341 
L1AD153 AC058784.17 13 INSERTED IN REPEATS R      
L1AD154 AC023812.7 3 ACCTCTACCTTACCACACCA CCTAACTCAGGTCATTCTGC FP 60 60 1475 175 260 
L1AD155 AC018923.21 3 INSERTED IN REPEATS R      
L1AD156 AC008436.5 5 INSERTED IN REPEATS R      
L1AD159 AC008496.5 5 INSERTED IN REPEATS R      
L1AD160 AC034194.4 3 AGAGCTACATGGCTAAATGC TCTGCAGTTTTAACACCTCTT IF 60 55 543 238 261 
L1AD161 AC011546.6 19 INSERTED IN REPEATS R      
L1AD162 AC020717.3 X TTCCTATAGGCTTGAATGGA TTTTGGTGCCCAATAGTATC FP 55 60 2923 198 219 
L1AD163 AC007132.3 2 CCCAGTATGTCCCTCACTCAG TAGGCAAACCCCAATTGAAA FP   6359 315 351 
L1AD164 AC006968.2 X TTCCCTGTCCAATGTAAAGAA AAAGTGCATATTGCACAGGA FP 55 55 836 107 158 
L1AD165 AC010685.3 Y INSERTED IN REPEATS R      
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L1AD166 AC010889.3 Y CCCTAACATTTCAAAATGCACTG ATTTTTCCAACTACTGGCACTCA FP 60 60 1256 162 214 
L1AD167 AC006334.3 7 INSERTED IN REPEATS R      
L1AD168 AC009489.3 Y TGCCTTTATAATATGGAAATGCAG TGCTCATGGAGTCAGAATATGAA FP 55 55 1080 196 183 
L1AD169 AC011745.4 Y TCCCATTGCATTTAGCAGATT AGGCCTGTATTTCAATTGTGCTT FP 60 55 3676 95 265 
L1AD170 AC007278.3 2 GTCTATTAATCCCCCTCCAC CAACGTTGAAAAGATGTAGAGA FP 60 52 6149 87 174 
L1AD171 AC006992.2 7 TGGAACTATTTCAGGAAATTAAA AACAAGGGGGAAGAGAATAA FP 55 55 6278 197 234 
L1AD172 AC006362.2 7 INSERTED IN REPEATS R      
L1AD173 AC015542.17 3 TTCCAATATACTTTGCCCTTA AGTAGGCATCAGCAACAGTC FP 55 55 546 393 322 
L1AD174 AC022013.3 3 TTTGGGGAGAACTATCTGTG GCTTGGACATTGGAATTTT FP 60 54 399 118 188 
L1AD176 AC026204.4 3 GCACTCTCATTTACTGCTGA CCACCTTTTACTATTTTGGTG IF 60 55 838 494 195 
L1AD177 AC018514.7 14 ACCAGATGGAAGCTAGATGA AAGTTTCCAAGGGAAATCAG FP 60 55 6370 256 373 
L1AD178 AC058791.3 7 ATTGTTTAGGGGAAAAGGAC CCAAAAGCAGGTTAATTCTC FP 55 55 629 203 322 
L1AD179 AC013738.4 10 ACTCCACTTTAATTCGCAAG GAAGGCGAGAAACTGTAGAA FP 55 60 1056 113 289 
L1AD180 AL627250.8 X INSERTED IN REPEATS R      
L1AD181 AL449304.19 9 TTCCATAGCCATTGATTACA AATTTTCAGGCACGTTTTTA FP 55 55 652 286 446 
L1AD182 AL137787.11 X INSERTED IN REPEATS R      
L1AD183 AL445312.5 X GTCCAGAAGTCTCTCCTGTT CGATTGCAGGCTTTCTAATA FP 55 60 2873 105 413 
L1AD184 AL360020.15 9 INSERTED IN REPEATS R      
L1AD185 AL391260.13 10 TTCTGTAGGGCTCCTGACTA ATTCACAGTTCCCCGTAGTA FP 60 55 7905 185 1829 
L1AD186 AC016951.9 3 ACTTGAAATTGGGGTAGATG ATTTTCTAGAGGGCTCCTTG IF 60 59 843 190 206 
L1AD187 AL365258.24 1 INSERTED IN REPEATS R      
L1AD188 AL603765.6 1 INSERTED IN REPEATS R      
L1AD189 AL596326.5 1 TGTTTCATGGAGTGTATTTCA TGCAATGTTAGAAGAAGTGG HF 55 55 456 198 289 
L1AD190 AL606752.11 1 GCTTGACACATAGTGCTTGA AAATGTGGCATTATTTTCACT FP 60 60 462 250 193 
L1AD191 AL589877.13 X ACCCAGAAACGCATATACAC GCAAATTGCAACAAGATAAA FP 55 55 1926 591 352 
L1AD192 AL513493.11 1 TGTCCAATTAAAAGGCACAT TGGAATATCTTTTTCTGCCTA FP 55 60 941 134 322 
L1AD193 AL359733.15 1 TCTTTTACTCCCAAAAGGAA TTGGGTAGATGAAGATGACC NP  55 1900 260 292 
L1AD194 AL357873.17 1 GCCCTGGATGTAGTGTATGT CTCTCTCTTCATCCGTTCAG FP 55 55 974 144 256 
L1AD195 AL592494.4 1 NO RESULTS NR 55 55    
L1AD196 Z82209.2 X TTCTCTCCTAACCCTCTTGG TTTAGGGTATGCGGTAGAAG FP 60 55 6581 349 385 
L1AD197 AL354949.10 1 GAAACTGAGATTCACGGAAG AGTTTCTCATCCCACCTTCT FP 60 60 6437 360 467 
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L1AD198 AL138785.8 1 GCTTCACCTCACTAGCCTTA CTCACAAAGCAGCATTTACA FP 60 60 456 87 163 
L1AD199 AL445197.4 1 TTCAGCATATCTGCAAAGTG GAAAGGATTCTCATTTCCTG FP 55 60 626 216 341 
L1AD200 AL136224.24 6 CAGTCTATCAATTCCTGTTGG TGATCATCCAGCTCAATTACT FP 60 55 2353 472 440 
L1AD201 AL607144.5 13 CAGACTTGGGCATCTTTTAG AAAACATCAGGGCCAAATA FP 55 57 1328 148 178 
L1AD202 AL513324.8 10 INSERTED IN REPEATS R      
L1AD203 AL390834.24 10 INSERTED IN REPEATS R      
L1AD204 AF245226.1 21 INSERTED IN REPEATS R      
L1AD205 AL596342.3 1 GACTCTTCCCCTTGAGAATC GCATGCCTACGATCTCTTAT FP 55 55 381 222 253 
L1AD206 AL603902.4 6 INSERTED IN REPEATS R      
L1AD207 AL592067.4 13 ATTTAGGTATGCGTTTCAGC ACATCTCTTCATGCCTTCAG FP 55 55 999 422 238 
L1AD208 AL353743.22 9 ATCTCCTATCCCCTTAGCTG AACCCAAGAGTCACAGTTGA HF 60 60 1978 530 280 
L1AD209 AL139282.10 1 TTGAGTCAAGGAAAAATAATGA AAAGCAAGGCAGGTATGTTA FP 60 60 1667 214 245 
L1AD210 AL512504.9 X INSERTED IN REPEATS R      
L1AD211 AL590439.12 10 ATATTGATTTGGCATCCTGA GTAAACGTTCTAGCCAAAGC FP 60 60 6207 155 169 
L1AD212 AC007347.3 16 CACGGGAGAAGATTTATGTC TTGTACCTACTCCACCCAAG FP 54 55 6400 210 310 
L1AD213 AC007262.4 14 GCCATAAACAGAAAACCATT GTTGCAGAAATAACAGCACA IF 60 60 494 182 294 
L1AD214 AC007221.2 16 GCAGTCAACATCTTCCAGTA TGAGCTAGAATCCCAAAGAT FP 55 60 6267 135 324 
L1AD215 AC007115.1 12 TGAAGAACCTTCACGTAAGAA AAATATGATGCTTTGCTTCC FP 60 55 556 176 362 
L1AD216 AC006143.1 X GAGGCTTACTGGAAGCATAG CTCACGGTTGATGTCACTTT FP 60 60 1494 430 520 
L1AD217 AC011594.8 12 CTGGCCAAAGAGGTAGTTT CAAAAGAGCATGGTACTGGT NP  55 7620 479 537 
L1AD218 AC004141.1 7 TCCTTAACCTAGTTGCTCCA AGGGTACATTGAAGTTGAGG NR 60 60 624 340 458 
L1AD219 AC002076.1 7 AGGGAATATTTGGGACATCT CCCCACCACACTAGAAACTA IF 60 60 6418 354 391 
L1AD220 AC003085.1 7 CCAGGGAACTTGATTTTAGA CAATTGGATAAGAGGGACTG FP 60 55 6500 303 199 
L1AD221 AC004161.1 UNK INSERTED IN REPEATS R      
L1AD222 AC006204.1 7 TTTGGAAGCTTCACTTTAGC TGGCCTTAATATTTTAGCAAC FP 60 60 590 167 246 
L1AD224 AL356096.11 13 INSERTED IN REPEATS R      
L1AD225 AL513355.16 10 CGGTTCTAAACACCATTTGT TTATGGCCCTTAATTTCATC FP 60 60 1739 177 192 
L1AD226 AL358873.25 6 GCATCTTTGAATCAACAAGTC TGTATCTAACTATTCCCAGTGATT FP 60 55 986 238 751 
L1AD227 AC004822.1 X TTGAGAGCATCCATATTTCC         CCAACCTCAGATTACCAAGA FP 55 60 768 115 202 
L1AD228 AC005053.1 7 INSERTED IN REPEATS R      
L1AD229 AL450312.10 9 INSERTED IN REPEATS R      
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L1AD230* AL583806.7 6 GCAATCCATAGACAACCAAT    AGGAGGAATATGCAAACTGA HF 55 55 2249 599 338 
L1AD232 AL583825.8 1 TCCCAGAACTACCTCATAACA GAGGAAGACAGTGTCACAGA IF 60 60 1162 219 329 
L1AD233 AF207955.1 21 AGGGGTAGATTTTGTTCAGA AGGACCATTTGCAATGTTAG FP 60 60 1283 747 667 
L1AD234 AL391992.8 10 TGGCTAGTCACCCTAAAAGA    GTTTTATAGGCTTGCATTGG FP 60 55 6487 388 360 
L1AD235 AL160234.3 14 GGAGCTATTAAGCCACAAAA GAGAGGGTATCCTCGTCTTA FP 55 60 6771 694 326 
L1AD236 AL079307.7 14 GAATGGGGAATTATACGTGA GTAAGGCACTTGGAAATGTG FP 60 60 6260 196 295 
L1AD237 AL162431.17 1 AAGTGAATGTGGATTTACCC TCTCAAGGAAATCAGCTCTT FP 60 60 6499 435 324 
L1AD238 AL389895.3 14 ACTTTTATGCCTGAAACCTG ATCCTTTCTCAGAGGGATCT FP 60 60 6370 325 278 
L1AD239 AL357045.10 1 INSERTED IN REPEATS R      
L1AD240 AL591770.1 14 GTCTCAGACACACAAGCTCA TTGGCCACTCATCTATCTTT HF 60 60 540 222 258 
L1AD241 AL512310.3 14 INSERTED IN REPEATS R      
L1AD242 AL136960.4 13 CCCCTGAAGAGTCCATATAA CCTAACAGTCAGGAAAGCTG FP 55 55 6347 288 197 
L1AD243 AL445466.9 1 CTGCTTGTCTTTGGTCTGAT GTGATCCTGTAGGCCTTCTT FP 60 60 2933 410 1229 
L1AD244 AL512790.1 14 GCATCCGTTTCTCTGATG TGCAGATTGTACAGAAAAGC FP 60 60 1394 166 296 
L1AD245 AL136295.3 14 ACTTTAGGATTCCGTGGTTT AATGCTGTTAGAGGAGGATTC FP 55 60 2193 482 222 
L1AD246 AL391838.9 13 INSERTED IN REPEATS R      
L1AD247 AL512662.8 UNK INSERTED IN REPEATS R      
L1AD248 AL138694.18 UNK INSERTED IN REPEATS R      
L1AD249 AL133241.3 14 INSERTED IN REPEATS R      
L1AD250 AL121852.3 14 CCCTCAAGAACGATTTTATG TGTCTAGAATGTTCCCCTTT FP 60 60 6397 280 237 
L1AD251 AL117191.6 14 CTGTGGAGGAAACATTGAAG TCACACTCAAAGACTCCTTTC IF 60 60 1995 172 288 
L1AD252 AL590370.2 6 GTGAAGGGCACTGGTTATTA TAATGAAATCGGACCTGTCT FP 60 60 6498 408 202 
L1AD253 AL163613.2 14 TTGCCTAGCTTTTCTACCAG TTCAAGCTACCTTCTCAAGC IF 60 60 1369 726 180 
L1AD254 AL118557.5 14 ACCTTGACATTCCTGCAA AATCCACCTGCAGACATTAC FP 60 60 1000 143 514 
L1AD255 AL117693.5 14 TCATTGTTCTATCCATGCCTTTT GTAGGTTTGGGGCTGGAAAT IF 55 60 961 197 228 
L1AD256 AL161804.4 14 INSERTED IN REPEATS R      
L1AD257 AL359545.12 10 INSERTED IN REPEATS R      
L1AD258 AL358293.4 14 GGTTCAATTGAGCGTTACTT TGCTGATATAGCACCTAGCA FP 60 60 6800 735 300 
L1AD259 AL158111.5 14 INSERTED IN REPEATS R      
L1AD260 AL133238.3 14 GGTGGATGTATCCATTGTTT TTTATGCATGCAAGAAATGA FP 55 55 627 436 464 
L1AD261 AL049838.3 14 CTATGGACCCATCTGACTGT AGTTATTAAACCGGCCACTA FP 60 60 6269 222 245 
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L1AD262 AC006568.7 4 ACACGGAGACACTTCAAATC ACCCGTTATTGTGTTCAGAC FP 60 60 6424 363 407 
L1AD263 AL355481.12 13 GGCTACTTTGGCTTCTGTAA ATTTGCTCAAACATTTCTGG FP 55 55 5616 511 531 
L1AD264 AL031681.16 20 GGGGAAGTTCCTCCTATATT AAATGGTAGGTTGGTTTATCA IF 60 60 1699 501 350 
L1AD265 AL589693.3 6 ATAAATTTTCAGGCCTTTCC GAACAAATTAGACACCATAAGGA FP 60 60 6218 172 189 
L1AD266 AL365508.19 6 INSERTED IN REPEATS R      
L1AD267 AL445258.4 X INSERTED IN REPEATS R      
L1AD268 AL034425.9 20 GTTTAACCCAGCTGTCCAT TCCTGTCTCATTTGCTTACC FP 60 60 2022 361 395 
L1AD269 AL136090.12 20 TGACATGGGAGCAATAATAGT CAGGTGAAATGTATTGAAGGA FP 55 55 1933 315 371 
L1AD270 AL135936.11 20 INSERTED IN REPEATS R      
L1AD271 AL390057.12 6 INSERTED IN REPEATS NR      
L1AD272 AL161901.18 13 INSERTED IN REPEATS R      
L1AD273 AC006947.2 17 GCCTGCTACATGTTCAGAT CCATCCTTTCTGGAGTGAT FP 60 60 6252 214 243 
L1AD274 AL161938.6 20 INSERTED IN REPEATS R      
L1AD275 AL157380.15 X INSERTED IN REPEATS R      
L1AD276 AL031679.1 20 ATTCTTCCTGCCACCTTATG TTAATAGCTGAGCATCATGG FP 60 60 993 492 372 
L1AD277 AC006265.1 17 GTACAAACCATGGACCAGTT    ATGCAAGTATTTGGCATCTT FP 55 60 6451 386 239 
L1AD278 AL121757.7 UNK INSERTED IN REPEATS R      
L1AD279 AL157881.14 UNK INSERTED IN REPEATS R      
L1AD280 AC006131.1 UNK INSERTED IN REPEATS R      
L1AD281 AF036938.1 X CAGAGTGAAGTGCTTGGTTT CTTAATATTTGGGCCATGC NR 60 55 1342 494 590 
L1AD282 AL450303.10 1 NO RESULTS NR      
L1AD283 AL358434.16 UNK INSERTED IN REPEATS R      
L1AD284 AL357141.8 6 NO RESULTS NR      
L1AD285 AL359252.17 6 ATCCAATCACCATCATCAGT ACCTGTGTTCCTATCTTTGC FP 55 55 823 423 272 
L1AD286 AL354937.12 9 TTTAACAACGCACACTTAGC ATTAAGCAATGGCAGGAAT FP 60 60 1385 337 444 
L1AD287 AL356430.19 13 TTGAAATCAATAATGAGGGATA AACATCAGTCAGCTAAAGCA FP 55 55 518 277 256 
L1AD288 AL121574.19 UNK INSERTED IN REPEATS R      
L1AD289 AL390039.10 UNK INSERTED IN REPEATS R      
L1AD290 AL158167.15 10 CCATGCCTCAACATCTCA ACCTTCCTTATCTTCCCTTG IF 60 60 750 175 237 
L1AD291 AL157398.6 10 TGGAAAAATATCCCATAATGA TTTCAGATGGTTTTTCAACA FP 55 55 6277 180 311 
L1AD292 AL136970.8 6 GGCAAATTGAGTCAAAGATG AACTCATTCACAGTAGCAACAA FP 60 60 6281 206 200 
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L1AD293 AL136117.12 6 TGGGAATCAGGAAATTTAAC CCTATTTCTTGGGTTTTCTG FP 60 60 2300 199 429 
L1AD294 AL356286.8 X INSERTED IN REPEATS R      
L1AD295 AL158201.19 X AAAGAAAGAAAACACCCACA CTCACGTATTATTCCGATTTG NP  60 2579 245 699 
L1AD296 AL136441.16 13 AACCAAGGACTTACACATGC ACTACCACTCATCCAGCAAA FP 60 60 6518 461 261 
L1AD297 AL357499.10 UNK INSERTED IN REPEATS R      
L1AD298 AL136455.6 1 TGCCACATCTGTTCAGTAAA GAAATAGGCTCGTTTTCTCT FP 60 60 1906 399 351 
L1AD299 AL359502.14 13 TTAATGCAAGCAGAGTTTCC TAAGAACCCATGGTCCAGTA FP 60 55 6269 180 291 
L1AD301 AL139334.10 6 AGTTGTCTGAGGAAACACCA TACGCAGCATCAAGTAAAGA FP 60 60 1823 700 288 
L1AD303 AL139092.12 6 INSERTED IN REPEATS R      
L1AD304 AC005358.1 17 ATCAGTGGTTCTTTGTCCTG AGCAGTTCACAGTCCTTAGC FP 55 55 1230 226 248 
L1AD305 AC004768.1 5 GCCAGGAGATAATTTGTAGC TACCTTGCCAGTAACCTTCT FP 60 60 2726 386 330 
L1AD306 AC004389.1 X END OF CONTIG EC      
L1AD307 AC004074.1 X INSERTED IN REPEATS R      
L1AD308 AC004523.1 UNK INSERTED IN REPEATS R      
L1AD309 AL138702.8 13 GCATTGCAGAAGAAAGCTA TACCTCCAAGGCAAAACTTA FP 60 60 1547 273 293 
L1AD310 AL121946.20 6 CAACACACGTACAGGTATGC TTAGCCTCTGTCTTTTGTGC IF 60 55 6557 519 372 
L1AD311 AL135932.7 11 TGACCTGTTCTGATGATTGA CTTCTCAGGGTATCTGTCCA FP 55 55 2281 271 327 
L1AD312 AL136086.8 1 TTGGGGATAACTTTAACTGC CCTTTTCATCCTCATGTTTT IF 55 60 6284 228 209 
L1AD313 AL137026.21 10 GCAGGAGAGAGTAAAGGGTTA TGACAACCACTGCTATCAAG FP 60 60 1382 86 165 
L1AD314 AL121938.10 6 GGCTCAGGGAGATTTGATA TCTGTTGTACTCTTTCAGGAACT FP 60 55 3462 311 322 
L1AD315 AL121933.15 6 GGTAACTAAAGCCATTGCAG TATCTTTGGATGCTGCATAA FP 55 55 2636 429 316 
L1AD316 AL133547.16 9 INSERTED IN REPEATS R      
L1AD317 AL157378.8 6 INSERTED IN REPEATS R      
L1AD318 AL355871.5 1 TGTGGCTAATTCTGAGACCT ACATGAGTTATCGTGGCATC IF 60 60 631 176 175 
L1AD319 AL157361.6 13 CCCAATGAACCTGTTGTAGT GGATTTACATGCCACTTAGG FP 55 60 392 188 241 
L1AD320 AL157360.8 UNK TCCAATGTTCTCTTAGAGGAGT TCAACATGCAAAAGACTGAA FP 60 55 489 114 248 
L1AD321 AL139115.5 9 CTTGTCCATTTTCTCCACTG CAACCCAGTAACTCCACTTC FP 60 60 1193 80 200 
L1AD322 AL049796.28 1 TTCTTCCTGGAAAATTGCTA TTCCTATGAATCCAGTAGTGC FP 55 60 6512 434 251 
L1AD323 AL117345.21 6 GATGGCTTCAAATCCTTCTT CACTTCAGATAGAACAAGAGCA FP 60 55 3744 395 379 
L1AD324 AL109920.15 6 TATCATTCCTTCAGGCCATA GGTGAATGCTTTGGACTTTA FP 55 60 1568 249 280 
L1AD325 Z98950.1 X TCGGCAGCACATATACTAAA TCCATAGCCAAGTGAGTTTT FP 60 55 1001 207 283 
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L1AD326 AL050309.4 X INSERTED IN REPEATS R      
L1AD327 AL030998.1 X AAAACATATTTGGAGGAGCA GTGACCTGGTGTTTTTGTCT FP 55 55 6315 202 314 
L1AD328 AL133353.6 10 TGCTAATAAAAGCACTCTGAAA AAGATGGTGAATGTTGTAGGA FP 55 60 2610 155 284 
L1AD329 AL136169.6 UNK INSERTED IN REPEATS R      
L1AD330 AL133404.8 6 INSERTED IN REPEATS R      
L1AD331 AL136363.4 X ATTTCTTCTGCAGCTCTGAC CATGATAACTTTGGTTTGTCAC FP 60 60 6213 188 279 
L1AD332 AL133247.1 2 TGACTGACCACTGTATGGAA GTGGCTGTTTGGATTCTTTA FP 60 60 1399 204 247 
L1AD333 AL078604.10 6 INSERTED IN REPEATS R      
L1AD334 AL021877.1 22 TTGACTTGTTTAGAAAGGGATT GGATAAAGCTGAAAGCTCAA FP 55 60 6322 233 215 
L1AD335 Z70758.1 X TCATCCAGCATTGAATCAG TTGGTAGAAAGTGAAGTGGAG FP 60 60 571 199 238 
L1AD336 AL096706.10 UNK INSERTED IN REPEATS R      
L1AD337 AL049589.15 X INSERTED IN REPEATS R      
L1AD338 AL021069.1 1 AAGAATCCAATTTGCAACAG TTTGATTCGGATTACACTGA FP 60 60 6248 173 233 
L1AD339 Z97181.1 X GTTAAAATGCCAGGCTGAT TGAGAAATGTGTTCTCCAAA FP 55 55 1169 136 349 
L1AD340 AL031117.1 X INSERTED IN REPEATS R      
L1AD341 AL034348.5 6 TGACTTCCATTTCAGGTACTC CCACATTAGAGGTTTTCCAA FP 55 60 4229 143 293 
L1AD342 AL022399.2 1 TATGCATTTCCATGACTTGA GTGGTAGGAGTAGGGGAAAG FP 60 60 6795 342 708 
L1AD343 AL033530.1 1 INSERTED IN REPEATS R      
L1AD344 AL031313.1 X INSERTED IN REPEATS R      
L1AD345 AL023806.1 6 AGTACCAATGAAGTGCCATT CAGGAGCATAAATAGGACCA FP 60 60 1770 379 500 
L1AD346 Z80232.1 X CGGAAAATCCTCAGTCATC ATGCCACAGCTTAAAAGTTC FP 60 60 1065 261 309 
L1AD347 Z84720.1 X INSERTED IN REPEATS R      
L1AD348 Z93018.1 X NO RESULTS NR      
L1AD349 Z99128.1 6 AGCACTCCTTTTATGAAGTCAACC AGAGGAGAGAGTGGTTGATATTGG FP 55 55 2851 1223 565 
L1AD350 Z82170.1 UNK GGCAGACCAAATGGATTAT GATCCAAATATCAGACAAAATGT FP 55 60 6342 288 184 
L1AD351 Z95126.1 X TGACATGCTTCCCTAAGTTT TATAGAAAGTGAGGCCCAGA FP 60 60 537 363 313 
L1AD352 Z95325.2 X CTTGCTGAATTAATCCCTTT GGAAGAAATGATCCATAAGAAA FP 55 55 3497 355 346 
L1AD353 AL022308.1 X CAAGGGGAAATCTCACAATA GGACTTTGGGACTTACATCA PARALOG 55 60 6238 174 263 
L1AD354 AL023095.1 X TCATCTTGCTCCCAAATATC TCCTTAACACAGTCAAGTGAAC FP 60 60 4839 170 338 
L1AD355 Z98948.1 X NO RESULTS NR      
L1AD356 AC000111.1 7 TGTGGCTATGTGAGATGAGA    CCTTAATTTGAGGGGTTTTT FP 55 55 4633 326 385 
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L1AD357 AP004241.2 11 CATAGGACGTTCAAGTGTGA ATTGTCTATGGCTGCTTTCT FP 60 55 765 387 593 
L1AD358 AP002803.3 11 AGGTTTTGAGGTTTGCTGTA   TCCCAATAATCACTTTCCAC FP 55 55 6274 205 264 
L1AD359 AP002002.4 11 AAGGGCATATAAAACTGGTG GCACCCATTAACTCATCATT FP 55 60 6460 356 328 
L1AD360 AP000764.4 11 CCATGCTTTCCACTCTTTAT GCAGAAAAGGGTGTTCATA FP 60 60 379 179 240 
L1AD361 AP002784.3 11 GGAAAAATGACAGTCAGGAG GCCTACCCAATGAATATCCT HF 60 60 1031 149 258 
L1AD362 AP003719.3 11 INSERTED IN REPEATS R      
L1AD363 AP000811.4 11 CCATTACTTGAAGCAGAACC CTGTGGGTCTCAGATCATTT FP 55 55 6419 367 175 
L1AD364 AP001977.4 11 TAAACTGGGGCTAGAAGTCA CCAATTGAGAACCATCTTGT FP 55 55 6335 383 344 
L1AD365 AP002982.2 8 ACAGAGATTTCCTGGGCACT TCAAACTGCATGCAAAATCC FP 55 55 811 109 208 
L1AD367 AP000789.4 11 CCAACAGGGATCAAAGGTTC GCCACCTTGAGTTGGTGAAG FP 55 55 378 147 175 
L1AD368 AP002006.5 11 TTTCTTTTCCTACTCTCCCTCTC GAGAAATAAAGGCAATTGCTCAC NP  55 4593 186 922 
L1AD369 AP001485.4 11 AAAACATATAAGCGGCCAAC CAGCACCTGTTATGGTTTGA FP 60 55 2437 466 187 
L1AD370 AP000462.2 11 TAAGAAGAGGGGAGGAGACT GCCTCTATGAAGCAGGTATG FP 55 60 793 178 237 
L1AD371 AP001709.1 21 CTAAATTGCTCCATTCCTTG ATCACTGTAGGGTGATCCAG HF 55 55 2525 581 562 
L1AD372 AP001678.1 21 CTTACGCCTCAATTATCTGG TGCAATTGATCTTACAAGGA FP 55 55 2325 280 269 
L1AD373 AP001674.1 21 CAAATAGCCAGCACAATATG TTGTCATTGGTCTTTTGTCA FP 55 60 823 165 226 
L1AD374 AP001669.1 21 INSERTED IN REPEATS R      
L1AD375 AB009801.1 14 AATCCACCTGCAGACATTAC AGAACATCCCCTATCCAAAC FP 55 55 688 87 202 
L1AD382 Z95325.2 X INSERTED IN REPEATS R      
L1AD383 AC090791.6 11 TGGTGGTCTCAGAGTAAACA ACCCAAAACATCATTAGTGC FP 60 60 1642 117 1026 
L1AD384 AL136441.16 13 INSERTED IN REPEATS R      
L1AD385 AP003123.2 11 GCACAGGTTTATCTCCTTGA ATTGAAGACCTGCAATTTGT FP 55 55 6379 284 287 
L1AD386 AC114975.2 5 INSERTED IN REPEATS R      
L1ADY8 AC010970.3 Y TCACACGTATCCCTTTGCAG TTTTCTGTGAAACATCTTGGAGA FP 55 55 1813 115 204 
 
* Indicates L1 preTa element identified by Ovchinnikov 2002  
 
1. Chromosomal location was determined from Accession information or by PCR analysis of NIGMS monochromosomal hybrid cell 
line DNA samples.  L1 elements with unknown locations are denoted UNK.  
2. Elements at the end of sequencing contigs are denoted (EC), those residing in other repeats (R), those having paralogs 
(PARALOG), and elements with inconclusive PCR results (NR).   Elements represented here are classified according to allele 
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frequency as: high frequency (HF), intermediate (IF), No pre-integration site in primate samples tested (NP), or as fixed present (FP) 
insertions.  Fixed present: every individual tested had the LINE element in both chromosomes.  Intermediate frequency insertion 
polymorphism: the element present in more than 30% of alleles tested and no more than 70% of the alleles.  High frequency 
insertion polymorphism: the element is present in more than 70% but not all alleles tested.  Indeterminable data is denoted (-). 
3. Amplification of each locus required 2:30 min @ 94°C initial denaturing, and 32 cycles for 1 min 94°C, 1 min Annealing  
    Temperature (A.T.), and 1 min elongation at 72°C.  A final extension time of   
   10 min at 72°C was also used. 
4. PCR product sizes: Empty product size is calculated computationally by removing the L1 preTa elements and 1 direct repeat from 
identified filled site.  Subfamily specific product size is calculated from internal subfamily specific primer located in the 3’ UTR to 
the proximal 3’ primer.  In cases where target site duplication sequence were not found flanking the element PCR product sizes may 
vary from those reported.   
 
Table 4 - Autosomal preTa L1 allele frequency and heterozyosity. 
 
African American Asian/Alaskan Natived German Caucasian Egyptian   
Genotypes Genotypes Genotypes Genotypes 
Elements  +/+ +/- -/- fc Ha +/+ +/- -/- fc Ha +/+ +/- -/- fc Ha +/+ +/- -/- fc Ha AHb 
L1AD10 0 5 14 0.13 0.23 0 8 12 0.20 0.33 3 7 7 0.38 0.49 3 7 10 0.33 0.45 0.37 
L1AD14 9 10 1 0.70 0.43 4 8 7 0.42 0.50 16 4 0 0.90 0.18 17 2 1 0.90 0.18 0.33 
L1AD19 13 7 0 0.83 0.30 15 2 0 0.94 0.11 14 6 0 0.85 0.26 14 6 0 0.85 0.26 0.23 
L1AD20 18 2 0 0.95 0.10 19 1 0 0.98 0.05 16 0 0 1.00 0.00 19 0 0 1.00 0.00 0.04 
L1AD75 0 5 15 0.13 0.22 0 1 18 0.03 0.05 1 9 9 0.29 0.42 0 9 11 0.23 0.36 0.26 
L1AD77 1 5 11 0.21 0.34 0 1 19 0.03 0.05 0 3 13 0.09 0.18 0 6 12 0.17 0.29 0.21 
L1AD82 19 1 0 0.98 0.05 17 0 0 1.00 0.00 20 0 0 1.00 0.00 19 1 0 0.98 0.05 0.03 
L1AD96 13 5 2 0.78 0.36 15 1 0 0.97 0.06 5 10 5 0.50 0.51 11 7 2 0.73 0.41 0.34 
L1AD100 19 0 0 1.00 0.00 19 0 1 0.95 0.10 20 0 0 1.00 0.00 20 0 0 1.00 0.00 0.02 
L1AD101 16 4 0 0.90 0.18 10 5 0 0.83 0.29 13 6 1 0.80 0.33 11 9 2 0.70 0.43 0.31 
L1AD102 14 0 0 1.00 0.00 14 1 0 0.97 0.07 12 1 2 0.83 0.29 0 4 16 0.10 0.18 0.13 
L1AD125 12 7 1 0.78 0.36 14 6 0 0.85 0.26 20 0 0 1.00 0.00 19 1 0 0.98 0.05 0.17 
L1AD135 19 1 0 0.98 0.05 20 0 0 1.00 0.00 20 0 0 1.00 0.00 20 0 0 1.00 0.00 0.01 
L1AD160 11 5 4 0.68 0.45 5 11 4 0.53 0.51 4 12 1 0.59 0.50 4 8 3 0.53 0.51 0.49 
L1AD176 7 3 2 0.71 0.43 2 9 5 0.41 0.50 0 1 15 0.03 0.06 1 0 11 0.08 0.16 0.29 
L1AD186 4 7 8 0.39 0.49 14 5 1 0.83 0.30 5 10 2 0.59 0.50 4 11 5 0.48 0.51 0.45 
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L1AD189 14 5 0 0.87 0.23 19 0 0 1.00 0.00 20 0 0 1.00 0.00 19 1 0 0.98 0.05 0.07 
L1AD208 14 6 0 0.85 0.26 19 0 0 1.00 0.00 14 0 0 1.00 0.00 14 0 0 1.00 0.00 0.07 
L1AD213 7 9 3 0.61 0.49 2 12 5 0.42 0.50 2 2 5 0.33 0.47 8 5 7 0.53 0.51 0.49 
L1AD219 3 14 3 0.50 0.51 0 10 10 0.25 0.38 1 5 14 0.18 0.30 2 11 7 0.38 0.48 0.42 
L1AD230 14 6 0 0.85 0.26 19 0 0 1.00 0.00 20 0 0 1.00 0.00 20 0 0 1.00 0.00 0.07 
L1AD232 13 7 0 0.83 0.30 8 7 3 0.64 0.47 12 2 0 0.93 0.14 13 4 1 0.83 0.29 0.30 
L1AD240 13 3 0 0.91 0.18 20 0 0 1.00 0.00 13 0 0 1.00 0.00 20 0 0 1.00 0.00 0.04 
L1AD251 3 9 7 0.39 0.49 10 8 2 0.70 0.43 14 4 0 0.89 0.20 8 11 1 0.68 0.45 0.39 
L1AD253 11 6 3 0.70 0.43 0 14 5 0.37 0.48 4 8 7 0.42 0.50 0 6 14 0.15 0.26 0.42 
L1AD255 1 8 10 0.26 0.40 1 9 10 0.28 0.41 6 7 7 0.48 0.51 3 14 3 0.50 0.51 0.46 
L1AD264 4 10 6 0.45 0.51 2 9 8 0.34 0.46 2 7 7 0.34 0.47 3 11 6 0.43 0.50 0.48 
L1AD290 7 12 1 0.65 0.47 4 8 7 0.42 0.50 3 13 0 0.59 0.50 6 9 5 0.53 0.51 0.49 
L1AD310 5 6 7 0.44 0.51 0 5 15 0.13 0.22 5 2 5 0.50 0.52 6 5 7 0.47 0.51 0.44 
L1AD312 0 4 16 0.10 0.18 11 6 2 0.74 0.40 2 9 5 0.41 0.50 2 7 9 0.31 0.44 0.38 
L1AD318 4 12 4 0.50 0.51 2 12 6 0.40 0.49 4 8 8 0.40 0.49 3 11 6 0.43 0.50 0.50 
L1AD361 17 3 0 0.93 0.14 19 0 0 1.00 0.00 20 0 0 1.00 0.00 20 0 0 1.00 0.00 0.04 
L1AD371 15 5 0 0.88 0.22 18 2 0 0.95 0.10 20 0 0 1.00 0.00 20 0 0 1.00 0.00 0.08 
L1AD264 4 10 6 0.45 0.51 2 9 8 0.34 0.46 2 7 7 0.34 0.47 3 11 6 0.43 0.50 0.48 
L1AD290 7 12 1 0.65 0.47 4 8 7 0.42 0.50 3 13 0 0.59 0.50 6 9 5 0.53 0.51 0.49 
L1AD310 5 6 7 0.44 0.51 0 5 15 0.13 0.22 5 2 5 0.50 0.52 6 5 7 0.47 0.51 0.44 
L1AD312 0 4 16 0.10 0.18 11 6 2 0.74 0.40 2 9 5 0.41 0.50 2 7 9 0.31 0.44 0.38 
L1AD318 4 12 4 0.50 0.51 2 12 6 0.40 0.49 4 8 8 0.40 0.49 3 11 6 0.43 0.50 0.50 
L1AD361 17 3 0 0.93 0.14 19 0 0 1.00 0.00 20 0 0 1.00 0.00 20 0 0 1.00 0.00 0.04 
L1AD371 15 5 0 0.88 0.22 18 2 0 0.95 0.10 20 0 0 1.00 0.00 20 0 0 1.00 0.00 0.08 
 
a. This is unbiased heterozygosity.  H=(2*sample size * (1-sum of homozygotes))/(2*sample size – 1) 
b. Average heterozygosity is the average heterozygosity for all populations. 
c. f represents the frequency of the element.   
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